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Abstract 
 Molybdenum-dependent xanthine oxidoreducatases (XOR) are a family of well 
characterized enzymes which are known to oxidise purines, imines and aldehydes in cellular 
metabolism. Despite significant studies relating to drug metabolism, application to chemical 
synthesis is relatively unexplored.. 
 Herein we report the first use of XORs in the cascade synthesis of carboxylic acids 
from activated and unactivated alcohols by the combination of the mutant alcohol oxidase 
GOaseM3-5 and XOR (E.coli XDH & PaoABC). Twenty five carboxylic acids were obtained in 
quantitative conversion and the methodology compares very well with state-of-the-art catalytic 
chemical oxidation methods. The reactions were performed in water at ambient temperature and 
pH using oxygen as the terminal oxidant with the only by-product being H2O2. The oxidation 
system was also applied to the synthesis of the biomass-derived platform chemical FDCA 
starting from HMF. The biocatalysts used were able to tolerate a substrate concentration of 100 
mM, 20 times higher than previous reported methods with 74% isolated yield of FDCA.  
Although XORs exhibited a wide substrate scope, no chiral selectivity could be demonstrated. 
 The application of XOR enzymes was also demonstrated in the synthesis of lactams 
from amino alcohols via an in situ generated imine intermediate. Although pyrrolidone was 
obtained in 85% yield from its corresponding amino alcohol, longer chain amino alcohols were 
not well tolerated with either poor or no conversion observed. Although currently limited in 
substrate scope, this novel biomimetic oxidative cyclisation represents an interesting synthetic 
approach to lactams, found in a wide variety of biologically interesting target molecules. 
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Chapter 1 
1.0 Introduction 
1.1 Biocatalysts in pharmaceutical and fine chemical industries  
Biocatalysts are increasingly being used to catalyse key steps in synthetic routes to complex 
molecules of industrial interest1-4. Enzymes facilitate the synthesis of complex organic 
molecules by chemo- regio- and stereoselective bond forming and breaking reactions. The 
enantioselective and regioselective power of enzymes make them an ideal match for the 
pharmaceutical and fine chemical industry.  
Thirty years ago the scope of biocatalysis did not extend far beyond esterification or 
hydrolysis. This was mainly due to the fact that the availability of enzymes was limited as 
efficient cloning systems were not available. However, today with the emergence of enabling 
technologies such as genome mining, directed evolution and homology modeling, this is no 
longer the case. Powerful C-C, C-N, C-O forming enzymes such as aldolases, 
hydroxynitralases, lyases and redox enzymes such as oxidases and reductases are now generally 
available5-8. 
The pharmaceutical market is one of the most important driving forces for innovation in 
biocatalysis. 54% of drug molecules are chiral and resolution remains an important and cost 
effective approach to chiral molecules9. With the emergence of enabling technologies such as 
large scale DNA sequencing, structural biology, protein expression, high throughput screening, 
directed evolution and metabolic engineering, biocatalysts can contribute significantly to the 
synthesis of active pharmaceutical ingredients (APIs)10-12. Incorporating biocatalysts can 
provide more efficient, atom economical and less hazardous synthetic routes, thus reducing 
capital costs. 
Second generation manufacturing processes for pharmaceuticals requires substantial 
resources and so efficient catalytic methods are highly desirable. The first generation 
manufacturing process for the anticonvulsant drug, pregabalin (1) was executed as a racemic 
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synthesis, followed by a late stage classical resolution with mandelic acid. This was required to 
obtain the API in high optical purity (99.5%)13. Although this route was cost effective, there 
were possibilities for improvement such as the use of an early (as opposed to late stage) 
resolution of enantiomers but also recycling of the unwanted enantiomer. To this end, a chemo-
biocatalytic route was developed for the second generation manufacturing process (Scheme 1). 
 
 
Scheme 1: Chemical vs biocatalytic synthesis of Pregabalin13. 
 
For the first generation synthesis, compound 2 was identified as a key intermediate 
which was converted to racemic ester 3 in a three step  reaction sequence that includes 
hydrolysis, reduction and a decarboxylation step. The racemic pregabalin ester 3 was then 
resolved using (S)-(+) mandelic acid in a three-stage crystalisation procedure. However, due to 
the resolution step being carried out on a late stage intermediate, the overall efficiency of the 
process was poor. The use of hydrolases for the synthesis of chiral compounds has been 
extensively reviewed and their application at large scale has also been reported14,15. To increase 
efficiency, an enzymatic kinetic resolution using the commercially available Lipolase® was 
developed using the same key intermediate 2 previously used in the first generation synthesis. 
Stereospecific hydrolysis of 2 led to the mono acid 5 with 45% conversion and > 98% ee. With 
the kinetic resolution being carried out at an earlier stage, the unwanted enantiomer 6 could be 
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recycled by base-assisted racemisation of the nitrile. The elegance of this process is that the 
diastereoselectivity in the desymmetrisation at the prochiral C-2 center is irrelevant as the 
stereochemistry at C-2 is destroyed while converting 5 to Pregabalin 1. Therefore the 
enatioselectivity of the kinetic resolution is more important. This new bio-chemo based 
synthesis combined with the recycling of unwanted enantiomer 6 resulted in higher yields of 
Pregabalin (40-45%), compared to the first generation manufacturing process (18-21%).  
 Another example of process improvement using biocatalysis was for the synthesis of 
atorvastatin 11. Atorvostatin is the active ingredient in Lipitor. The key building block in the 
synthesis of atorvastatin (11) is ethyl (R)-4-cyano-3-hydroxybutyrate 7 (Scheme 2). 
 
 
Scheme 2: Lipitor Synthesis16 
 
First generation synthesis of 10 started with Claisen condensation of 7 to 8, borane-chelation 
controlled reduction of 8 to 9 with both steps under cryogenic conditions, followed by acetal 
protection of the two hydroxyl groups and subsequent Ni-catalysed nitrile reduction to form 10. 
Paal-Knorr condensation of 10 with a diketone provided the final API16. To replace the 
hazardous reagents, cryogenic conditions and mixed solvents used to furnish 9 from 8, a 
reductase Ox-28 from Candida magnoliae was used as a lysate stabilized with IPA for the 
biotransformation. Upon reduction, the atorvastatin intermediate 9 was formed with 100% 
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diastereoselectivity compared to chemical methods, which furnished a mixture of cis and trans 
products (Scheme 3)17. 
 
 
Scheme 3 Enzymatic reduction of intermediate 817 
 
Further improvements of this process were made with the biocatalytic installation of the 
stereocenter and cyano functionality of the key building block hydroxy ester 7.  Although the 
original synthesis of 7 was high yielding, many toxic reagents such as sodium cyanide and HBr 
were used as well as harsh hydrogenation conditions16. To circumvent these harsh conditions, 
Dowpharma exploited the inexpensive starting material, epichlorohydrin 12 leading to an 
enzymatic desymetrisation of bisnitrile 13 (Scheme 4). The nitrilase was able to tolerate 
substrate concentration of 3M and the stereoselectivity of the biocatalyst was able to be tuned to 
99% by applying gene site saturation mutagenisis18. This method led to a significant reduction 
of by-products, toxic wastes and organic solvents associated with chemical routes. 
 
 
Scheme 4: Biocatalytic alternative to key intermediate 718 
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Biotransformations are also used to manufacture products on a scale of several 100s to 
10,000 tons per year. Acrylamide is an important example where the chemical route has been 
abandoned and replaced by a biocatalytic approach. The chemical process for acrylamide 
involves the hydration of acrylonitrile by using copper catalysis at 70-120°C, resulting in large 
amounts of waste, including HCN.  Under these conditions acrylamide tends to polymerise and 
undergo further hydrolysis to the acid. A hydralase of Rhodococcus rhodochrous J1 was able to 
produce acrylamide in higher yield at a concentration of 400g L-1 at 10°C. 19,20.  
Overall the substitution of chemocatalysis by biocatalysis has many advantages in 
industry. Enzyme reactions are usually carried out at ambient temperature and pH. Organic 
solvents can be replaced with water and thus may provide a greener process. However, wild 
type enzymes often exhibit low industrial applicability as a natural enzyme often lacks substrate 
promiscuity and also will tolerate only low substrate concentrations. Moreover, enzymes can 
provide new synthetic routes by exposing synthons which cannot be obtained by classical 
chemical methods21. High chemoselectivity can circumvent the use of protection and 
deprotection stratagies and so atom economy can be satisfied as additional chemical steps are 
not required. 
It is evident that a major driving force in biocatalytic innovation stems from the 
pharmaceutical and fine chemical industry. Green alternatives to chemocatalysts are required to 
provide sustainable synthesis of commercial products. However, extensive enzyme 
modifications are necessary to fine tune wild type enzymes for a chemical process by expanding 
their substrate scope or increasing their stability. To accomplish this task, it is necessary to 
understand the biological and chemical properties of these biocatalysts. 
 1.2 Biocatalysts 
1.2.1 Enzyme Structure. 
Enzymes are protein macromolecules that have an amino acid sequence, which is 
determined by the DNA sequence of the encoding gene. There are four distinct levels of protein 
structure; primary, secondary, tertiary and quaternary (Figure 1). The primary structure of the 
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enzyme consists of a defined sequence of α-amino acids linked together by amide bonds. Due to 
amino acids possessing both hydrogen bond donors and acceptors, hydrogen bonding occurs 
between residues and side chains giving rise to higher order secondary structure (α-helix and β-
Sheet). The 3D structure of the protein is determined by its tertiary structure in which the 
protein adopts the conformation with the lowest ΔG in which the secondary structures are 
folded into a compact globular structure. This folding is driven by the burial of hydrophobic 
residues (aryl, alkyl chains) within the protein thus pushing the hydrophilic residues (-COOH, -
OH, - NH2, -SH, CONH2) to the surface of the enzyme. Other non-covalent interactions such as 
salt bridges, van der walls interactions, π-π stacking and also covalent disulfide bonds 
contribute to the stability of the proteins tertiary structure.  
 
 
Figure 1 Illustration of primary, secondary, tertiary and quaternary structure.22 
 
Finally, some enzymes possess quaternary structure. Quaternary structure is the three 
dimensional structure of a multi subunit enzyme and how it fits together. These subunits interact 
with each other with the same non-covalent interactions and disulfide bonds as tertiary 
structure. 
 Due to the weak forces holding the enzyme together, they are unstable in solution and 
can be deactivated easily by denaturation as a result of high temperature, salt concentration and 
extreme pH23. Functional groups of amino acid side chains asparagine and glutamine can be 
hydrolytically cleaved to give aspartic acid and glutamic acid respectively.  As a result a new 
Introduction! ! Chapter!1!|!Literature!Review!
! 7!
negative charge is created from a neutral group of the enzyme ie –COO- from –CONH2 and in 
order to become hydrated it forces a rearrangement of the enzyme’s structure. Thiol groups may 
also interchange with disulfide groups and finally elimination and oxidation reactions will also 
force permanent conformational change in the enzyme resulting in irreversible deactivation. 
Many enzymes are stable to high temperature and also to organic solvents24. These enzymes 
possess fewer asparagine and more salt or disulfide bridges, which increase their stability. 
 
1.2.2 Mechanistic aspects of biotransformations. 
Enzymes are remarkable catalysts and their rate enhancements range 5-17 orders of 
magnitude. The distinguishing feature of an enzyme catalysed reaction is that the reaction takes 
place in a confined space in the enzyme called an active site. The surface of the active site is 
lined with different amino acid residues and sometimes metals and organic cofactors which 
interact with the substrate and catalyse chemical reactions. 
 As in every catalytic reaction, an enzyme accelerates the rate of reaction without 
affecting the equilibrium. A simple enzymatic reaction can be seen in Figure 2.  
 
 
 
Figure 2 Simple enzymatic reaction where E = Enzyme, S = Substrate, ES = Enzyme-substrate 
complex, EP = Enzyme-product complex and P = Product 
 
Any reaction, chemical or biocatalytic, can be described by a reaction coordinate diagram 
(Figure 3). The starting point for either the forward or reverse reaction is called the ground state. 
If the difference between the free energies of the substrate and product is negative then reaction 
favors product formation. However, favourable equilibrium does not necessarily mean 
conversion will occur at a detectable rate. 
E S ES EP E P
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Figure 3 Reaction coordinate diagram comparing enzyme catalyzed and uncatalysed reaction22 
 
Enzymes lower the activation energy by stabilising the transition states or by supplying an 
alternative reaction pathway. Lowering the activation energy of the system will allow the 
reaction to progress faster, increasing the reaction rate. Computational models suggest that 
transition state stabilisation is the largest contribution to catalysis by enzymes25.  
 In 1984, Emil Fischer proposed the lock and key mechanism26. He believed that 
enzymes are structurally complementary to their substrate. Given his rationale, substrates 
smaller than the natural substrate should have a higher rate of reaction due to a larger active site. 
However this is not the case. Furthermore an enzyme completely complementary to its substrate 
would be a very poor enzyme as shown in Figure 4 (a). In order to accommodate the transition 
state, covalent bonds need to rearrange. However, this would not be possible and the substrate 
may not be able to escape the ES complex which has a negative ΔG. A more feasible 
mechanism in which enzyme must be complementary to the transition state was proposed by 
Haldau (1930). The new [ES] has a positive ΔG and so will not be trapped in the active site. 
Additional energy is required however to turn S into P. This energy requirement is paid for in 
binding energy.  
 Binding energies are a major source of free energy used by enzymes to lower the 
activation energies of reactions. Enzymes are at least 100 times larger than common chemical 
catalysts. This allows enzymes to totally engulf their substrate and position their catalytically 
active residues close to the substrates reactive group, thus reducing entropy 
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Figure 4 A) Representation of an uncatalysed reaction. B) Enzyme with active site 
complementary to substrate. C) Enzyme with active site complementary to transition state22 
 
Constraining the motion of reactants has many rate enhancement affects. A chemical example 
of this is intramolecular vs intermolecular substitution reactions. Also the formation of weak 
bonds between substrate and enzyme results in desolvation of the substrate. Enzyme-substrate 
interactions replace most or all hydrogen bonds between substrate and water. Finally the 
enzyme itself can undergo a conformational change. On approach of the substrate, the enzyme 
can change its conformation and make the binding site more complementary to the substrate. 
This is known as the induced fit model and was postulated by Daniel Koshland27. Induced fit 
serves to bring specific functional groups of the enzyme into contact with substrate to catalyse 
the reaction (Figure 5). 
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Figure 5 Induced fit model 
 
 Once a substrate is bound to an enzyme, properly positioned catalytic functional groups 
aid the cleavage and formation of bonds. These interactions provide an alternative low energy 
reaction path which lowers the activation energy further. Amino acid residues such as Glu, Asp, 
Cys, His, Ser and Tyr can participate in acid-base catalysis and also as nucleophiles or 
electrophiles creating transient covalent bonds. The active site can also contain metals that can 
stablise the transition state via ionic interactions or can participate directly in oxidation or 
reduction pathways. 
 The binding energy that provides energy for catalysis discussed previously also gives 
rise to the enzyme specificity. Anabolic enzymes are known to have quite high substrate 
specificity whereas catabolic and detoxification enzymes tend to be broader. 
 The space restriction imposed by enzymes in their active site also give rise to high 
chemo- regioselectivity but also enantiodescrimination which has been rationalized by three 
point  attachment rule first postulated by O. G Ogston3. In the active site, the substrate has to be 
positioned to ensure spatial recognition and high enantioselectivity. As a result, three points of 
contact with stabilising groups on the active site is required (Figure 5). Enantiomer A represents 
an sp3 carbon atom and enantiomer B its mirror image. If the active site is complementary to the 
substrate then optimal binding of the reactive group and efficient catalysis due to the 
stabilisation of its transition state will be observed as shown by enantiomer A.  However, if the 
there is uncomplementary binding as is the case of enantiomer B, then poor catalysis will be 
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observed as the activation energy can not be sufficiently decreased and the reaction of one 
enantiomer will dominate over the other. Prochiral, sp2 carbons28 and also sp3 heteroatoms such 
as phosphorous or sulfur  can be subject to this principle 29. 
 
 
Figure 5 Illustration of enantiomeric recognition by enzyme active site. 
 
1.2.3 Isolated enzymes versus whole cell biocatalysts 
Biocatalysts can be applied in many forms, either as pure isolated enzymes or as part of 
a whole cell system. Enzymes utilized in the 1960s were largely restricted to use in whole cells. 
However, with the emergence of efficient protein purification techniques, the possibility of 
using purified enzymes was realised. The final decision on which biocatalyst preparation to 
employ depends on the type of reaction, the co-factors required, reaction scale and price. 
 A proportion of synthetically useful enzymes require co-factors that provide redox 
equivalents (NAD+/NADP+, NADH/NADPH) or chemical energy (ATP)3. When co-factor 
dependent enzymes are employed as biocatalysts, the stoichiometric addition of their respective 
co-factor is required when using isolated enzymes. However, this addition is expensive and the 
stability of NADPH in solution is low. To this end a whole cell biocatalyst has the distinct 
advantage in that cofactors are regenerated within the cell by microbial metabolism. Other 
important protecting enzymes are also present within the cell which act as a shield against toxic 
side products such as hydrogen peroxide which may destroy the activity of isolated enzymes3.  
 Isolated enzymes are easy to use, often as either lyophilized powder or as a solution. 
Reactions generally proceed with significantly higher reaction rate when compared with whole 
cell reactions. This advantage, when coupled with easy product removal (due to the elimination 
of cell debris), can make the use of isolated enzymes extremely efficient. For redox enzymes, a 
D
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D
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number of cofactor regeneration strategies have been developed so that only catalytic amounts 
of the cofactor is required30,31.  
 NAD(P)+ is required in many enzymatic oxidation processes and its regeneration is 
crucial when using isolated enzymes. When using ADHs, an excess of sacrificial ketone allows 
sufficient regeneration of NAD(P)+ however with the generation of large amounts of alcohol co-
product32. More elegent and atom economical alternatives however have also been developed 
using NADH oxidase as the regeneration catalyst33. NADH oxidases utilise oxygen as the 
terminal oxidant and thus the generates water and hydrogen peroxide as the co-product (Scheme 
5). 
 
Scheme 5 Co-factor regeneration stratagy using NADH Oxidase with an ADH 
 
1.2.4 Limitations of biocatalysts 
 As mentioned previously enzymes can possess extraordinary chemo-, regio- and 
enantioselectivity. However, there are a number of drawbacks associated with  the use of wild 
type enzymes. 
 Most enzymes function at ambient temperature and pH, which can be a limitation. For 
example, the reaction rate of a chemical reaction is too slow at a given temperature. Increasing 
temperature or extreme pH can have a detrimental affect and lead to denaturation although there 
are exceptions where this can be beneficial34. 
 The use of water as solvent allows enzymes to display their highest catalytic activity 
but the majority of organic molecules are poorly soluble and so only very low substrate 
concentrations are possible. The use of organic solvents is desirable to allow high 
concentrations of substrate but at a loss in catalytic activity35. 
 Enzymes are prone to substrate and product inhibition phenomenon, which causes a 
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drop in reaction rate at high substrate and/or product concentration. Substrate inhibition can be 
easily addressed by keeping substrate concentration low, however product inhibition is much 
more difficult to address. 
 Despite enzymes showing remarkable enantioselectivity for a single enantiomer it is 
often very difficult to obtain the opposite enantiomer. In chemical asymmetric catalysis, 
switching the chiral ligand from (S) to (R) will allow a switch in enantioselectivity. However, 
this approach is not possible for enzyme reactions.  
 To combat these limitations, protein engineering has emerged as a useful and efficient 
tool to optimize and remove the limitations of wild type enzymes. Substrate scope, reaction rate, 
enantioselectivity, regioselectivity, chemoselectivty and enzyme stability can all be improved 
by protein engineering. 
1.3 Enzyme optimization 
Despite the clear advantages of enzymes, further improvement of their substrate scope, 
activity, stereoselectivity are paramount to their broader appliciations on an industrial scale. To 
address these challenges, protein engineering by rational design has provided numerous 
successful solutions. Directed evolution has become a method of choice in tackling many of 
these issues however genome mining is becoming an increasingly popular alternative. 
 
1.3.1 Directed Evolution  
Directed evolution involves repeating cycles of gene mutagenesis, expression and 
screening of mutant enzyme libraries in an overall process that simulates natural evolution 
(Figure 6)36. The availability of a suitable high throughput screening of mutants is critical to the 
success of this approach, particularly when using random or semi-random approaches that result 
in large libraries of mutants. 
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Figure 6 General directed evolution strategy36. 
 
1.3.1.1 Directed evolution techniques 
The Polymerase Chain Reaction (PCR) has emerged as a very powerful gene 
amplification technique and can be modified for the introduction of random or specific 
mutations into a target gene36. 
 When the experimental conditions of PCR are altered with the addition of MnCl2 or 
increasing MgCl2 concentration, 2-3 wrong base pairs are incorporated into each replicated 
DNA strand. This technique is called error-prone PCR (epPCR) which targets the entire gene. 
Additionally bacterial mutator strains can be used in which natural mutation is enhanced. These 
approaches have the advantage that structural data for the enzyme is not required. 
In contrast to epPCR, oligonucleotide-based saturation mutagenesis involves 
combinatorial randomization at predetermined sites. However, this requires structural 
information on the enzyme. For improvement of enantio-, regioselectivity and substrate scope, 
the enzyme’s active site is the logical choice for mutations.  
Another gene mutagenesis method is termed DNA shuffling. A family of homologous 
mutated genes are digested by DNase to provide double stranded oligonucleotide fragments that 
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are then ligated to reassemble full length mutant genes (figure 7.0). This allows back shuffling 
for recombination of mutually beneficial mutations 
 
  
Figure 7 Illustration of DNA shuffling techniques36 
 
1.3.2.2 Selected examples of directed evolution 
Low thermostability is a major limiting factor for industrial application of biocatalysts. 
Using epPCR and adding thermal stress to screening processes, mutant laccases were identified 
with improved thermostability37. The thermostability of CALB was also improved by rational 
mutations based on the crystal structure. Hotspot residues were identified by using B-Fit 
analysis which resulted in improved thermostability at 60°C38. 
 Fine tuning enzyme enantioselectivity is challenging considering the small relative 
differences in energy barriers for the activated enzyme-substrate complex between 
stereoisomers. Therefore, rationally designing the enzyme active site through successive single 
amino acid mutations may not provide the desired results. In general, simultaneous mutations 
tend to show synergistic effects rather than additive and so pairs of amino acids are altered in a 
process known as CASTing. By applying this methodology, CALB was evolved to hydrolyse 
stereocomplementary α-substituted carboxylic esters such as 2-arylpropionic acids39. CASTing 
was also used to engineer alcohol dehydrogenase for the asymmetric reduction of prochiral 
ketones such as 4-alkylidene cyclohexanones to produce axially chiral (R)-configured alcohols 
in excellent ee (>99%)40. 
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1.3.2 Genome mining. 
Database mining is another promising strategy to discover new enzymes based on 
genomic and enzyme structure information41. Large amounts of sequence information have been 
deposited in public databases, for example NCBI has more than 6000 genomes and 110 million 
protein sequences. Systematic mining of such databases with bioinformatics tools allows the 
identification of additional enzymes and homologs of characterized enzymes. In addition, 
software such as 3DM has been developed for the accurate homolog-based structure 
prediction42. 
 
1.4 Enzymatic oxidations 
Oxidation reactions represent a cornerstone of organic chemistry providing access to functional 
groups such as aldehydes, ketones carboxylic acids, imines and amides. Traditionally, many of 
these oxidation reactions have been performed using stoichiometric amounts of toxic transition 
metal based oxidants43. Despite the high selectivity and product purity associated with these 
methods, the applicability of stoichiometric toxic and dangerous reagents in fine chemicals and 
pharmaceutical industry is low, as the modern world shifts to green manufacturing44. 
 The term green chemistry was coined in the early 1990s and the concept is paraphrased 
in the following 12 principles45. 
 
1) Waste Prevention 
2) Atom efficiency 
3) Less hazardous/toxic chemicals 
4) Safer products by design 
5) Innocuous solvents and auxiliaries 
6) Energy efficient by design 
7) Preferably renewable materials 
8) Shorter Synthesis 
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9) Catalytic reagents 
10) Design products for degradation 
11) Analytical methods for pollution prevention 
12) Inherently safer process 
 
Green chemistry efficiently utilizes raw materials, eliminates waste and avoids the use of toxic 
and hazardous reagents and solvents. To be able to compare the greenness of a reaction, the E-
Factor developed by Sheldon, represents a simple metric to initially assess the environmental 
impact.  
 Biocatalysts have many benefits to offer green chemisty especially for oxidations. 
Reactions are performed under mild reaction conditions (physiological pH and ambient 
temperature and pressure) with a biodegradable biocatalyst using oxygen as a terminal oxidant 
and producing water as by-product. In addition reactions of multifunctional molecules proceed 
with chemo-, -regio and stereoselectivity generally without the need of protecting groups. This 
can afford a process that is much more step economic with less waste generated resulting in 
better E-Factor ratings. This being said, a general green claim cannot be made for biocatalysis 
since the environmental impact has to be assessed on a case by case basis. 
Enzymatic oxidations have been extensively explored in the last 20 years with many 
green alternatives emerging when compared with classical oxidation methods46,47. Alcohol, 
aldehyde and amine oxidations are all possible using a range of metal free biocatalysts. 
Additionally, selective C-H activation is now possible using heavily engineered cytochrome 
P450 hydroxylases. 
 
1.4.1 Enzymatic alcohol oxidation 
Oxidation of primary and secondary alcohols to their corresponding aldehydes, ketones 
and carboxylic acids are among the most important reactions in organic chemistry. Classical 
chemical oxidising reagents employ toxic metals and include Jones, Sarrette and Collin’s 
reagents. Explosive hypervalent organoiodine reagents (Dess-Martin, IBX) and sulphur 
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oxidations (Swern, Corey-Kim) are available as a metal-free alternative. Other limitations of 
these oxidants include poor regioselectivity and stereoselectivity4. 
 With green principles 45,48 in mind, developments have been made to provide more 
environmentally friendly oxidations. Extensive research has been carried out in the use of gold 
nanoparticles and also N-oxo-ammonium salts such as TEMPO and its derivatives. State of the 
art oxidation of unactivated alcohols has been reported recently by Milstein49 with a novel Ru 
based catalyst in refluxing water. Despite being inherently green the reaction suffers from high 
temperature, tricky experimental set up, expensive catalyst and side reactions which limit its 
generality. Molecular oxygen is an ideal oxidant but the application of chemocatalysis to realize 
this at ambient temperature and pressure has not yet been realized50. 
 A variety of different enzymes (dehydrogenases, oxidases, laccases, peroxidases) are 
available for biooxidation of alcohols. Alcohol dehydrogenases (ADHs) are the most 
extensively studied catalyst for the oxidation of alcohols3,51. Dehydrogenases are 
NAD(P)+/NAD(P)H dependent oxidoreductases that catalyse freely reversible redox processes 
in which both oxidized or reduced products are obtainable,  depending on the cofactor present. 
For oxidation processes, excess NAD(P)+ is necessary. The nicotinamide pyridinium is the 
active oxidant in abstracting a hydride from the carbinol group. (Scheme 6).  
In many cases however ADHs have been used in reduction mode for the generation of 
enantiomerically pure alcohols2,3,52. Another class of oxidation enzymes is the alcohol oxidases 
(AOX), although they are not widely distributed in nature. Galactose oxidase (GOase) is a Cu2+ 
oxidase requiring molecular oxygen as its terminal oxidant53,54. However, this enzyme displays 
limited substrate scope without protein engineering. The flavin-dependent alcohol oxidases are 
much more prevalent in the literature and accept a variety of aromatic and aliphatic alcohols55-57. 
Introduction! ! Chapter!1!|!Literature!Review!
! 19!
 
Scheme 6 Reversible redox chemistry of NAD(P)H cofactor used by alcohol dehydrogenases 
 
 
Scheme 7 Interconversion of reduced and oxidised FAD 
 
The flavin moiety acts as a primary hydride acceptor in which excess reducing equivalents are 
shuttled to molecular oxygen (Scheme 7). Oxidases have the advantage over dehydrogenases in 
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that molecular oxygen is used as the terminal oxidant. Finally, laccases belonging to the blue 
copper oxidases and catalyse hydrogen abstraction reactions from phenoxy radicals58. These 
phenoxy radicals can regenerate an oxidized mediator which then carries out subsequent 
oxidation reactions.  
 1.4.1.1!Biooxidation!of!primary!alcohols!to!carboxylic!acids.!
The ‘through’ oxidations of primary alcohols to carboxylic acids has been dominated by 
the use of microbial whole cells rather than isolated enzymes perhaps due to the fact that whole 
cells guarantee the regeneration of NAD(P)+ which is necessary to shift equilibrium to oxidized 
products. Acetobacter possessing alcohol dehydrogenase (ADH III), has been utilized in a 
number of alcohol oxidations. The Orleans process, for the production wine acetic acid from 
ethanol was the first example of such a biotransformation in 1670. Ethanol is oxidized by ADH 
III into acetaldehyde and an additional cell bound enzyme, aldehyde dehydrogenase (aldDH) 
immediately oxidises the aldehyde to acetate. This process was applied to the preparation of a 
number of carboxylic acids starting from the corresponding primary alcohol on a multigram 
scale (Scheme 8)59,60. Interestingly, these fermentation reactions showed chiral selectivity for 
certain substrates and thus kinetic resolution of racemic primary alcohols including solketal 61,62, 
glycidol62 and 2-phenyl-propanol63 have been performed using whole cells expressing ADHs 
(Scheme8) . 
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Scheme 8 Selected examples of products obtained on a gram scale through oxidation and 
kinetic of various alkyl and aromatic alcohols catalyzed by whole cell biocatalysts61,62,64,65 
 
Isolated alditol oxidase (AldO) from Streptomyces coelicolor, an FAD dependent 
oxidase, has successfully facilitated the oxidation of a number alditol substrates66 to their 
corresponding aldehydes, however in the case of aromatic and aliphatic 1,2 diols, hydroxy acids 
were formed, showing remarkable regioselectivity albeit with low conversion. AldO does 
provide an attractive alternative to glycerol dehydrogenase67 for the kinetic resolution of diols as 
the reaction does not require expensive co-factors and uses molecular oxygen. The main 
limitation of such a kinetic resolution process is that the maximum yield of the desired 
enantiomer is limited to 50%.  
Another interesting application of through oxidations is shown in the oxidative 
lactonisation of symmetrical diols using purified ADH. This desymmetrisation approach has an 
advantage over classical kinetic resolutions as potentially 100% yield of the required 
enantiomer is possible. The purified ADH is not active towards aldehydes. However, if 
intramolecular hydroxyl groups are present, lactol formation can occur followed by oxidation to 
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the lactone (Scheme 9). A number of 1,4 and 1,5 symmetrical diols have been desymmetrised 
using isolated ADH68,69 and more recently valerolactone derivative 2570 have been prepared 
using horse liver ADH (HLADH) and the appropriate NADP+ regeneration system. These 
examples highlight how the meso-trick can result in high conversions and enantioselecivity.  
 
 
Scheme 9 Desymmeterisation of 1,4 and 1,5 diols by isolated ADH68,69 
  
1.4.1.2 Oxidation of primary alcohols to aldehydes 
Molinari63,64 has published many papers documenting whole cell ADH-catalysed 
biotransformations of alcohols. However, it is difficult to stop the oxidation at the aldehyde 
stage due to the presence of other enzymes including aldehyde dehydrogenases. Microbial 
screening of various acetic acid bacteria identified a strain, Gluconobacter oxydans R, in which 
aldehyde oxidation was diminished, however limited substrate specificity was observed64. In 
addition, large scale microbial screening of various bacterial and yeast strains has been a 
powerful tool in identifying novel biocatalysts for the chemoselective oxidation of primary 
alcohols71. 218 lyophilised microbial strains have been tested for their ability to oxidise benzyl 
alcohol in buffer and the result was an extremely powerful chemoselective biocatalyst 
Janibacter terrae DSM 13953 with no benzoic acid being observed. Lyophilised cells from 
Janibacter terrae have since been employed for the oxidation of substituted benzyl alcohols, n-
alkanols, and allylic alcohols in excellent conversions >95% of high substrate concentration 
(96mM) using acetaldehyde as hydrogen acceptor. However, steric interactions have a major 
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affect on conversions with o-substituted benzyl alcohols giving poor conversions in most 
cases72.  The screening of microbes with diminished aldehyde oxidising activity is a labour 
intensive task and to this end simpler approaches have been developed to counteract ‘through’ 
oxidation. 
 Reaction engineering can avoid the through oxidation of alcohols, namely by the 
addition of a second hydrophobic organic layer to remove the aldehyde intermediate. The 
biphasic system allowed a range of primary aldehydes to be prepared in good conversion by 
acetic acid bacteria (Scheme 10) 73. Moreover, the carboxylic acids could be obtained in high 
conversions if the biphasic system was substituted for the regular buffered aqueous system.  
However, the major limitation that the substrate scope is extremely narrow and no aromatic 
substrates are accepted.  As mentioned previously, aldehyde oxidation is a result of endogenous 
aldehyde oxidases/dehydrogenase and good results have been obtained from microbial 
screening of strains with diminished oxidase activity. An alternative to finding ‘what nature has 
provided’ is by using genetically modified whole cells which have the problematic enzymes 
knocked out. This would allow alcohol oxidation only. However, as demonstrated by Wu, 
genetically modified Gluconobacter oxydens benefited from both the biphasic system and 
genetic modification, oxidizing the aromatic benzyl alcohol to benzaldehyde in 100% 
conversion after 1 hour74 and so the combination of multiple solutions to this problem seems 
promising. 
The use of isolated ADHs eliminates the over oxidation alcohols but NAD(P)H 
regeneration strategies need to be incorporated into the biocatalytic process to drive the 
equilibrium towards oxidation products. After seminal work by Bryan Jones75, alcohol  
dehydrogenase from horse liver (HLADH) was identified as an exciting enzyme with great 
synthetic potential. As already shown, HLADH shows high selectivity towards meso diols 
(Scheme 9), however it also boasts higher activity and substrate scope when compared with 33 
other commercially available ADHs, showing remarkable chemoselectivity for alcohol 
functionality71. 
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Scheme 10 Control of selectivity of acetic acid bacteria catalyzed oxidation of primary alcohols 
by choice of reaction conditions73. 
     
 The use of isolated oxidases has the distinct advantage over dehydrogenases in that 
oxygen is used as the terminal electron acceptor and in turn is reduced to H2O2. H2O2 is 
detrimental to the activity of many isolated enzymes and its removal is necessary. The simple 
addition of catalase can circumvent the effects associated with H2O2 by its decomposition into 
water and additional equivalents of O2.  
 Flavin-dependent alcohol oxidase (AlcO) from the yeast Pichia pastoris has been 
shown to provide a number of interesting unbranched aldehydes including propargyl aldehyde, 
2-chloroethanal and 2-cyano ethanol however increased chain length and additional hydroxyl 
functionality are not tolerated54,56. Enantioselective oxidations have also been reported using 
AlcOx76 from different yeast strains. However, poor enantioselectivity and limited substrate 
range (2-methyl-1-pentanol) limit its practical application. Another interesting oxidase which 
has recently been discovered by Fraaije is hydroxymethylfufural oxidase (HMFO)77. HMFO 
shows a broad substrate scope accepting, aromatic alcohols such as benzyl alcohol, cinammyl 
alcohol and vanillyl alcohol. HMFO also accepts aldehyde hydrates which is not a common 
feature of oxidases. The main limiting factors are low substrate concentration and reaction rates, 
but directed evolution strategies have been employed to make HMFO more general78. Oxidases 
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may therefore represent an important tool for the oxidation of alcohols with more directed 
evolution and genome mining facilitating enzyme discovery and optimisation  
The Cu2+ dependent galactose oxidase (GOase) is another alternative for the oxidation 
of primary alcohols to aldehydes. WT GOase shows remarkable selectivity for substrates 
possessing a D-galactose moiety such as melibiose, raffinose, lactose and lacticol, however no 
activity for hydrophobic alcohols was observed54. Much research has been carried out on the 
development of GOase mutants to circumvent poor substrate specificity. The GOaseM3-5 mutant 
has been reported for the oxidation of a number of secondary and primary alcohols, both in high 
conversion and enantioselectivity53 and this interesting development will be discussed in more 
detail later. 
Finally, laccases offer a chemo-enzymatic alternative for the oxidation of primary 
alcohols to aldehydes. Laccases generally have a redox potential in the range of 0.5-0.8 V and 
so cannot directly oxidise primary alcohols. This can be overcome by using a redox mediator 
(LMS) in catalytic amounts which is kept in its oxidized form by a laccase and oxygen as the 
terminal oxidant.79. HBT 32, ABTS 33 and TEMPO 31 have all been demonstrated as redox 
mediators80, with TEMPO most often employed81. Additionally, the laccase mediated system 
(LMS) produces water rather than H2O2 produced by oxidases, which may be preferable 
(Scheme 11). 
 
 
Scheme 11 Laccase-catalysed substrate oxidation in presence of chemical mediator80,82. 
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This type of biotransformation has been applied to the oxidation of a number of 
benzylic82,83, allylic82, propargylic84 and aliphatic alcohols82 however with variable conversions 
depending on the reactivity of the alcohol. Recently, a new chemical mediator AZADO  (2-
azaadamantane N-oxyl) was reported for the selective and mild oxidation85 of primary alcohols 
providing excellent yields and broad substrate scope, even with highly functionalised alcohols 
containing sensitive functional groups. The major limitation of the LMS is poor regioselectivity 
as reactivity is dictated by the oxidised mediator and not the active site of the enzyme. Low 
mediator turnovers also limit applicability for preparative scale reactions86. 
 
1.4.1.3 Enzymatic secondary alcohol oxidation 
Oxidation of secondary alcohols is often considered less interesting from a synthetic 
point of view because chiral information is destroyed in the transformation.  Using 
enantioselective ADHs in the oxidation direction allows the accumulation of a single 
enantiomer secondary alcohol, however with the inherent disadvantage of a maximum 50% 
yield. Nevertheless, a range of oxidative kinetic resolutions have been reported using both 
whole cell and isolated alcohol oxidases and dehydrogenases yielding enantiopure alcohols in 
moderate yields (>40%)87-91.  
To overcome this intrinsic limitation of maximum 50% conversion symmetrical 
prochiral alcohols can be used in desymmetrisation reactions. This has been shown to be very 
efficient in the oxidation of syn-cyclohexanediol92 and  2,3-butanediol65 using isolated glycerol 
dehydrogenase (GDH) and whole cell Acetobacter respectively, providing enantiopure hydroxy 
ketones. Faber et al. have also reported the desymmetrisation of meso-2,5 hexanediol93 using 
recombinant ADH-A in E.coli utilising acetone as hydrogen acceptor, in 88% conversion and 
>99% ee. The recombinant enzyme is able to withstand a maximum acetone concentration of 
50% and so remarkably high substrate concentrations up to 1.8 mol/L are tolerated. However, 
despite the efficiency of desymmetrisation reactions, the number of meso-compounds and their 
uses are few and so using the meso-trick is not a viable solution for the limitations set by kinetic 
resolutions. Deracemisation by stereoinversion is a more effective solution to this problem.  
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This includes a two step interconversion reaction in which the first step includes a 
stereospecific oxidation of one enantiomer or a non-specific oxidation of both, followed by a 
selective reduction (Scheme 12).  
 
 
Scheme 12 Approaches for deracemisation of secondary alcohols using combined enzymatic 
oxidations and reductions. 
 
Sodium borohydride (NaBH4) has been used to facilitate the chemical deracemisation of 
secondary alcohols and in combination with immobilised Geotrichum candidum94 has provided 
a number of aromatic and aliphatic alcohols in varied ee and conversion (Scheme 13). Despite 
the elegance of this one pot chemo-enzymatic redox process, incomplete reduction and low 
yields are major drawbacks to this methodology.  
 
 
Scheme 13 Chemo enzymatic racemization of secondary alcohols with NaBH494 
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More recently, highly efficient cascade enzymatic systems have shown great promise 
for deracemisation processes. The application of two stereocomplementary reduction and 
oxidation catalysts is extremely attractive as only one redox cycle is necessary for total de-
racemisation of secondary alcohols.  Kroutil and co-workers have demonstrated this concept 
using whole cell Alcaligenes faecalis DSM 13975 for the (R) selective oxidation step and 
isolated RE-ADH from Rhodicoccum erythropolis for the S-selective reduction (Scheme 14)95. 
With this dual enzymatic system a number of aliphatic, allylic and aromatic secondary alcohols 
were provided in quantitative conversion however ee is heavily affected by bulky substituents 
near the reaction centre, ie 38. In addition, the applicability of this methodology was 
demonstrated on preparative scale to furnish enantiopure 4-phenyl-2-butanol in 91% isolated 
yield and >99% ee  
The use of two isolated enzymes for this process has an inherent disadvantage in that an 
efficient oxidation and reduction process is not possible if both dehydrogenases require the 
same phosphorylated or non phosphorylated co-factor (NADPH or NADH). As mentioned, 
oxidation and reduction by dehydrogenases is an equilibrium process and co-factor regeneration 
is required for complete oxidation or reduction. If two enzymes require the same co-factor then 
only one regeneration strategy can be used and as a result only oxidation or reduction can take 
place efficiently. To circumvent this major problem, two co-factor independent dehydrogenases 
can be used. This has been demonstrated again by Kroutil96 utilizing an NADPH-specific (R) 
selective ADH and a NADH specific (S)-selective ADH with two separate regeneration 
strategies working in tandem, for the de-racemisation of secondary alcohols (Scheme 15). 
This compared very well with the whole cell-isolated ADH process discussed 
previously, providing similar enantiopurity and conversions on the same substrates, albeit with 
longer reaction times. It is notable that in both these processes the other enantiomer could be 
obtained by switching the selectivity of the biocatalysts. 
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Scheme 14. Tandem biocatalysis for the deracemisation of racemic secondary alcohols95.  
 
Dual whole cells with complementary enantioselectivity are viable alternative to 
isolated enzymes and has the advantage of in situ co-factor regeneration. An alcohol 
dehydrogenase from Microbacterium oxydans and a ketone reductase with complementary 
stereoselectivity from Rhodotorula sp. have been used to obtain many secondary aryl alcohols 
with in high yield and excellent optical purity.97 
 
 
Scheme 15. Cascade combing four enzymes with opposite co-factor and stereopreference to 
access 10 enantiopure (S)-alcohols by biocatalytic deracemisation96 
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Recently, the deracemisation of racemic 3-aryl-2-hydroxyacids (2-HA) to (R)-2-HA 
have been reported by employing two resting-cell biocatalysts (Scheme 16)98. Pseudomonas 
aeruginosa CCTCC M 2011394 was shown to possess an extremely active ADH for the 
enantioselective oxidation of (S)-2-HAs and when combined with S. cerevisiae ZJB5074, which 
possesses an R selective ADH for the reduction of 2-ketoacids, provided an extremely powerful 
deracemisation system. Substituted enantiopure (R)-2-hydroxy acids were provided in good 
yield (>90%) using this one-pot tandom redox process. However, electron donating substituents 
on the aromatic ring decreased conversion. 
 
 
Scheme 16 Biocatalytic deracemisation of racemic 2-hydroxy acids98 
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secondary alcohols which in organic chemistry is performed using the Mitsunobu inversion 
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Chaemtomium sp. KCh 6651 has been reported102, however compared to deracemisations little 
attention has been paid to this green methodology. 
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1.4.1.4 Regioselective alcohol oxidation 
For the chemical oxidation of polyol containing compounds, protection strategies are inevitable 
to allow the regioselective oxidation of specific alcohol groups. These strategies add two 
additional steps to the synthesis and thus the overall yield will be decreased. Polyol 
dehydrogenases and oxidases show remarkable regioselectivity and thus are an attractive 
alternative to protection strategies. 
 The ideal substrates to showcase the regioselective power of enzymes is the polyol 
containing sugars.  Gluconobacter oxydans whole cells facilitated the stereo and regioselective 
oxidation of a number of polyol containing compounds to provide important chemical 
intermediates and products from glycerol (42)103, N-butylglucamine (44)104, glucose (40) 105 and 
ribitol (43)106. Other different biocatalytic approaches have been developed for the 
transformation of ribitol into L-ribulose such as the use of isolated ribitol dehydrogenase107 and 
a mutant of mannitol-dehydrogenase108 to provide the large scale production of L-ribulose. 
 
Scheme 17 Preparative scale applications of Gluconobacter oxydans for the regioselective 
oxidation of polyols104-106. 
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1.4.2 Amine Oxidation 
The principal enzymes used to carry out amine oxidations belong to the flavin-dependent 
oxidases and include amino acid oxidase, D-amino acid oxidase and monoamine oxidases. The 
use of enzymes to catalyse the oxidation of C-N to C=N bonds is an extremely attractive 
prospect, as many chemical methods require aggressive conditions let alone stoichiometric 
reagents.  Selectivity is also an issue with the chemical oxidation of amines as multiple oxidized 
side products such as N-oxides, nitroso and nitro compounds can be formed.  Imines, although 
less reactive than aldehydes, are versatile synthetic intermediates in redox chemistry and their 
formation has been exploited in a number of desymmetrisation and deracemisation reactions to 
form optically pure amines. 
 
1.4.2.1 Deracemisations and stereoinversion of amines 
 D-amino acid oxidase (D-AAO) has been used in conjunction with the non-selective 
reductant sodium borohydride to facilitate the stereoinversion of D-alanine and L-alanine to the 
corresponding enantiomers109. Subsequently this methodology was furthered in the 
deracemisation of DL-proline and DL-pipecolic acid110,111. Turner et al. furthered this research 
and demonstrated that the deracemisation process could be applied to compounds containing 
two stereocenters such as isoleucine (48) to provide products in high yield and diasteromeric 
excess.112 (Scheme 18)  
 
 
Scheme 18 Stereoinversion of β-substituted α-amino acids112. 
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In addition, amino acid oxidase based deracemisation has been cleverly combined with the 
asymmetric hydrogenation of dehydroamino acids to provide all 4 diasteroisomers of β-
arylalanines with yields ranging from 68-92% and excellent ees (>98%)113 (Scheme 19).  
Although AAOs are extremely efficient at providing enantiopure products in excellent 
conversion, the inherent limitation is substrate specificity. D-AAO and L-AAO only accept 
substrates with an α-carboxy group which limits their synthetic application.  
To this end, alternative biocatalysts such as monoamine oxidase have been developed. 
The FAD dependent monoamine oxidase (MAO-N) from Aspergillus niger represents an 
alternative to D and L amino acid oxidases, as the α-carboxy group is not required for amine 
oxidation. There are currently three mechanistic proposals for MAO catalysis114,115 which 
include single electron transfer, direct hydride transfer and a concerted polar nucleophilic 
mechanism. 
 
 
Scheme 19 Asymmetric hydrogenation and subsequent enzymatic stereoinversion to provide all 
diastereoisomers of  β-branched  α-amino acids113 
 
However, thus far there has been no agreement concerning the mechanism of these enzymes. 
The wild-type MAO-N substrate scope is rather limited to simple amines such as butylamine, 
amylamine and benzylamine116, and to this end MAO-N has been subjected to a series of rounds 
MeAr
CO2MeAcHN
MeAr
CO2MeH2N
MeAr
CO2MeH2N
H
H
H
H
MeAr
CO2MeAcHN
H
H
MeAr
CO2MeAcHN
H
H
D-AAO
NH3-BH3
NH3-BH3
L-AAO
Rh(
R,R
-Et-
DuP
hos
)
Rh(S,S-Et-DuPhos)
HC
l
HCl
12 examples
68-92% Yield
>98% ee
Introduction! ! Chapter!1!|!Literature!Review!
! 34!
of directed evolution117-119 which provided a toolbox of MAO-N variants (MAO-N D3, D5, D9, 
D11) that display complementary substrate specificity. For example,  MAO-N variants D3 to 
D11 are able to facilitate the chemoenzymatic deracemisation of secondary and tertiary cyclic 
amines with broad structural features. Acyclic imines however undergo problematic hydrolysis 
to provide unwanted ketones/aldehydes that cannot be recycled and thus are not suitable for 
general chemoenzymatic deracemisation.  
Recently, MAO-N D9 and D11, which exhibit high activity and enantioselectivity 
towards substrates containing bulky aryl substituents have been developed. Late stage 
intermediates in the synthesis of the generic APIs levocetirizine and solifenacin119 have  been 
provided by MAO-N D11 catalysed deracemisation. In addition, these variants have enjoyed 
great success in the preparative deracemisation of tetrahydro-β-carbolines120 to provide optically 
pure secondary amines (Scheme 20). Interestingly, a switch in enantioselectivity (S to R) is 
observed as the nature of the C1 substituent is varied from small substituents (methyl) to bulky 
(isopropyl).  Furthermore, the sterically unhindered substrates displayed lower ee (R = ethyl, 
36% ee) as a result of poor enantiodiscrimination by MAO-N between enantiomers. 
 
 
Scheme 20 Deracemisation of bulky amines by the combination of an  enantioselective amine 
oxidase with a non selective reducing agent120 
 
Lately, the chemoenzymatic deracemisation of benzylisoquinoline alkaloids121 by MAO-N D11 
has been coupled with another enzyme, the flavin dependent berberine bridge enzyme (BBE), to 
provide (S)-berbines (Scheme 21)122. This concept combines the interconversion of 51 by 
MAO-N to the opposite enantiomer ent-51, with a kinetic resolution by BBE and affords 
conversions of up to 98%, with up to 93% of the optically pure product being isolated. 
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Scheme 21. Deracemization of benzylisoquinolines to berberines by a MAO/BBE/borane redox 
cascade121 
 
The natural product harmicine can be obtained in four linear steps with an overall yield of 59% 
using a MAO-N D9 facilitated deracemisation 119. Interestingly, MAO-N provides an alternative 
route to harmicine via a Pictet-Spengler type cyclisation using a tryptophan derivative as the 
starting material in a single step (Scheme 22). The intermediate iminium ion 55 undergoes 
nonstereoselective cyclisation to form racemic harmicine 57. The (S) enantiomer was then 
further oxidized to the corresponding iminium ion and upon reduction with BH3-NH3 is fully 
converted to (R)-harmicine ent-57 in >99% ee and 83% conversion. 
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Scheme 22. Biocatalytic Oxidative Pictet−Spengler Approach to the Synthesis of (R)-
Harmicine119  
 
Despite the elegance of the previously described chemoenzymatic deracemisations, their utility 
with acyclic structures is limited by competing hydrolysis of the imine under aqueous 
conditions.  Turner et al123 has addressed this issue by employing a ω-transaminase to 
regenerate the chiral amine from the hydrolysed imine (Scheme 23). The approach relies on 
selective MAO-N mediated oxidation of one enantiomer of the amine to the imine, which 
undergoes spontaneous hydrolysis to the corresponding ketone. Subsequent amination mediated 
by ω-TA provided optically pure R amines in excellent conversions without the use of chemical 
reductants. 
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Scheme 23. Deracemisation of 1-phenylethanamine using a MAO-N/ ω-TA cascade process123 
 
1.4.2.2 Desymmetrisation of amines. 
 
 
Scheme 24 Stereoselective  synthesis of  amino acid 64 and other  accepted substrates for the 
biotransformation124. 
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corresponding pyrrolines were found to serve as useful building blocks for the synthesis of L-
proline analogues and R amino nitriles of high enantiomeric purity. In addition, the oxidized 63 
was subjected to HCN resulting in the highly diastereoselective trans-addition of cyanide to 
form the amino nitrile, which was then hydrolised to the corresponding proline analogue 64. 
Such proline analogues are components of the hepatitis C viral protease inhibitor telepavir and 
bocepravir. 
 
1.4.3 Enzyme-catalysed Baeyer Villiger oxidations 
The Baeyer-Villiger oxidation involves the oxidative cleavage of a carbon-carbon bond adjacent 
to a carbonyl group and subsequent insertion of an oxygen atom between these two carbons 
(Scheme 25).  
 
 
Scheme 25 Classical Baeyer villiger oxidation 
 
Classical Baeyer villiger oxidations lack the high chemo-, and enantioselectivity which are 
needed in organic synthesis125. The waste associated with the use of peracid is one equivalent of 
carboxylic acid salt per ester formed, which in an atom economic world is not efficient. In 
addition many of the peracids used are intrinsically unstable, costly, shock sensitive or 
explosive in condensed form. To this end, a number of transition metal complexes have become 
available to perform this transformation in a highly enantio-, chemo and regioselective fashion 
but employ toxic and expensive precious metals126,127. A bio-based alternative to the abiotic 
Baeyer villigar oxidation would be of importance as reactions could be conducted at ambient 
temperature, in water and with a biodegradable catalyst. 
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1.4.3.1 Baeyer Villiger monooxygenases 
 Baeyer-Villiger monooxygenases (BVMOs) are most suited to Baeyer-Villiger 
oxidations. These enzymes are part of the class B subgroup of the larger class of flavoprotein 
monooxygenases128. BVMOs possess the ability to catalyse the insertion of oxygen with both 
high regio- and enantioselectivity. Cyclohexanone monooxygenase from Acinetobacter 
calcoaceticus (CHMO) 129,130 is the most studied BVMO.  
BVMOs use a flavin cofactor for catalysis, which after coenzyme-mediated reduction 
by NADPH and reaction with molecular oxygen, forms a peroxyflavin intermediate (Scheme 
26)128. The reactivity of the peroxy intermediate does not depend on substrate binding, which 
explains the broad substrate scope of BVMOs. Despite BVMOs being promiscuous enzymes, 
they instil remarkable enantioselectivity and provide access to unexpected Baeyer-Villiger 
products due to space restrictions in the active site of the enzyme. This has been exploited in a 
number of desymmetrisation reactions and kinetic/dynamic resolutions131-133.  
 
Scheme 26 Peroxyflavin formation by NADPH and O2 in BVMOs 
 
Cyclopentanone monooxygenase from Comamonas sp (CPMOComa) is an enzyme 
believed to be complementary to CHMO with many examples of opposite regio- or 
stereoisomers being formed depending on which enzyme is used134. This can be seen in the 
desymmetrisation of bridged cycloketones. For almost all ketones tested in this work, 
enantiodivergent behavior of both enzymes was observed with CPMO catalyzed reactions 
providing (+) lactones and CHMO forming (-) lactones (Scheme 27) 
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. 
Scheme 27 Enantiodivergent behavior of CHMO and CPMO on selected bridged  
cycloketones134 
 
Another example of the complementary nature of these enzymes can be seen in the 
formation of abnormal lactones. Sterics, conformation and electronic effects govern the 
migration of the carbon centre in the Baeyer-Villiger oxidation.  Due to the addition of the 
peroxy group from the flavin moiety occurring in the active site of the enzyme, steric factors 
play a larger role in migration and so depending on substrate, the least substituted carbon can 
migrate providing abnormal lactones. For example, Baeyer-Villiger reaction of (-) trans 
dihydrocarvone (76) catalyzed by CHMO type enzymes led to the formation of expected 
lactones 77135. However, when the catalyst is substituted for CPMO type enzyme, unexpected 
lactones 78 were formed albeit in low yield (Scheme 28).  These reactions highlight nicely how 
CPMO and CHMO complement each other with opposite enantiomers and regioisomers being 
accessible from a common starting material. 
 
 
Scheme 28 Formation of abnormal and expected lactones from CPMO and CHMOs135. 
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BVMOs display remarkable chemoselectivity. Chemical oxidants such as mCPBA can 
lead to multiple oxidation products if there are more than one oxidisable group, such as alkenes. 
With the use of BVMOs this chemical limitation is overcome as the active site of enzymes is 
specific. However, that being said, reactions of BVMOs usually employ whole cells reactions 
(to regenerate NADPH) and multiple enzymes such as alcohol dehydrogenase (ADH) and old 
yellow enzyme (OYE) may be present in the expression system136. This can lead to side 
reactions such as ketone reduction and also alkene hydrogenations. This limitation is illustrated 
in the whole cell oxidation of Wieland-Miescher ketone 79 in which the alcohol 80 is formed as 
a result of indigenous ADHs (Scheme 29)136. Isolated BVMOs would circumvent this problem 
however cofactor regeneration strategies such as the [Cp*Rh(bpy)(H2O)]2+  flavin regeneration 
system developed by Fraiije137, would be required to make the process cost effective. 
 
 
Scheme 29 Formation of side products resulting from additional enzymes in whole cell 
biocatalysts136. 
 
1.4.3.2 Kinetic resolutions of racemic ketones catalysed by BVMOs 
Many kinetic resolutions of cyclic ketones have been reported to provide enantiopure 
chiral building block chemicals. A key chiral starting material in prostanoid synthesis was 
obtained in the kinetic resolution of a fused hetero bicylic ketone (Scheme 30)138. Recombinant 
E.coli expressing gene Rv3049c (BVMOMtb5) displayed excellent kinetic resolution for the 
formation of abnormal lactone 84 and at 50% conversion the ketone 83 was obtained in its 
enantiopure form. When the reaction was allowed to proceed further, a steady decrease in 
enantiopurity was observed as the unwanted enantiomer was converted.  
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Scheme 30 Kinetic resolution of lactone 88 catalysed by BVMOmtb5138 
 
 Initially kinetic resolutions were limited to cyclic ketones however, with the discovery 
of a BVMO from P. fluorescens DSM 50106, this methodology has been expanded to acylic 
ketones (Scheme 31)139. The new BVMO shows little activity towards cyclic substrates however 
it accepts a variety of acyclic β hydroxyl ketones. Under the reaction conditions, β-hydroxy 
acetates were furnished in >90% ee and overall (S) configuration in every case using 
recombinant whole cells E.coli expressing the BVMO.  
 
 
Scheme 31 Enzymatic Baeyer Villiger oxidation of racemic 4-hydroxy-2 ketone 91 by 
BVMOs139. 
 
Recently, the gram scale kinetic resolution of chiral building block 89 was 
demonstrated140. BVMO M014 was expressed in E.coli in a 2L bioreactor (Scheme 32). At 50% 
conversion the ketone 89 was formed  with 96% ee and this example illustrates the applicability 
of BVMOs  to industrial processes. 
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Scheme 32 Enzymatic Baeyer Villiger oxidation of racemic ketone 90 by MO14140. 
 
1.4.3.3 Dynamic kinetic resolutions of racemic ketones catalysed by BVMOs 
 Due to the inherent limitation associated with kinetic resolutions of 50% maximum 
yield, dynamic kinetic resolutions are of much interest. DKR was first described for the 
selective oxidation of racemic 2-benzyoxymethylcyclopenanone 91 (Scheme 33)141. The 
substrate posses an enolisable proton and thus under high pH would racemise the unwanted 
enantiomer. Using whole cells expressing CHMO, the desired lactone 92 was formed in 75% 
yield and 98% ee. This proved that DKR was possible, however at high pH BVMOs are known 
to lose activity.  To circumvent this issue, anionic exchange resins have been used to facilitate 
racemisation at neutral pH which resulted in higher conversion142. 
 
 
 
Scheme 33 Dynamic kinetic resolution of racemic 91 using a recombinant E. coli. expressing 
CHMO142  
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performed using an isolated HAPMO and the anion exchange resin DOWEX MWA-1, thus 
expanding DKR methodology to acylic compounds (Scheme 34)132.  However, this reaction was 
plagued with long reaction times (>116hr), modest conversions (>46%) and ee’s (58-84). The 
optimal substrate 93 was afforded in high conversion and optical purities (84%, 86% ee). 
 
 
Scheme 34 HAPMO-catalyzed DKR of 93 employing anion exchange resins1 
 
Fraaije also demonstrated that BVMOs can catalyse the oxidation of β-ketoesters to form 
acylated hydroxyl esters143, whose hydrolysed products are of importance to the pharmaceutical 
and cosmetics industry144 (Scheme 35). β-Keto esters posses an acidic α-proton and require only 
slightly basic pH for enolisation, which eliminates the need for anion exchange resins. 
Therefore DKR was carried out using isolated phenylacetone monoxygenase (PAMO) from 
Thermobifida fusca and 5% MTBE as co-solvent. These conditions afforded the final ester in 
conversions close to 100% and >99% ee. PAMO was chosen as it has shown increased stability 
at high pH values145. Chemical hydrolysis of the ester furnished the desired hydroxyl acid 97 
without affecting the enantiopurity. 
 
  
 
Scheme 35 BVMO-catalyzed dynamic kinetic resolution of aliphatic α-alkyl-β-ketoesters and 
subsequent hydrolysis of the diesters to obtain the corresponding enantioenriched α-hydroxy 
esters143.  
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1.4.4 Enzymatic epoxidation reactions 
Enantiopure epoxides are extremely important building blocks in the fine chemical 
industry146. The versatility of the epoxide is attributed to the oxirane functionality that can be 
opened by various nucleophiles or undergo rearrangements or reductions to more elaborate 
intermediates.147 
 The most prominent catalytic reaction for epoxide formation is the transition metal 
catalyzed Sharpless epoxidation which allows the asymmetric epoxidation of prochiral allylic 
alcohols148,149. Katsuki-Jacobson epoxidation of cis-substituted alkenes150 and Shi’s 
epoxidation151 of trans substituted alkenes are other transition metal protocols that have been 
developed. However, not all substrates are accepted by chemical methods and thus biological 
alternatives have been explored. 
 A number of enzymes from microorganisms, plants and animals are capable of 
catalyzing the asymmetric epoxidation reaction in a regio-, diastereo and enantioselective 
fashion. The most common biocatalysts are either monooxygenases and peroxidases. However, 
these enzymes lack flexibility in their substrate scope, which is a major limitation. Often many 
microbial strains are screened or engineered to carry out the desired biotransformation.  
 
1.4.4.1 Enzyme-catalysed epoxidations of aliphatic alkenes. 
The non-heme diiron alkane monooxygenases (AMOs) are very powerful epoxidation 
catalysts. Diiron monooxygenases catalyse the reductive activation of molecular oxygen 
resulting in high valent metal oxo complexs which are excellent oxidising agents152,153. Since 
these enzymes are complex and relatively unstable, the majority of studies are focused on whole 
cell biotransformations.   
A number of microbial oxidation systems harboring AMOs have been reported for the 
epoxidation of a number aliphatic alkenes but with moderate ee (>86%)(Scheme 36).154,155.  
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Scheme 36 Examples of selective microbial alkene epoxidations155 
 
Nocardia corallina B-276, catalysed the epoxidation of a broad range of terminal alkenes to 
their (R) epoxides with optical purities reaching 90% in product titers 80 g L-1 156,157, however 
optical purities decrease with alkyl chain length.  
Interestingly, depending on bacterial growth conditions, enantioselectivity varies. This 
indicates stereocomplementary epoxidation systems are active within the cell, which is a major 
limitation of whole cell epoxidation systems. A further limitation of using whole cells is the 
extreme toxicity of epoxides. This issue can be easily circumvented using biphasic mixtures and 
concentrations of 150 g L-1 have been reported158. Despite AMOs being an extremely effective 
biocatalyst for epoxidation, their presence in recent literature is lacking. With the development 
of molecular biology techniques the more interesting and powerful cytochrome P450s and 
chloroperoxidases (CPO) have gained considerable interest in aliphatic alkene oxidation. 
P450 monooxygenases contain a heme-iron complex. The catalytically active oxyferryl 
species is formed through a sequence of NAD(P)H reduction and O2 activation (Scheme 37). 
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Scheme 37 Structure and simplified redox chemistry of P450 monoxygenases. 
 
Bacillus megaterium was the first organism reported to catalyse the P450-dependent 
epoxidation of alkenes. This system facilitated the epoxidation of a number of unsaturated fatty 
acids, however poor conversion to the desired epoxides was observed <34%159. The responsible 
enzyme was identified as P450 monooxygenase BM3 (P450BM3) and has since undergone a 
series of rounds of directed evolution to expand its substrate scope160.  The mutant P450BM3 G4 
was capable of providing artemisinic- 11S, 12- epoxide (107) an important intermediate in the 
synthesis of the antimalarial drug artemisinin at titers of 250 mg L-1 in E. coli,(Scheme  38)161. 
 
 
Scheme 38 Enantioselective epoxidation by P450BM3 furnishing artemisinic - 11S, 12- 
epoxide161 
 
The use of P450 monooxygenases however is hampered by their general low activity. In the 
conversion of limonene, pinene and valencene (108), a number of unwanted side reactions such 
as hydroxylation and overoxidation have been reported(Scheme 39) 162,163.  
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Scheme 39 Product distributions of P450-catalysed transformation of valencene 108162 
 
This inherent limitation can be overcome with excessive rounds of directed evolution as 
demonstrated recently by Reetz164. The natural product (+)-nootkatone (121) has a number of C-
H oxidation sites and carbonyl functionality and thus makes it a challenging substrate for 
selective epoxidation. The heavily engineered variant of P450BM3 provided the epoxide product 
in 96% conversion (Scheme 40) eliminating the formation of side products through extensive 
directed evolution. Although P450 monooxygenases remain a powerful force in C-H activation 
their application as off the shelf biocatalysts is low due to their poor chemoselectivity without 
protein engineering.  
  
 
Scheme 40 Chemoselective oxidation of (+)-nooketone by the highly engineered P450BM3 
variant1. 
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Finally, peroxidases such as chloroperoxidase from Caldariomyces fumago (CPO) are 
known to catalyse epoxidation of double bonds. Chloroperoxidase is heme containing glyco 
protein that requires H2O2 to regenerate its oxidised catalytically active protoporphyrin 
prosthetic group. Compared to P450s, CPO may be considered a better candidate as a practical 
epoxidation catalyst since it utilizes H2O2 whereas the P450 systems utilize molecular oxygen 
but also require NAD(P)H. This allows CPOs to be used as isolated enzymes and thus 
stereocomplementary epoxidation systems are no longer an issue that could be present within 
the cell. 
A number of cis alkenes and gem-substituted alkenes have been efficiently epoxidised 
by CPO reaching high enantiopurities (Scheme 41) 165-167. However, low enantioselectivity is 
observed with trans-alkenes. Recently, the successful epoxidation of chloropropene and allyl 
alcohol has been reported to provide the C3 building block chemicals epichlorohydrin (123) and 
glycidol (124) in excellent ee (>97%).168 
 
Figure 41 Epoxidation of different olefins catalysed by chloroperoxidase165-168 
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1.4.4.2 Styrene enzymatic epoxidation: 
Due to the activated nature of aromatic alkenes a number of flavin and heme-dependent 
monoxygenases as well as peroxidases are suitable biocatalysts for epoxidation. Styrene 
monooxygenase (StyAB) from a Pseudomonas sp. strain is a two component enzyme consisting 
of a FADH2-dependent oxygenase (StyA) which transforms its natural substrate styrene into 
(S)-epoxides with high enantioselectivity via reductive activation of molecular oxygen. The 
other reductase component (StyB) catalyses the transfer of hydrogen between the reduced 
NAD(P)H and oxidised flavin. As a result of SMOs cofactor dependence, whole cell 
biotransformations are the preferred medium however isolated enzymes coupled to co-factor 
regeneration systems have been reported with great success169. SMOs not only accept their 
natural styrene substrate but also a series of styrene derivatives with aromatic or carbon chain 
substitution, resulting in high (S) enantioselectivity in most cases (Scheme 42)169-171.  
 
Scheme 42 Substrate scope of styrene monooxygenase (StyAB) 169-171 
 
Bulky substituents and/or electron withdrawing groups are associated with diminished enzyme 
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StyAB. Directed evolution or genome mining strategies may provide a solution to this 
limitation, however this has not yet been realized. 
 
1.4.5 Aldehyde Oxidations 
Compared to the oxidation of alcohols, the oxidation of aldehydes is less popular. The Pinnick 
oxidation utilises sodium chlorite under mild acidic conditions to provide highly pure 
carboxylic acids from the corresponding aldehydes.172 This remains the cornerstone of chemical 
green aldehyde oxidation. However, its intolerance to amines, pyroles and thioethers provides 
an inherent limitation. Protection strategies can circumvent this issue although the use of 
stoichiometric protecting groups does not coincide with green chemistry principles and thus 
alternative catalysts for chemo- and regioselectivie oxidations are required. Alcohol 
dehydrogenase (ADHs), aldehyde dehydrogenases (AldDH), Baeyer-Villiger monooxygenases 
(BVMOs) and members of the xanthine oxidase family all possess powerful aldehyde oxidation 
capabilities, yet comparably few biocatalytic procedures have been reported. 
HLADH was the first reported ADH to catalyse the NAD(P)+ dependent oxidation of 
aldehydes173-176. However, the NAD(P)H dependent aldehyde reduction represents a common 
side reaction. The so called aldehyde dismutase activity of some ADHs has been considered 
more of a curiosity than a viable synthetic method. Recently, Faber and co-workers177 have 
exploited the dismutase activity of ADHs. They successfully demonstrated their biocatalytic 
equivalent to the Cannizzaro reaction to provide non racemic primary alcohols and α-chiral 
carboxylic acids, in equimolar amounts through a neutral redox process. Elegantly a dynamic 
kinetic resolution is possible via the easily enolisable aldehyde and so enantiopure products are 
possible. Interestingly, with increasing enzyme concentration, an increase in carboxylic acid is 
produced albeit with diminished ee values (Scheme 43). 
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Scheme 43 Asymmetric Canizzaro-type reaction177 
 
When a sufficient NADP+ regeneration system is used, the dismutation activity can be switched 
into oxidative mode and predominantly the formation of carboxylic acid occurs. This has been 
exploited by Hollmann178 in which an engineered recombinant ADH in E.coli, ADH9-V1 
coupled with NADPH oxidase provided phenyl propionic acid in 97% ee and greater than 90% 
yield (Scheme 44). The preparative scale application was hindered however due to the 
instability of NOX under reaction conditions. A solution to this problem would be the use of an 
alternative regeneration system such as Laccase mediated system (LMS) or the use of an 
oxidase. However, these alternatives have yet to be explored. 
 
 
Scheme 44 Oxidative dynamic kinetic resolution of profen aldehydes 
 
 BVMOs such as CHMO have been known to transform aliphatic aldehydes into their 
respective carboxylic acids179-181. CHMOs are known to oxidise phenylacetaldehydes producing 
both the formate ester and carboxylic acid. The potential for BVMOs to carry out this 
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biotransformation in general is relatively unexplored. Recently, a newly characterised BVMO 
(BVMO4) from a strain of Dietzia182, has displayed high activity for aldehydes containing a 
phenyl group and also for long chain aliphatic aldehydes with preference for carboxylic acid 
formation.  BVMO4 is the first promising candidate for the practical synthesis of propionic acid 
drugs using BVMOs although it resulted in poor conversion and enantioselectivity (57% yield, 
40% ee) (Scheme 45).  Despite the modest performance, the aforementioned highlights that 
BVMOs could be applied to the asymmetric synthesis of α-substituted carboxylic acids after 
optimisation by protein engineering. Although interesting, it would need to compete with the 
highly developed alcohol dehydrogenase systems. 
 
 
Scheme 45 2-Phenyl propionaldehyde oxidation by BVMO4 
 
Finally, an attractive alternative to the aforementioned cofactor dependent oxidation is 
the use of oxidases. A family of molybdenum iron-sulphur flavoprotein hydroxylase such as 
xanthine oxidase (E. coli XDH)183 and periplasmic aldehyde oxidase (PaoABC)184 show 
promising activity. Although both XO and PaoABC show remarkable substrate promiscuity, 
and have the clear advantage of using molecular oxygen as the terminal oxidant, their use in 
synthetic applications is non-existent. These molybdenum-dependent enzymes are the subject of 
this work and will be discussed in detail later. 
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1.4 Enzyme cascade reactions 
Single step enzyme biocatalysis has emerged as a powerful tool for the synthesis of 
chiral key intermediates with the main advantage of using mild reaction conditions in a chemo-, 
regio- and stereoselective manner. However, the isolation and purification of intermediates is 
associated with a decrease in yield. 
 In nature a large number of enzyme cascades can be found in different metabolic 
pathways inside the cell185. These enzymes work synergistically in cascade or multistep 
reactions, without isolation of intermediates to provide complex natural products. The 
utilization of such enzyme cascades in vivo or in vitro can provide efficient artificial synthetic 
pathways towards the generation of important complex molecules or building block chemicals 
from biomass in one pot. In addition, one-pot cascades of reaction sequences can substantially 
decrease the amount of chemicals used for each reaction as no isolation or purification of 
intermediates is required.  Such cascades also eliminate the accumulation of unstable or toxic 
intermediates, which often hinder single step biotransformations. Depending on the catalysts, 
cascades can be classified into either chemo-bio or totally enzymatic bio-bio cascades. 
 
1.4.1 Chemo-bio catalytic cascade reactions 
 An example of a chemo-bio cascade is represented by the work of Simon et al186 in 
which all four diastereoisomers of disubstituted 2,6-piperidines were obtainable from 
asymmetrical 1,5 diketones (Scheme 46). The regio- and stereoselective monoamination of 
several 1,5 diketones was evaluated using 6 enantioselective whole cell transaminases. The 
reactions with 141, were generally highly S selective using ω-TA from C. violaceum and the 
opposite enantiomer could be easily obtained using Arthrobacter sp. ω-TA. Diastereoselective 
hydrogenation of the resulting Δ1-piperideines provided enantiopure piperidines, however the 
chemical reductants proved incompatible in an aqueous environment and thus isolation of the 
intermediate was necessary. Cis piperidines were prepared with excellent de (>99%) from the 
enantiopure piperdines using H2, Pd/C however, the preparation of trans piperdines occurred 
with poorer dr.  
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Scheme 46 Monoamination of 141 and subsequent hydrogenation providing all four 
diastereoisomers of disubstituted 2,6 piperidines186. 
 
Although the method described represents the highest yield and shortest chemical route to 2,6 
di-substituted piperidines, the isolation of the unstable imine is an additional unwanted step.  
 One-pot two step reaction sequences are a common requirement in chemo-bio catalysis 
due to the incompatibility of reaction conditions for each step. Suzuki cross coupling of aryl 
boronic acid with aryl keto bromides was successfully combined with an enantioselective 
biocatalytic reduction by (S)-ADH from Rhodococus sp. to provide biaryl substituted alcohols 
with high conversion of 91% and >99% ee187. However, subsequent adjustment of the reaction 
medium after the formation of the biaryl compound  must occur to accommodate the biocatalyst 
and to ensure full conversion to the intermediate. Pd-catalysed Heck cross-coupling reactions 
combined with ADHs have also been reported by Cachi (Scheme 47)188 but again a two-step 
one-pot reaction was required for successful conversion to the corresponding alcohols in yields 
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up to 92% and with >99% ee in all cases. This methodology has been successfully applied to the 
enantioselective one pot synthesis of (R)-rhododendrol (151) resulting in 90% yield and with 
>99% ee.188 
 
 
Scheme 47 One-pot chemoenzymatic synthesis of (R)-rhododendrol (157)188 
 
The use of chemo-bio cascades can be very powerful tools to provide enantiopure 
products in high yields, often in which would not be possible if either catalysts are used alone. 
The major drawback of two-step sequential addition of either the biocatalyst or chemocatalyst is 
the time taken for the formation of the intermediate. To this end, much research has been 
devoted to the development of biocatalysts and chemocatalysts that are mutually compatible and 
can operate in a simultaneous manner rather than in a stepwise fashion. 
Chemo-bio simultaneous catalysis has been demonstrated recently in which Turner et 
al.189 reported a novel one-pot chemoenzymatic cascade for the regio and stereoselective 
synthesis of a panel of 2,5-substituted pyrollidines from their corresponding 1,4 diketones 
(Scheme 48). Commercially available ω-TA provided the mono transaminated product which 
spontaneously cyclises in excellent regioselectivity and ee (>99%). This has been demonstrated 
on a preparative scale in which both enantiomers were obtained using an (S) or (R) selective 
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pot manner. Unfortunately, not all diastereoisomers were obtainable in this work as a MAO-N 
mutant for the opposite enantiomer was not available. 
 
Scheme 48. Chemoenzymatic synthesis of 2,5 disubstituted pyrrolidines by employing ω-TA, 
MAO-N and an unselective reductant189. 
 
A more elaborate but interesting solution to the problem posed by chemical and biological 
incompatability involves the creation of artificial metalloenzymes. 
The reaction scope of enzymes can be quite limiting when compared with transition 
metals such as Pd, Ru, and Rh. To some extent, this can be attributed to the poor bioavailability 
of these precious transition metals and so nature has not had the opportunity to explore the 
wealth of reactivity of these metals. Groups including Ward and Turner have tried to pick up 
where ‘nature left off’ by developing novel artificial biocatalysts that combine the richness of 
transition metal catalysis with the selectivity and rate enhancements of biocatalysis. These 
artificial enzymes are a step forward in reaching the goal of simultaneous chemo/bio catalysis as 
the reaction conditions when employing these hybrid biocatalysts often mimic those of natural 
enzymes but more importantly the incompatibility of the metal complex with the enzyme is 
eliminated. 
Cp*Ir(Biot-p-L)Cl, an imine reduction catalyst was shown by Ward and Turner190 et al. 
to completely inactivate monamine oxidase (MAO-N), which has enjoyed great success in the 
oxidation of a multitude of amines. To circumvent this inactivation, molecular 
compartmentalisation of the organometallic imine reduction catalyst within a protein scaffold 
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(Steptavidin) proved to shield it from the biocatalyst and in turn created a highly active artificial 
transfer hydrogenase metallozyme (ATHase). ATHase was compatible with several other co-
factor dependent oxidases such as MAO-N, L-amino acid oxidase and D- amino oxidase in a 
simultaneous rather than a successive manner. The scope of the cascade reactions included 
reductions of prochiral imines with subsequent deracemisation190, stereoinversion of nicotine190 
and also the synthesis of L-pipecolic acid190. Interestingly, the protein scoffold can be further 
improved by directed evolution to increase enantioselectivity or fine tune regioselectivity much 
like a natural enzyme.  
Another cascade involving an artificial metallozyme was demonstrated in the 
Backväll191 laboratory. Two catalysts, lipase CALB and palladium nanoparticles were co-
immobilised in siliceous mesocellular foams to form a multifunctional hybrid catalyst. This 
artificial metallozyme was used in the dynamic kinetic resolution of primary amines affording 
the acylated amine product in quantitative yields and >99% ee. The main drawback is that this 
artificial “deracemase” metallozyme’s activity decreases with each subsequent reaction due to 
the deactivation of CALB by denaturation. Despite this, Backvall has highlighted that chemo-
bio cascades are possible by immobilising both a chemical and enzyme within a mesopourous 
material.  
 This relatively young discipline of using artificial metalloenzymes is very exciting as 
potentially any transition metal could be incorporated into the active site of a protein. This could 
give rise to a variety of powerful hybrid catalysts which may include Heckases, Suzukiases, 
Sonogashirases and perhaps novel carbocylases in the future. 
  
1.4.2 Bio-Bio Catalytic cascades (in vitro) 
The combination of two or more natural biocatalysts as either isolated enzymes, 
lyophilised whole cells or resting cells has received much attention in recent years192. The 
combination of multiple enzymes in vitro has the advantage in that mutually compatible 
reaction conditions are likely and so simultaneous catalysis is possible. However, problems can 
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occur when enzymes compete for the same substrate or are inhibited by an intermediate in the 
cascade193-196. 
 In a recent example of a bio-bio cascade all four diastereoisomers of norephedrine 196 
were obtained from benzaldehyde (156) and pyruvate (157) by the combined action of either 
multiple isolated enzymes or lyophilised whole cells (Scheme 49). In the first step, two 
enantiocomplementary carboligases recombinatly expressed from E. coli, were used to 
synthesise (R) and (S) phenylacetylcarbinol (163,164), which then underwent transamination by 
employing two stereocomplementary transaminases. However, simultaneous catalysis was not 
possible in this case as the benzaldehyde substrate can be transaminated by ω-TA and so the 
sequential addition of the biocatalysts was necessary. This two-step one-pot biotransformation 
provided (1R, 2R) and (1R,2S) norephedrine in >98% ee and de by employing the (R) selective 
carboligase AHAS-1 and either  AT-(R) transaminase or Cv-(S) transaminase. The other 
diasteroisomers were accessed using a recently engineered carboligase from Acetobacter 
pasteurianus ApPDC (E469G) and so all four diastereomers were obtainable in titrs up 26g L-1 
d-1.  
With clever biocatalytic retrosynthetic analysis21, elegant multienzyme cascades have 
been developed in which the product formed by the action of the first enzyme becomes the 
starting material for the subsequent biotransformtion and thus competition between the enzymes 
is non-existent allowing simultaneous catalysis. This approach can also highlight suitable 
enzymes that would provide a neutral redox process in relation to co-factor regeneration and 
thus the process becomes self-sufficient. This approach was demonstrated in which the un-
natural amino acid, L-phenylglycine (168) was obtained through a series of biotransformations 
using isolated enzymes starting from the readily available L-mandelic acid (165)(Scheme 50)197.  
Mandelate racemase was identified as suitable racemisation catalyst for the initial 
stereoinversion. The resulting D-enantiomer 166 was then oxidized by a novel D-mandelate 
dehydrogenase and subsequent reductive amination by L-amino acid oxidase provided the un-
natural amino acid 168 in 86.5% yield and excellent ee in a 1 pot 1 step biotransformation. 
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Scheme 49 Enzymatic synthesis of all 4 disastereoisomers of norephedrine196 
 
All enzymes work cooperatively in this artificial synthetic in vitro pathway to provide the 
desired product without isolation. In addition, internal cofactor regeneration resulted in a redox 
neutral process and thus the use of these enzymes in tandem is beneficial as no external cofactor 
regeneration strategies are required and the process is self-sufficient. The use of redox self-
sufficient biocatalyic systems is a very popular trend within the area of bio-bio in vitro 
cascades. Kroutil and co-workers198 demonstrated a redox self-sufficient cascade for the 
amination of primary alcohols using three isolated enzymes (Scheme 51). 
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Scheme 50 Synthesis of L-phenyl glycine encompassing a redox neutral process NAD+ is 
regenerated in the final transamination step197. 
 
The first step in the sequence was the oxidation of the alcohol 169 by an alcohol dehydrogenase 
(ADH-hT) that consumes NAD+ leading to the formation of the aldehyde and NADH. In the 
second step, ω-transaminase (CV-ωTA) aminates the intermediate aldehyde 170. L-Alanine was 
chosen as the amine donor which was regenerated by L-alanine dehydrogenase (AlaDH) at the 
expense of NADH from pyruvate. This redox neutral cascade was successfully applied to a 
range of aliphatic and aromatic alcohols however increased chain length was associated with a 
decrease in conversion. 
 
 
 
Scheme 51 Artificial redox neutral multi-enzyme network for the bioamination of primary 
alcohols198 
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Another cofactor recycling strategy has also been demonstrated recently by 
Bornschauer193 in which the important building block chemical ε-caprolactone (ε-CL, 174) was 
obtained from cyclohexanol (172), by combining ADH, CHMO and CAL-B in a single one-pot 
in vitro cascade reaction (Scheme 52). Although BVMOs are known to catalyse the formation 
of ε-caprolactone (ε-CL, 174) from cyclohexanone (173), the reaction suffers from poor 
productivity as a result of enzyme instability, cofactor regeneration and also product inhibition. 
As before the use of NAD+ dependent ADH and NADH dependent BVMO results in a redox 
neutral process. The toxicity effects of ε-CL on BVMO are eliminated by the utilization of the 
acetyltransferase activity of CAL-B to provide oligo- ε-CL 175 directly. With this artificial 
enzymatic pathway titers of up to 20 g L-1 of oligomeric ester have been obtained and highlights 
how multienzymatic cascades can be used in the synthesis of important polymer chemicals. 
 
 
Scheme 52 Enzyme cascade synthesis of ε-CL and its oligomers193. 
 
The most sophisticated use of bioretrosynthetic analysis has recently been reported194 in 
the six-enzyme isolated cascade for the synthesis of 6-aminohexanoic acid (180) from 
cyclohexanol (172)(Scheme 53). It was postulated that the use of two cofactor independent 
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enzymes could provide a self-sufficient biocatalytic system. Each module would involve an 
oxidation step requiring NAD(P)+ and one step consuming NAD(P)H thus allowing  two self 
sufficient redox cascades working independently from each other. The first module involved the 
production of ε-CL (174) from cyclohexanol (172) by the combination of the NADP+ dependent 
ADH and the NADPH dependent BVMO mutant C376L M4001. The combination was 
successful and ε-CL (174) was formed in >99% conversion and titers up to 20 g L-1. The more 
demanding second module involved transesterification of the ε-CL (174) with methanol by 
horse liver esterase followed by the NAD+ dependent alcohol oxidation and subsequent NADH 
dependent transamination to provide the amino ester 179. Horse liver esterase also catalysed the 
hydrolysis reaction of 179 to provide 6-amino hexanoic acid (180). Module two on its own 
provided 75% conversion within twenty hours and the preparative scale transformation of 1g of 
ε-CL was demonstrated. Despite the elegance of both modules, the combination of all six 
enzymes resulted in the poor conversion of cyclohexanol (172) to aminohexanoic acid (176) 
(24%) due the inactivation of BVMO by the high percentage of methanol required for the 
esterification reaction. Although low yielding, this study represents how clever biocatalytic 
synthesis can provide a highly atom efficient, two co-factor self sufficient multi enzymatic in 
vitro cascade for the synthesis of high value chemicals. 
 
1.4.3 Metabolic engineering and bio-bio in vivo cascades 
Microbes have long been adapted for the biosynthetic production of useful compounds.  
The concerted interaction of numerous enzymes within the cell allows exceptionally high 
conversions in multistep biosynthetic pathways. Many microbial primary metabolites (vitamins, 
nucleotides and ethanol) and also secondary metabolites (antibiotics, cholesterol lowering 
compounds and anti-tumor compounds) have a global market of several billion dollars. Now, 
we are seeing the assembly of microbial factories by combining diverse range of enzymes in a 
heterologous host and also improve pre-existing metabolic pathways to produce compounds that 
were previously unattainable.  
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Scheme 53 Two co-factor independent enzyme cascades for the synthesis of 6-aminohexanoic 
acid, 180194 
 
 Pre-existing metabolic pathways can be optimized by mediating strict control over the 
expression of the encoded pathway enzymes but also by engineering the enzymes to improve 
efficiency. This has been successfully demonstrated in which a novel E.coli strain was 
engineered to provide short chain alkanes by the manipulation of its own fatty acid biosynthesis 
and degradation pathways199. Similarly this approach has been successful in the production of 
1,3 propane diol200, 1,4-butane diol201 and the artemisisin intermediate, artemisinic acid in titers 
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metabolic pathway is required. Alternatively, host microorganisms may be used to 
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pathways.  
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violaceum were recombinatly expressed in E.coli BL21 for the direct amino functionalization of 
unactivated C-H bonds (Scheme 54). Dodecanoic acid methyl ester (181) was successfully 
converted to aldehyde 183 by alkBGT in a two step oxidation and subsequently transaminated 
by CV2025 with L-alanine serving as amine donor to provide the amino ester 184. Poor mass 
transfer of the hydrophobic substrate over the cell membrane and competing enzyme reactions 
severely crippled the productivity and only 4% of the desired amino ester formed. 
 
 
Scheme 54 Terminal amino functionalisation of dodecanoic acid methyl ester using an in vivo 
enzyme cascade203. 
 
 Bornscheuer and coworkers204 have recently demonstrated the application of in vivo 
enzyme cascades in desymmetrisation and kinetic resolutions. They developed an artificial mini 
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into the desired lactone in 60% yield and >99% ee, albeit at low substrate concentration (4mM).  
The limited substrate concentration may reflect poor enzyme expression of one or more 
enzymes in the system although this issue is not commented on by the author.  
 
 
Scheme 55 An artificial metabolic pathway composed of an alcohol dehydro- genase (LK-
ADH), an enoate reductase (XenB), and a Baeyer–Villiger-mono- oxygenase (CHMOAcineto) 
starting from 2-cyclohexenol (186)204 
 
Hollmann205 has recently published a one-pot conversion of cycloalkanes to lactones 
using a similar recombinant system containing CYP450s, ADHs and BVMOs. However, in this 
study, poor expression of all enzymes was observed in the single E.coli host resulting in the 
desired lactone being obtained in low concentrations <1mM. The lower expression level was 
postulated to be a result of metabolic burden caused by the simultaneous expression of all three 
enzymes in a single host and represents a major limitation posed by multienzymatic in vivo 
cascades. This limitation was circumvented by the use of cell free lysates of separately 
expressed enzymes in vitro, which provided 23mM of caprolactone (174) from 30 mM 
cyclohexane.  
Despite the inherent limitation of low substrate concentration, a number of whole cell in 
vivo enzyme cascades have been developed to provide a range of important building blocks 
chemicals from renewable resources. These include for example ω-amino fatty acids203, ω-
hydroxy fatty acids and dicarboxylic acids206 and most recently azelic acid207. However, these 
reports are only proof of concept studies and are plagued with low yields with scarce industrial 
application. That being said further improvement via metabolic engineering to increase enzyme 
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expression and directed evolution may allow these strategies to become competitive in the 
future. 
The prospect of a single whole cell designer biocatalyst to carry out multistep 
biotransformations in vivo is indeed highly desirable. However, low productivity as a result of 
low protein expression and substrate diffusion across the cell membrane are common problems 
associated with this type of catalysis. Although these issues can be engineered out, this is labour 
intensive and time consuming. Other drawbacks to using in vivo whole cells include lower 
chemoselectivity as unwanted enzyme activities may be present within the cells and also the 
control of the synthetic flux maybe difficult. In contrast, in vitro approaches are less complex 
and therefore reaction conditions are easier to control and optimize. In addition, higher purity 
products and substrate concentrations are possible. This may explain why, at this time, in vitro 
cascades is the method of choice for multienzyme cascade reactions. 
Molybdenum-dependent oxidoreductases are a family of enzymes, which are relatively 
unexplored for their application in chemical synthesis. These enzymes catalyse the oxidation of 
imines and aldehydes to their corresponding amides and carboxylic acids. The use of these 
oxidoreductases for in vitro cascades is very appealing as aldehydes and imines can be 
generated by a variety of enzymes such as alcohol oxidases, and indirectly using transaminases  
1.5 Molybdenum dependent oxidoreductases 
Hydroxylation of either aromatic or aliphatic carbons is a common metabolic reaction. 
Many  enzymes such as cytochrome P450 monoxygeneases have evolved to utilise molecular 
oxygen as the source of oxygen that is incorporated into the product. These require reducing 
equivalents as already discussed. In contrast, molybdenum hydroxylases use water as the source 
of oxygen for incorporation and also generate reducing equivalents such as NAD(P)H. These 
hydroxylases are known to accept a range of imines and aldehydes to provide the corresponding 
oxidation products208.  
The xanthine oxidoreductase (XOR) family consists of a number of well characterized 
molybdenum hydroxylases that include xanthine dehydrogenase (XDH), xanthine oxidase (XO) 
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and aldehyde oxidase (AO)209,210. XOR is recognised as the key enzyme in the catabolism of 
purines, oxidising hypoxanthine and xanthine to the terminal catabolite uric acid with 
concomitant reduction of NAD+ (XDH) or O2 (XO) 211,212. The biological function of AO is still 
largely obscure but it is believed, due to its broad substrate specificity, to be involved in the 
elimination of xenobiotics. Periplasmic aldehyde oxidase (PaoABC) from E.coli has a 
preference for aromatic aldehydes and its suggested biological function is the detoxification of 
aromatic aldehydes in the periplasm213. 
 
1.5.1 Structure of molybdenum hydroxylases 
Molybdenum is an essential component of this family of enzymes and is required for 
enzyme catalysis. Many molybdenum hydroxylases posses a similar overall architecture and 
contain a pair of [2Fe-2S] clusters, an FAD binding domain and a molybdenum binding 
domain214,215 (Figure 8).  
 
 
Figure 8: Crystal structure of bovine xanthine oxidase illustrating the major components in 
molybdenum hydroxylases: [Fe-S] clusters green and blue respectively, FAD domain (grey), 
molybdenum-binding portion (red)216.  
 
The Mo-binding domain consists of a pterin moiety which positions the catalytic Mo correctly 
within the active site of the enzyme and controls redox activity participating in electron transfer 
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to and from the Mo centre. For xanthine metabolising enzymes in this class, amino acid residues 
are highly conserved at positions; Phe914, Phe1009, Glu802, Glu1261 and Arg880 (Bovine XO 
numbering). Crystal structure analysis indicates that two glutamate residues lie on opposite 
sides of the substrate binding cleft that is defined by the phenylalanine residues. Glu802 is 
within H-bonding distance of the substrate and Glu1261 is in close proximity to the catalytic 
molybdenum (Figure 9). Interestingly, variants that favor aldehyde oxidation have tyrosine 
residues in place of phenylalanine residues. The Mo center itself consists of the metal in a 
distorted square pyramidal coordination geometry. The apical position is occupied by an Mo=O 
group,  the four equatorial ligands are a terminal Mo=S, two sulfurs from the pterin moiety and 
a water derived hydroxide (Figure 10) 217. 
 
 
 
Figure 9 Active site structure of Bovine xanthine oxidoreductase. The orientation at right is 
rotated 90° about the vertical217. 
 
 
 
Figure 10 Structure of the pyranopterin cofactor bound Mo (MoCo) 
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1.5.2 Mechanism 
The mechanism of oxidation of imines and aldehydes by molybdoenzymes has been 
determined using 18O-labeling experiments, EPR analysis and also computational methods. The 
result of the experiments indicated that incorportated oxygen is derived from the water. The 
accepted mechanism is shown in Figure 11216. The initial step in the biotransformation is the 
base assisted (Glu1261) nucleophilic attack of the Mo-OH group leading to a tetrahedral 
Mo(VI) intermediate 189 that rapidly decays by hydride transfer to the Mo(VI)=S to yield 
reduced Mo(IV)-SH 190. Water then displaces the bound product 191 (Figure 11). Mo(VI) is 
then reformed by two-electron transfer out of the molybdenum center through the pterin moiety 
into the Fe/S cluster and finally to the FAD where molecular oxygen accepts the electrons and is 
subsequently reduced to H2O2 for XO. 
1.5.3 Substrate scope of molybdenum hydroxylases 
Extensive research has been conducted in the area of drug and other xenobiotic 
metabolism and it has been established that AO and XOR catalyse the oxidation of aldehydes to 
carboxylic acids, cyclic iminium ions to lactams and aromatic azaheterocyclic compounds to 
oxoheterocycles. 
  
Figure 11. Proposed mechanism of molybdenum containing hydroxylases216. 
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AO is known to metabolise a number of aliphatic and aromatic aldehydes to the corresponding 
carboxylic acids such as retinal into retinoic acid218. Secondary metabolites (190-191) derived 
from drug molecules such as Tamoxifen219, Citalopram220 and Tolbutamide221 but also ethanol 
(192) are successfully oxidized, highlighting the wide substrate specificity of AO208. (Figure 12) 
 
Figure 12. Aldehyde substrates for AO, metabolites derived from the drugs citralopram, 
tamoxifen and tolbutamide208 
  
The hydroxylation of aromatic azaheterocycles is another important biotransformation 
carried out by molybdenum-dependent hydroxylases, especially XO and XDH. Quinazoline 
derivatives are metabolized to give their corresponding oxoheterocycles222. The sterically 
challenging selective dopamine D3 receptor antagonist SB-277011 (197)223 and methotrexate 
(196) are metabolised by molybdoenzymes (Figure 13)224. 
Iminium ions are generated as intermediates during the metabolism of cyclic amines by 
P450 or MAO enzymes. These iminium ions are further metabolised to cyclic lactams by AO 
and XOR. Zapetin (198)225, oxidized nicotine (199) 226, nicotinamide (200)227 and prolintane 
(201)228 all generate iminium ions during metabolism that are subsequently oxidized by XOR or 
AO to form lactam products. (Figure 14) 
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Figure 13 Aromatic azaheteroclic substrates for XOR type enzymes with arrows indicating 
oxidation site208 
 
 Despite the wide substrate specificity and interesting reactivity associated with 
molybdoenzymes, their synthetic application has not yet been explored. The regioselective and 
chemoselective hydroxylation of imines poses as an extremely interesting biotransformation as 
chemical methods in the literature for the regioselective oxidation of heterocycles are currently 
lacking. In addition, molybdoenzymes provide a distinct advantage over chemical oxidation 
methods which some employ toxic transition metals, as oxygen is used as the terminal oxidant 
and so may provide and selective, mild green alternative to traditional methods. 
 
Figure 14 Iminium ion substrates for XOR208 
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1.6 Creation of Galactose Oxidase M3-5 (GOaseM3-5) 
Galactose oxidase (GOase) is a copper-containing free radical oxidase that can 
transform a range of primary alcohols into their corresponding aldehydes with reduction of 
molecular oxygen albeit with poor conversion. GOase has been applied in a broad range of 
areas including biosensors229, cancer detection230 and more recently, glycoprotein labeling231. 
Reports of its use in synthetic chemistry however, are limited in the literature. GOase is very 
efficient at oxidising substrates containing a β-galactose moiety such as melibiose, raffinose and 
lactose, however primary alcohols such a benzyl alcohol derivatives are poor substrates. To this 
end Turner53 and Arnold232,233 have developed novel GOase mutants to overcome this inherent 
limitation and to develop chiral variants. 
   
1.6.1 Evolution of GOase for enantioselective secondary alcohol oxidation 
Error prone PCR was conducted on WT GOase by Arnold233 and after sufficient 
screening, a variant containing six mutations was discovered to provide a higher expression 
level and stability in E.coli (GOaseM1). Additional mutations on GOaseM1 using saturated 
mutagenesis provided an improved variant with a further three mutations232. The new variant 
(GOaseM3) was capable of oxidizing D-Glucose but also showed low activity towards but-3-en-
2-ol. GOaseM3 exhibited low enantioselectivity towards 1-phenyl ethanol with the (R) 
enantiomer showing approximately 30-fold greater activity than the (S) enantiomer.  Mutant 
libraries of GOaseM3 were generated by epPCR with the aim to improve enantioselectivity and 
also broaden the substrate scope. The M3-5 variant was found to exhibit good activity against a 
range of substituted 1-phenylethanol analogues and provided these in high ee via kinetic 
resolution (Scheme 52). 
 
Scheme 52 Kinetic resolution of a 1-phenylethanol (202) using the GOaseM3-5 variant53. 
OH OH O
GOaseM3-5
>99% ee
202 203 204
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Figure 15 Active site structure of GOaseM3-5 showing (R)-1-phenylethanol 3 docked into active  
The M3-5 variant contains a single mutation at position 330 compared to M3 (Figure 15). This 
active site residue had previously been identified as important in controlling substrate 
recognition. Interestingly, this new variant has decreased activity towards its natural substrate 
galactose, indicating a switch in specificity with mutation of this residue. Recently GOaseM3-5 
has been used in the redox desymmetrisation of biaryl atropisomers234 
GOase has the advantage over the already established ADHs as no additional cofactors 
are required for oxidation. Oxidation only requires molecular oxygen and produces H2O2. As a 
result of the pioneering work by Arnold and Turner, a very stable and easily expressed GOase 
variant is available in which further directed evolution stratagies are possible with the already 
established screening methods. To this end the use of GOase mutants is very appealing in 
enzyme cascades as they can be fine tuned to meet further requirements. 
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Project Aim 
Molybdenum-dependent oxidases have rarely seen use in synthetic chemistry. Their precedence 
in the literature remains limited to metabolic studies of xenobiotics, structural elucidation and 
more recently application in biosensors. E. coli XDH or PaoABC accept both aldehyde and 
imine functionalities to give the corresponding carboxylic acids and lactams. When compared 
with other oxidizing biocatalysts, molybdenum-dependent oxidoreductases have the advantage 
that molecular oxygen can often be used as the terminal oxidant and that NAD(P)+ is not 
required as with alcohol dehydrogenases. Furthermore, the aldehyde and not the hydrate (as for 
FAD dependent oxidases) is the substrate for these oxidases and so oxidation is not dependent 
on hydrate formation. This has the benefit that electron rich aldehydes are accepted, which can 
prove problematic for FAD-dependent oxidases such as HMFO. 
Herein, we attempt the design of enzyme cascade reactions, combining either E. coli 
XDH or PaoABC with GOaseM3-5 to provide carboxylic acids from alcohols and also lactams 
from amino alcohols via an in situ generated imine. In addition, any chiral induction by the 
biocatalysts will be explored. Finally, we aim to apply this green methodology to the 
environmentally friendly synthesis of 2,4-furandicarboxylic (FDCA) from biobased 5-
hydroxymethylfurfural (HMF). 
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Results and Discussion 
Chapter 2 
2.0 The oxidation of activated and unactivated alcohols to carboxylic acids via a two-
enzyme one-pot cascade. 
2.1 Introduction 
The oxidation of alcohols to carboxylic acids often requires a stepwise process via the 
aldehyde intermediate and typically employs catalytic ruthenium or chromium and strong 
oxidants.235 Biocatalytic processes using whole cells60 and isolated enzymes47,236 as already 
mentioned, are attractive tools for the synthesis of carboxylic acids due to the green attributes of 
biocatalysis. However, with whole cells, products often need to be removed from the reaction 
due to the toxicity of the intermediate aldehyde. To this end the use of isolated enzymes in vitro 
offers an attractive alternative. The use of alcohol dehydrogenases (ADH)194 and aldehyde 
dehydrogenase (aldDH)178 have been reported for this biotransformation but the use of NAD(P)+ 
may limit their synthetic application as cofactor recycling is required. The use of two oxygen-
dependent oxidases would have the advantage that no additional cofactors are required. 
Galactose oxidase mutant M3-5 (GOaseM3-5) is known to accept a range of benzylic 
alcohols53, converting them to their corresponding aldehydes at the expense of molecular 
oxygen as the terminal oxidant. Molybdenum-dependent hydroxylases, such as the 
commercially available E. coli XDH, have been documented to metabolise aldehyde 
xenobiotics converting them to the more polar carboxylic acids to facilitate elimination from the 
body208. However, the use of molybdenum hydroxylases to carry out this transformation for 
synthetic purposes has not been explored. The combination of both these enzymes in tandem 
would provide an extremely green synthetic route to carboxylic acids from alcohols as oxygen 
is used as the terminal oxidant with the only side product being hydrogen peroxide. 
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2.2 Oxidation of activated alcohols 
2.2.1 Xanthine oxidase substrate scope 
Molybdenum hydroxylases are known to metabolise various aldehyde containing drug 
molecules. The commercially available molybdoenzyme, xanthine oxidase (XDH) from E. coli 
was chosen as an ideal enzyme for the cascade due its availability. E. coli XDH uses O2 as an 
electron acceptor in the absence of other mediators or co-factors. To quickly identify substrates 
for XDH, we believed it was necessary to develop a screening method in which oxidation of 
aldehydes could be observed by eye. The redox active dye, dichlorophenolindophenol (DCPIP, 
205) has been used routinely to assay XDH (Scheme 54). 
 
 
Scheme 54 DCPIP assay for XDH activity 184,237. 
 
Using a 96 well plate a range of 56 aldehydes, were screened with the above method. E. 
coli XDH showed remarkable activity towards benzylic aldehydes with both electron 
withdrawing and donating groups in either ortho-, meta- and para positions. In addition, 
nitrogen, oxygen and sulphur containing heteroaromatic compounds were tolerated. The 
substrate specificity of E. coli XDH for aromatic aldehydes appeared to be dictated by enzyme 
substrate interactions, as no clear electronic effects were present (Scheme 55). Unfortunately, 
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the enzyme did not accept the less activated aldehydes such as phenylacetaldehyde (231) 
cinnamaldehyde (232) and alkyl aldehydes which was indicated by a negative result in our 
DCPIP screen (Scheme 56). This could be explained by the highly active nature of 
benzaldehyde derivatives to oxidation in air. Although the crystal structure of E. coli XDH is 
not known, the homologue R.capsulatus XDH contains two phenylalanine residues in the active 
site which may play an additional role216. The phenyl rings on the amino acids possibly pi stack 
with the benzyl aldehydes and so stabilize the transition state lowering the activation energy 
further. In the case of phenylacetaldehyde the reaction center may be too far from these 
interactions. 
  
 
Scheme 55 Substrate scope of the E. coli XDH catalysed oxidation of benzylic alcohols as 
indicated by DCPIP screen. Activity as good as with natural substrate xanthine: +++; good 
activity: ++; moderate to low activity: + 
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Scheme 56 Non-substrates for E. coli XDH as indicated by a negavite response in the DCPIP 
screen 
 
 
2.2.2 Oxidation of selected benzaldehyde derivatives by E. coli XDH at 1mM substrate 
concentration 
The major limitation posed by our substrate screen was that the extent of oxidation 
remained unknown. To this end, a selection of aldehydes was chosen and the conversion 
monitored by RP-HPLC to gain a detailed insight into the extent and rate of oxidation by E.coli 
XDH.  
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Figure 16 1 mM benzaldehyde derivatives oxidation time course. Reaction conditions: 3 µL 
substrate (100mM in MeCN), 297 µL 50 mM KPi buffer pH 7.6, RT. RP-HPLC conditions: 
ThermoFischer Hypurity C-18 column, flow rate 1.0 mL/min, UV 254 nm, Method A: 25% 
MeCN: 75% water + 0.1% TFA 
 
Only full conversion was observed with m-anisaldehyde (220)(Figure 16). p-Nitrobenzaldeyde 
and o-anisaldehyde were also oxidised at a reasonable rate, albeit with a longer reaction time of 
18 hours. However, the fluoro analogues were converted more slowly (73% for m-
fluorobenzaldehyde (213) after 16 hours). We postulated that the low conversion and long 
reaction time was due to an inadequate supply of molecular oxygen dissolved in the buffer due 
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to the reaction being performed in sealed eppendorfs without agitation. The reactions were 
subsequently repeated with periodic opening of the reaction to air and subsequent shaking to 
allow oxygen to be dissolved in the buffer medium. Gratifyingly, with this modified procedure 
all the tested aldehydes were oxidized to the corresponding acid in excellent conversion (>92%) 
within one hour (Scheme 57). This observation highlights the importance of molecular oxygen 
in this catalytic system, as it is essential to re-activate the reduced molybdoenzyme. The 
different rates observed in Figure 10 presumably reflects differences in the Km/Kcat under 
oxygen limiting conditions. 
 
 
 
Scheme 57. Substrate scope for aromatic aldehyde oxidation by  E.coli XDH 
 
2.2.3 Oxidation of benzaldehydes at 10mM substrate concentration 
p-Nitrobenzaldehyde (221) was chosen as a starting point for optimisation due to its 
activated nature (Table 1). At 1 mM the corresponding carboxylic acid was formed with 
quantitative conversion (Table 1, entry 1), however when the substrate concentration was 
increased beyond 10 mM a significant decrease in conversion was observed (Table 1, entry 2-
4). p-Nitrobenzaldehyde is a solid and under our reaction conditions is poorly soluble in 
aqueous buffer. We considered this might be the reason behind the poor reactivity.  The 
addition of co-solvents to aid solubility has enjoyed great success in many enzyme catalysed 
oxidations47 and we believed we could incorporate this into our system. 
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Table 1 10mM substrate optimisation for the oxidation of benzaldehdye 220 and 221 using E. 
coli XDHa 
 
 
 
Entry Compound 
[Substrate] 
(mM) 
Enzyme 
Volume            
(1 mg/mL)( µL) 
Additive 
Time 
(hr) 
Conversion 
(%)c 
1 221 1 20 None 1 100 
2 “ 10 “ “ “ 15 
3 “ 30 “ “ “ 7 
4 “ 50 “ “ “ 6 
5 “ 1 “ 10% IPA 1 46 
6 “ 30 “ “ “ 0 
7 220 “ 15 None 16 9 
8 “ “ 20 “ “ 11 
9 “ “ 50 “ “ 12 
10 “ “ 70 “ “ 19 
11 “ “ 100 “ “ 11 
12 “ “ 120 “ “ 18 
13 “ 10 50 None “ 53 
14 “ “ “ SOD b “ 55 
15 “ “ 50 Catalaseb 1 100 
16 “ 20 “ “ 2 100 
aReaction conditions: X µL E.coli XDH (1.1 mg/mL), (3.3 mg/mL), X µL 221 or 222 (2 M in 
MeCN) in 50 mM pH 7.5 potassium phosphate buffer (300 µL final volume) 37°C. 
bConcentration of enzymes used was 1mg/ml). cConversion calculated from peak areas of HPLC 
analysis using a Thermofisher hypurity C-18 column. Conversions were adjusted according to 
an NMR analysed 1:1 mix of aldehyde:acid and then analysed by RP-HPLC. SOD = Superoxide 
Dismutase 
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10% IPA did indeed help solubilise the substrate but it also reduced the activity of E.coli XDH 
(Table 1, entry 5-6). The next possibility we explored was substrate inhibition. We postulated if 
the substrate concentration remains low (1mM) by periodical addition of the substrate (221), 
this inhibition could be circumvented. However, decreased activity was observed after each 
subsequent addition of p-nitrobenzaldehyde (Figure 17). 
 
 
Figure 17 Periodic addition of 1mM p-nitrobenzaldehyde (221) to a final concentration of 3 
mM 
3-Methoxybenzaldehyde (220) was chosen as an alternative to p-nitrobenzaldehyde (221) as it 
showed high activity at 1mM but also it is a liquid and is more soluble in aqueous buffer. We 
believed that increasing enzyme concentration may overcome inhibition but this approach was 
met with no major increase in conversion even when 8 times the enzyme concentration was 
used (Table 1, entry 12).  In the oxidation, molecular oxygen is reduced to H2O2 which is a 
known enzyme inhibitor46. In whole cell reactions, catalase is present as a protective enzyme 
that eliminates oxidative cell damage by this powerful oxidant. In our case the isolated enzyme 
has no protective enzymes and so can be subjected to oxidative damage by this side product. 
Two protective enzymes, superoxide dismutase and bovine catalase were employed, however 
only bovine catalase provided an increase in activity with quantitative conversion up to 20 mM 
in less than 2 hours (Table 1, entry 16). The use of catalase in isolated enzymatic oxidations is 
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often necessary if oxygen is the terminal oxidant. This has been documented by many groups 
working with oxidases53. However, this is the first time catalase has been reported to have a 
beneficial effect when using a molybdenum containing hydroxylase.  
 
2.2.4 10mM GOaseM3-5/XO cascade and preparative scale biotransformation 
Our collaborator, Prof Nick Turner (University of Manchester, UK) has previously 
developed variants of F. graminearum galactose oxidase (GOase), such as GOase M3-5 that 
show remarkable ability to oxidise secondary and primary benzylic alcohols to their respective 
ketone and aldehyde products with H2O2 as by product53. We believed that by combining GOase 
M3-5 and E.coli XDH we could achieve direct and clean conversion of aryl alcohols to acids via 
an in situ generated aldehyde. The aryl alcohols corresponding to the best aldehyde substrates 
for E. coli XDH were selected for a one-pot-one step GOase M3-5-XDH cascade approach. In 
all, quantitative conversion of the benzyl and heteroaryl alcohols (241-257) to the 
corresponding carboxylic acids (258-274) was observed within 16 hours (Scheme 58) using [S] 
= 10 mM. 
 
 
Scheme 58 Bio-bio cascade reaction for the conversion of alcohols to acids using GOaseM3-5 
and E.coli XDH. 
 
We next attempted to scale up the enzymatic cascade to [S] = 100 mM. 3-
Methoxybenzylalcohol (241) was chosen as the most suitable candidate as it performed best in 
our cascade (Table 2). Increased substrate concentration up to 20 mM (Table 2, entry 2) was 
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tolerated, however when the concentration was increased to 40 mM a decrease in activity was 
observed (Table 2, entry 3). The addition of co-solvents to increase solubility was met with 
decreased activity as previously observed (Table 2, entries 4 & 5). As a result of higher 
substrate concentration an increase in H2O2 production would ensue and we postulated that the 
catalase concentration would need to be increased to provide sufficient protection. Gratifyingly, 
increasing catalase concentration provided the desired carboxylic acid in 94% conversion with 
81% isolated yield after 5 hours (Table 2, entry 6). Increasing the substrate concentration further 
to 100 mM met with much lower conversion although no 241 was present after HPLC analysis 
(Table 2, entry 7). 
 
Table 2 Optimisation of the GOaseM3-5-E. coli XDH reaction for the formation of m-methoxy 
benzoic acid (258) from 3-methoxybenzyl alcohol (241) in a one step approacha. 
 
 
Entry 
[Substrate] 
mM 
Additive 
Catalase 
(1.1 mg/ml) 
Time 
(Hr) 
Conversion 
(%) 
1 10 - 75 µL 1 100b 
2 20 - “ 2 100b 
3 40 - “ 16 82b 
4 40 5% IPA “ 16 69b 
5 40 15% IPA “ 16 21b 
6 40 - 100 µL 5 94b(81c) 
7 100 - ‘ 48 57b(50c) 
aReaction conditions: 103 µL GOaseM3-5 (3 mg/mL), 50 µL E.coli XDH (1.1 mg/mL), 33 µL 
catalase (3.3 mg/mL), X µL 241 (2 M in MeCN) in 50 mM pH 7.6 potassium phosphate buffer 
(300 µL final volume) 37°C, 16 hr bConversion calculated from peak areas of HPLC analysis 
using a Thermofisher Hypurity C-18 column. Yields were adjusted according to an NMR 
analysed 1:1:1 mix of the aldehyde:acid:alcohol. cIsolated yields in parenthesis 
 
OH
O
GOase M3-5, Additive
buffer pH 7.6, 37oC
catalase, O2 (air)
       E. coli XDH
  buffer pH 7.6, 37oC
    catalase, O2 (air)
OHArCHO
OMe OMe
241 220 258
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The 10mM cascade reaction was further analysed by RP-HPLC by means of time course to 
identify relative rates of conversion by both enzymes (Figure 18). Clean and complete 
conversion to the aldehyde by GOaseM3-5 was observed after 10 minutes followed by a slower 
conversion to the acid by XDH. 
 
 
Figure 18 Time course 10 mM 3-Methoxybenzyl alcohol (241) to 3-methoxybenzoic acid (258) 
cascade with GOaseM3-5 and E.coli XDH 
 
This experiment was repeated on 40 mM scale which indicated a similar reaction profile with an 
initial fast oxidation by GOaseM3-5 followed by a slower XDH catalysed oxidation of the 
intermediate aldehyde to reach 94% of the acid after 5 hours (Figure 19).   
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Figure 19 Time course 40 mM 3-Methoxybenzyl alcohol (241) to 3-methoxybenzoic acid (258) 
cascade with GOaseM3-5 and E.coli XDH 
 
From the results it is clear that E.coli xanthine oxidase is the limiting factor in the cascade. 
GOaseM3-5 cleanly and efficiently converts aryl alcohols to their corresponding aldehydes up to 
100mM substrate concentration.  The major problem lies in the second oxidation step. E.coli 
XDH does not tolerate high substrate concentration (>40mM) possibly due to product or 
substrate inhibition. Alternative molybdoenzymes or immobilization of XDH may facilitate the 
scale up these cascades. 
 
2.3 Enzyme cascades for the oxidation of unactivated alcohols to acids 
2.3.1 PaoABC optimization and substrate screen 
To expand the substrate scope of our cascades system an alternative molybdenum 
oxidase was required. Our collaborator Prof Silke Leimkühler (University of Potsdam) kindly 
donated a recently reported oxidase, periplasmic aldehyde oxidase (PaoABC) that uses oxygen 
as the terminal electron acceptor although this has not been reported213.  PaoABC is a 135 kDa 
heterotrimer enzyme with a large (78.1 kDa) molybdenum cofactor containing PaoC subunit, a 
medium (33.9 kDa) FAD containing PaoB subunit and a small (21.0 kDa) [2Fe-2S] containing 
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PaoABC. Its is believed that E.coli PaoABC  plays a role in the detoxification of aromatic 
aldehydes213. 
 PaoABC has never been used for a synthetic application so it was unclear as to the 
optimum reaction conditions. To this end we decided to examine the effect of pH and buffer 
composition on the activity of PaoABC (Table 3).  
 
Table 3 Optimisation of PaoABC-catalysed oxidation of to 3-methoxybenzaldehyde (220) 
 
Entry 
Molarity 
(mM) 
PaoABC 
(13.3mg/mL) 
Additive 
Buffer 
(50 mM) 
pH 
Time 
(Min.) 
Yield 
(%)b 
1 1 mM 20 µL None Citrate 5 60 100 
2 “ “ “ Phosphate “ “ 100 
3 “ “ “ Acetate “ “ 100 
4 “ 10 µL “ Phosphate “ 5 100 
5 “ 1 µL “ “ 5 30 100 
6 “ “ “ “ 5.5 5 70 
7 “ “ “ “ 6 “ 85 
8 “ “ “ “ 6.5 “ 100 
9 “ “ “ “ 7 “ 86 
10 “ “ “ “ 7.5 “ 65 
11 10 5 “ “ 6.5 60 41 
12 “ “ Catalase “ “ “ 71 
aReaction conditions: X µL PaoABC (13.3 mg/mL), 3 µL 220 (1M in MeCN 10 mM final 
concentration) in 50 mM pH X potassium phosphate buffer (300 µL final volume) 37°C. bYield 
was calculated by RP-HPLC on a ODS hypurity C-18 column with a flow rate 1mL/min and 
mobile phase 25% MeCN: 75% Water + 0.1%TFA 
 
PaoABC is able to tolerate citrate, phosphate and acetate buffers. It was determined that pH 6.5 
is the optimum pH for efficient catalysis (Table 3, entry 8). Catalase is also necessary for 
catalysis at higher substrate concentrations and this coincides with previous observations using 
E.coli XDH. The rate of oxidation of 220 was determined at different pH values in phosphate 
PaoABC
Buffer, Additive
O H
OMe
O OH
OMe
220 258
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buffer (Table 3, Entries 5-10) and it was shown that pH below 6 results in slower conversions 
(Figure 20).  
 
 
Figure 20 Rate of oxidation of 10mM to 3-methoxybenzaldehyde (220) by PaoABC in 100mM 
KPi buffer at different pHs. 
 
Interestingly Leimkühler et al. reported that the optimum pH for PaoABC was pH 5.5 which 
contradicts these results. It is only recently that PaoABC was determined to be an oxidase, 
accepting oxygen as its terminal electron acceptor in the absence of other acceptor molecules. 
Previous work conducted by Leimkühler used ferricyanide as electron acceptor at pH 5.5213 and 
also osmium complexes but at pH 9238. The ability of PaoABC to pass its electrons to an 
acceptor molecule appears to be dependent on pH and this may be the reason why we see higher 
activity at pH 7 as oxygen is now the electron acceptor.   
 With optimized conditions in hand we set out to identify additional substrates which 
could be used in new cascade reactions. Using the previously described DCPIP screen we found 
that  a range of aldehydes were accepted by PaoABC which were not substrates for E.coli XDH. 
PaoABC had an expanded substrate scope accepting bulky, aromatic and aliphatic alcohols, not 
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oxidized by E.coli XDH (Scheme 59). Our collaborators working on the crystal structure of 
PaoABC have identified that the active site for PaoABC is extremely large and so it is no 
surprise that its substrate scope is wide. Interestingly, imine containing compounds such as 
DHIQ (356) and xanthine (206), the natural substrate for XDH are not accepted by PaoABC. 
 
 
Scheme 59 Newly identified substrates for PaoABC as determined by a positive result from our 
DCPIP screen 
 
2.3.2 Tempo-mediated alcohol oxidation  
GOaseM3-5 has high activity towards benzyl alcohol derivatives but initial work by the 
Turner group indicated much lower activities towards unactivated aliphatic alcohols. For this 
reason we believed that a replacement oxidant was necessary. Alkyl alcohol oxidase or aryl 
alcohol oxidase was not available to us so we postulated that a chemo-bio oxidation would be a 
sufficient alternative. The laccase mediated TEMPO oxidation has enjoyed great success in 
many preparative scale transformations82,239 and we anticipated that this system might allow us 
to obtain alkyl and bulky aldehydes that would not be possible using GOaseM3-5. m-
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Fluorobenzaldehyde was chosen as the test substrate for the chemo-bio cascade (Table 4). It 
was found to be necessary to lower the pH to 5, below the optimum pH of PaoABC, in order for 
sufficient oxidation of the alcohol to occur, albeit with poor subsequent conversion to the acid 
(Table 4, entry 2). Control reactions were conducted without PaoABC and it was seen that the 
addition of PaoABC has little affect on the formation of the carboxylic acid (Table 4, entry 2 
and 5) which suggests PaoABC is being deactivated by TEMPO. 
 
Table 4 Optimisation of TEMPO Laccase- PaoABC chemo-bio cascade for oxidation of 3-
fluorobenzaldehydea 
 
Entry [M] pH 
TEMPO 
(mol%) 
Laccase 
(U) 
Catalase 
(µL) 
PaoABC 
(µL) 
Yield 
(242:213:259)b 
1 10 mM 6.5 15 1.5 100 5 100:0:0 
2 “ 5 “ “ “ “ 5:79:14 
3 “ “ “ - “ “ 69:10:20 
4 “ “ “ 1.5 - “ 4:84:10 
5 “ “ “ “ 100 - 1:82:16 
6 “ “ “ “ - - 1.5:80:17 
7 “ “ “ - - - 62:37:0 
8c “ “ “ 1.5 100 5 2:11:86 
9d “ “ “ “ “ “ 4:5:89 
aReaction conditions: X µL PaoABC (13.2 mg/mL), X µL catalase (3.3 mg/mL), 3 µL 242 (1 M 
in MeCN 10 mM Final concentration) in 50mM pH X potassium phosphate buffer (300 µL final 
volume) 37°C, 16hr.bYield was calculated by RP-HPLC on a ODS hypurity C-18 column with a 
flow rate 1mL/min and mobile phase 25% MeCN: 75% Water + 0.1% TFA.cAfter 4 hour the 
reaction was heated to 80°C for 5 minutes and allowed cool. After this time PaoABC was 
added. dAfter 4 hour the reaction was heated to 80°C for 5 minutes and allowed cool. After this 
time PaoABC was added and catalase. 
 
 
O H
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50mM KPi pH X, O2
O OH
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Chemocatalysts are sometimes not compatible with biocatalysts for a variety of reasons. 
Reaction of the enzymes amino acids with the chemocatalyst can render the biocatalyst inactive 
as a result of a conformational change of the quaternary structure. This was observed by Turner 
and Ward in which they attempted to combine an iridium transfer hydrogenation catalyst with 
MAO-N190 which resulted in deactivation of the biocatalyst. In these cases a one pot two step 
reaction sequence is required. Therfore after initial oxidation of the alcohol by TEMPO, the 
reaction was heated to 80°C to denature the laccase and to prevent TEMPO regeneration. 
PaoABC was then added which resulted in a significant increase of conversion to the acid 
(Table 4, entry 8). PaoABC is working below its pH optimum and so this may be a reason for 
incomplete conversion to the acid.  However, when this system was applied to the oxidation of 
cinammyl alcohol, low conversion to the acid was observed with many additional 
uncharacterised side products. To this end, GOaseM3-5 was revisited which resulted in 
quantitative conversions of the alcohol to the acid over 16 hours (Table 5). 
 
Table 5. Optimisation of GOaseM3-5-PaoABC bio-bio enzymatic cascade for the oxidation of 
cinnamol. 
 
 
Entry pH 
GoaseM3-5 
(3.7mg/mL) 
Catalase 
(3.3mg/mL) 
PaoABC 
(13.3mg/mL) 
Yieldb 
(283:232:294) 
1 5 60µl 30µl 5µl 100:0:0 
2 6.5 “ “ “ 5:14:79 
3 7.5 “ “ “ 0:0:100 
aReaction conditions: X µL GOaseM3-5 (3 mg/mL), X µL PaoABC (13.2 mg/mL), X µL catalase 
(3.3 mg/mL), 3 µL X (1M in MeCN, 10 mM final concentration) in 50mM pH X potassium 
phosphate buffer (300 µL final volume) 37°C. bYields calculated by GC 
 
 
 
GOase M3-5
50mM KPi pH X, 37oC 
catalase, O2 (air)
PaoABC
50mM KPi pH X, 37oC
catalase, O2 (air)
O
OHPh
O
HPh
OHPh
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2.3.3 GOaseM3-5/PaoABC cascade 
The alcohols corresponding to the best aldehyde substrates (283-293) for PaoABC were 
selected for a one-pot-one step GOaseM3-5-PaoABC cascade. This resulted in the successful 
conversion of all primary alcohols to carboxylic acids (294-303) with, in most cases, 
quantitative conversion at 10 mM substrate concentration (Table 6). 
 
Table 6 Scope of the GOaseM3-5-PaoABC enzymatic cascadea 
 
 
aReaction conditions: 103 µL GOaseM3-5 (3 mg/mL), 5 µL PaoABC (13.2 mg/mL), 33 µL 
catalase (3.3 mg/mL), 3 µL  (1M in MeCN 10mM final concentration) in 50 mM pH 7.6 
potassium phosphate buffer (159 µL),  37°C shaking overnight. bConversions calculated by GC. 
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A time course study for the conversion of phenyl ethanol to phenyl acetic acid revealed no 
aldehyde intermediate (Figure 21), indicating that the second oxidation catalysed by PaoABC is 
extremely rapid. 
 
 
 
 
Figure 21. 10mM Phenyl ethanol GOaseM3-5-PaoABC bio/bio cascade time course 
 
This methodology compares very well against state-of-the-art chemical oxidations such as the 
ruthenium based method recently reported by Milstein49. Our catalytic system utilises molecular 
oxygen as the terminal oxidant and operates under mild conditions and is totally 
chemoselective. Milstein’s procedure requires refluxing NaOH, argon atmosphere but is also 
plagued by side reactions such as hydrogenation of double bonds. Interestingly, in one substrate 
we obtained 50:50 aldehyde:carboxylic acid (Table 6, compound 303) which suggests that 
PaoABC may be showing chiral selectivity. This will be explored in a later chapter (Chapter 4). 
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2.3.4 Preparative scale biotransformations. 
We then set out to scale up our new catalytic system using 3-phenylbutan-1-ol (285) 
however increasing substrate concentration to [S] = 30 mM was met with decreased acitivity of  
GOaseM3-5 (Table 7, entry 1). Large quantities of GOase were required to obtain high 
conversions of 3-phenylbutan-1-ol (Table 7, entry 2). Interestingly, PaoABC showed a 
remarkable tolerance of high substrate concentration, as NMR of the crude reaction could 
identify no aldehyde intermediate. Since GOaseM3-5 currently represents the limiting activity it 
will be necessary to engineer GOase variants that are more tolerant to higher alcohol 
concentrations. Overall the GOaseM3-5-PaoABC one-pot conversion provides a highly green 
and direct method for the conversion of alcohols to carboxylic acids. However, if it is to become 
industrially relevant the limitation of low substrate concentration must be addressed. 
 
Table 7 Optimisation of GOaseM3-5-PaoABC 30mM scale cascade oxidation of 3-phenylbutan-
1-ol (285)a. 
 
Entry 
Temp 
(°C) 
Catalase 
(3.3 mg/mL) 
GOaseM3-5 
(1.3 mg/mL) 
PaoABC 
(13.3 mg/ml) 
Conversion 
(285:280:301)[a] 
1 25 109 µL 268 µL 16.6 µL 62:0:38 
2 37 “ 400 µL “ 30:0:70 
3 “ 180 µL “ “ 12:0:88 
4 “ “ 500 µL “ 15:0:85 
aReaction conditions: X µL GOaseM3-5 (3 mg/mL), X µL PaoABC (13.2 mg/mL), X µL catalase 
(3.3 mg/mL), 285 µL (2 M in MeCN 30 mM final concentration) in 50 mM pH 7.6 ptassium 
phosphate buffer to a final volume of 1 mL, shaking overnight. bConversions calculated by 1H 
NMR of crude isolated product 
 
2.4 GOaseM3-5 unusual activity with PaoABC (inhibition studies) 
Interesting unpublished results from the Turner group indicate that many of the substrates such 
as phenylethanol (284), which were successful in our cascade, are not substrates for GOaseM3-5. 
GOase M3-5
50mM KPi pH 7.5, 37oC 
catalase, O2 (air)
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This led us to believe that perhaps the aldehyde product of the alcohol oxidations are inhibitors 
for GOaseM3-5. However, in our system the PaoABC removes the aldehydes rapidly. 
Benzyl alcohol has been shown by us to be a very good substrate for GOaseM3-5. 
Therefore we tested if phenylacetaldehyde at different concentrations would act as an inhibitor 
(Table 8). Indeed phenylacetaldehyde did have an inhibitory affect even at concentrations as 
low as 1 mol% (Table 7, entry 2). However activity still remained, which does not account for 
total inactivity observed when phenyl ethanol is used as substrate.  
We postulated that perhaps the phenylacetaldehyde that is formed from phenylethanol, 
in the active site, irreversibly binds to the protein and thus inactivating it. To simulate this we 
preincubated 1 mM phenylethanol with GOaseM3-5 (to form phenylacetaldehyde in the active 
site), prior to the addition of 10 mM benzyl alcohol. 
 
Table 8 GOaseM3-5 inhibition by phenylacetaldehyde 
 
Entry 
Molarity 
[S] 
Inhibitor (mM) Conversion (%)a 
1 10 mM 0 100 
2 “ 0.1 75 
3 “ 0.3 45 
4 “ 0.7 38 
5 “ 1 36 
aReaction conditions: 103 µL GOaseM3-5 (3 mg/mL), 5 µl PaoABC (13.2 mg/mL), 33 µL 
catalase (3.3 mg/mL), 3 µL benzyl alcohol (1 M in MeCN 10 mM Final concentration), X µL 
Phenylacetaldehyde (100 mM in MeCN), in 50 mM pH 7.6 ptassium phosphate buffer to a final 
volume of 1 mL, 1 hr. aYield was calculated by RP-HPLC on a ODS hypurity C-18 column with 
a flow rate 1ml/min and mobile phase 25% MeCN: 75% Water + 0.1% TFA 
 
Despite this preincubation benzyl alcohol was converted to 56% within an hour and although 
inhibition had taken place, this was not to the extent we had observed when phenylethanol was 
used on its own.  
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 We then attempted to simulate cascade conditions by the addition of PaoABC to rescue 
the GOase in the previous reaction and to identify if we could obtain the carboxylic acid 
product. Only phenyl ethanol, benzyl alcohol and benzoic acid were present in the reaction 
mixture after a further hour, indicating that GOaseM3-5 has been inactivated as both alcohols 
have not been transformed to the corresponding aldehydes after this time. It is evident from this 
result, PaoABC must be present from the beginning of the reaction to instill its positive effect 
on GOaseM3-5 
Thus it remains unclear why phenylethanol is a substrate for GOaseM3-5 only under 
cascade conditions. Phenylacetaldehyde is indeed an inhibitor although the extent of inhibition 
does not reflect the inactivity observed in the absence of PaoABC. To this end we believe that 
there is some sort of potentiation of GOaseM3-5 by PaoABC. This could be a result of a 
conformational change of GOaseM3-5 by protein-protein interactions240 between both oxidases 
or perhaps the presence of reactive oxygen species241 generated by PaoABC, that activates the 
GOase active site. Ongoing studies are being conducted to determine the mechanism of this 
apparent potentiation. 
  
2.5 Conclusion 
We have demonstrated a one-pot, single stage tandem cascade for the quantitative conversion of 
26 alcohols directly to their corresponding carboxylic acids, including aliphatic examples, 
employing three oxygen-dependent enzymes, GOaseM3-5, PaoABC and E.coli XDH. This is the 
first time XOR enzymes have been applied in preparative biocatalysis and the two we have used 
have the distinct advantage in that they do not require addition of cofactors.  
 A novel enzymatic screening method was developed, utilising artificial electron 
acceptors DCPIP to facilitate the transfer of electrons out of the molybdenum centre resulting in 
a colour change, indicating oxidation. This concept of using artificial electron acceptors238 is 
exciting as water soluble metal catalysts could potentially be used to facilitate electron transport 
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which could subsequently carry out a chemical transformation such as hydrogenation in novel 
bio-chemo cascade. 
 The major limitation of the discovered bio-bio cascades is the relatively low substrate 
concentration in which one of the combined enzymes tolerate. In the first benzyl alcohol 
cascades, E.coli XDH was highlighted as the limiting factor. When substrate concentrations 
above 50 mM were employed, a decrease in aldehyde conversion was observed but GOaseM3-5 
remained highly active. PaoABC may circumvent the issues of scale up associated with E.coli 
XDH as the new enzyme is much more active than the commercially available XDH. Utilising 
PaoABC and GOaseM3-5 in tandem one-pot oxidation of benzyl alcohols could tolerate much 
higher substrate concentrations and this work is ongoing in our laboratory. 
 In contrast, the cascades using inactivated alcohols indicated the alcohol oxidase was 
now the limiting factor. When substrate concentrations were increased past 30 mM, the activity 
of GOaseM3-5 decreased most likely as a result of substrate inhibition. Unfortunately, this could 
not be addressed by increasing GOaseM3-5 concentration. Interestingly, no aldehyde 
intermediate was present in the reaction mixtures indicating rapid oxidation of the aldehyde 
intermediates by PaoABC. Evaluation of PaoABC, GOaseM3-5 and E.coli XDH stability, 
immobilisation and creation of additional mutants will facilitate scale up of these cascade 
processes. 
 In addition, we have observed a novel potentiation effect by combining GOaseM3-5 and 
PaoABC. We have successfully expanded the substrate scope of GOaseM3-5 by combining the 
alcohol oxidase with PaoABC. Substrates previously believed to be not accepted by GOaseM3-5 
furnished  carboxylic acids in cascade conditions. Although the mechanism of this potentiation 
is unknown at this time it may be key to unlocking a potentially very powerful alcohol oxidase 
with a wide substrate scope.  
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Chapter 3 
3.0 Steps towards the dynamic kinetic resolution of α-substituted aldehydes 
3.1 Introduction 
With the growing demand for homochiral active pharmaceutical ingredients, 
environmentally friendly synthetic routes to enantiomerically pure compounds are being 
increasingly investigated242-246. 
There are many chemical methods for the synthesis of carboxylic acids from alcohols. 
These methods can also be applied to the of synthesis of α-substituted carboxylic acids such as 
profens, however only from an enantiomerically enriched starting material. Traditional chemical 
methods employing chromium reagents247, potassium permanganate248, palladium249, 
ruthenium250 often operate at high temperature and use strongly basic or acidic conditions which 
have the further drawback of racemisation of enantiopure intermediates. For this reason 
alternative routes have been explored. The use of chiral auxiliaries to install the chiral methyl 
group on profen drugs have been reported242 but installation and hydrolysis of the auxiliary are 
required leading to unwanted extra steps, lower yields and lack of green chemistry credentials. 
To this end numerous biological approaches have been developed applying lipases in 
both the kinetic and dynamic kinetic resolution of profen esters251.  Recently Holmann178 has 
reported an oxidative dynamic kinetic resolution of profen aldehydes using ADH-9VI with in 
situ NAD+ regeneration to promising ees, albeit at low substrate concentration (Scheme 59). 
 
 
 
Scheme 59 Oxidative dynamic kinetic resolution of profen aldehydes by ADH. 
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With the seminal work by Holmann in mind, we believe our recently developed 
GOaseM3-5-PaoABC could be applied to the synthesis of enantiopure α-substituted carboxylic 
acids via an enzymatic dynamic kinetic resolution one pot cascade.  
3.2 Dynamic kinetic resolution of profen esters 
Results from the previous cascade indicated that one particular chiral substrate 303 was 
only converted to 50% of the carboxylic acid (Table 6, substrate 303) suggesting that perhaps 
PaoABC was showing enantioselectivity.  To this end a range of α-substituted aldehydes 
including profen precursors were synthesized to explore the extent of enantioselectivity 
exhibited by PaoABC and to assess its applicability in the synthesis of enantiopure profens via 
dynamic kinetic resolution (DKR) (Scheme 60). 
 
 
Scheme 60 Dynamic Kinetic resolution of profen aldehydes. 
 
In a DKR, as with a classical kinetic resolution, one enantiomer reacts slowly under the 
reaction conditions. In addition, the rate of racemisation of the starting material is fast relative 
to the rate of the asymmetric transformation. Therefore using DKR it is possible to convert 
100% of racemic starting material to enantiopure product due to equilibrating racemisation of 
starting material. 
 
 
R
O
H
R
O
H
R
O
OH
R
O
OH
Krac
kFast
kSlow
Results!and!Discussion! ! Chapter!3!|!!
! 101!
3.2.1 Synthesis of  profen aldehydes and kinetic resolution. 
Flurbiprofenal (304), ibuprofenal (305) and ketoprofenal (306) were synthesised via 
their corresponding methyl esters by diisobutyl aluminium hydride reduction (DIBAL-H) as test 
substrates for the biotransformation (Scheme 51). 
 
 
Scheme 51 Synthesis of profen aldehydes. 
 
The profen aldehydes were indeed substrates for PaoABC as determined by the previous DCPIP 
screening method. However, HPLC analysis indicated that no enantioselectivity was observed 
at 50% conversion. The initial substrate 2-ethyl hexanol, which indicated potential 
enantioselectivity posses a bulkier α-substituent compared to the methyl substituent of the 
profens. We believe this steric bulk may be required for the enzyme to discriminate between 
enantiomers and so we set out to examine this hypothesis by synthesising a variety of α-
substituted aldehydes to determine the E value for each substrate. 
 
3.3 Kinetic resolution of α-substituted aldehydes 
3.3.1 Synthesis of substrates 
A range of aldehyde substrates and carboxylic acid standards were synthesised using a 
three step reaction sequence from methyl 2-phenylacetate (307) as starting material (Scheme 
52). We postulated that increasing R group chain length may provide additional bulk in which 
enantiomers may be easily differentiated by the enzyme active site. Additionally, benzyl and 
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allyl substrates were chosen as π-stacking interactions may allow them to adopt a conformation 
not possible with alkyl chains and may lead to increased enantioselectivities. 
 
 
Scheme 52 Reaction sequence for the synthesis of substrates and racemic standards (for yields 
see Chapter 6). 
 
The strong sterically bulky lithium disopropylamide (LDA) was chosen as a suitable 
base for ester alkylation over other strong bases such as NaOH or sodium hydride (NaH) to 
avoid unwanted dialkylation of the starting material252. In the case of the unreactive secondary 
halide isopropyl bromide, alternative reaction conditions employing the lithium de-aggregator 
1,3-Dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone (DMPU) was used to facilitate efficient 
alkylation by increasing reactivity of the resulting lithium enolate253, albeit with low conversion 
to 315. Base hydrolysis of the resulting esters provided the α-substituted carboxylic acid 
standards in quantitative conversion in all cases. The aldehyde substrates were synthesised via 
Lithium aluminium hydride (LiAlH4) reduction of the corresponding esters followed by 
subsequent Swern oxidation254 to yield the desired racemic α-substituted aldehydes. 
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3.3.2 Kinetic resolution of alpha substituted aldhehydes (Calculation of E values) 
When a racemic substrate is subjected to an enzymatic reaction, chiral discrimination 
between the can enantiomers occur. As a consequence, each of the enantiomers can be obtained 
in only 50% yield. For an efficient kinetic resolution the rate of oxidation of one enantiomer 
must be much faster than the rate of the other enantiomer. In an extreme case the reaction will 
only proceed on one enantiomer leaving the other enantiomer unreacted. However this is not the 
case in many enzymatic reactions and in practice one a decrease in reaction rate beyond 50% 
conversion. In such cases the velocity of the transformation of each enantiomer varies with the 
degree of conversion and the optical purity of both substrate (eeS) and product (eep) becomes a 
function of conversion3. 
For irreversible reactions such as oxidation, selectivity is expressed as Enantiomeric 
Ratio (E) and can be mathematically linked to  the conversion (c) of the reaction and the optical 
purities of substrate (eeS) and product (eep). The dependence of enantioselectivity and 
conversion can be expressed in the following equation, which is used to obtain all the E values 
relating to PaoABC with each subsequent α-substituted aldehyde oxidation3. 
 
! = In[1 − c 1 + ee+ ]In[1 − c(1 − ee+)] 
 
Using the previous DCPIP screen, all our synthesised aldehydes were confirmed as 
substrate for PaoABC. The oxidations were initially performed for 5 hours and the conversions 
and any ees were determined by chiral HPLC (Table 9). 
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Table 9 Initial PaoABC catalysed oxidation of α-substituted aldehydesa 
 
Entry 
Substrate 
R = 
Time 
(hr) 
Conversion to 
acidb 
(%) 
ee of acidc 
1   5 91 16 
2  “ 86 23 
3  “ 97 7 
4  “ 65 25 
5  “ 36 0 
6 
 
“ 90 9 
7 
 
“ 56 5 
8  “ 13 3 
aReaction conditions: 2 µL PaoABC (13.2 mg/mL), 33 µL catalase (3.3 mg/mL), 3 µL (1 M in 
MeCN 10mM final concentration) in 50 mM pH 7.5 potassium phosphate buffer (262 µL). 
bConversions determined by HPLC using a chiracell AD-H column 95:5 hex:IPA, flowrate (1 
mL/min). Conversions adjusted by the comparison of a 1:1 NMR authenticated standard of 
aldehyde and acid. cee calculated by chiral HPLC 
 
All substrates except 328 (Table 9, entry 5) showed some selectivity and also straight chain 
aliphatics were converted faster than the bulky substrates (Table 6, entry 5,7,8). To this end the 
E value of all substrates was calculated and the best substrates were examined in detail via 
timecourse analysis to identify if any substrates could potentially be used in DKR (Table 11). 
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Table 10 E value of α-substituted aldehydesa 
 
 
Entry R E[a] 
1 Me 3 
2 Et 6 
3 Pr 4 
4 Bu 2 
5 CH2iPr 1 
6 CH2Cy 1 
7 Bn 1 
8 CH2C(H)CH2 2 
9 iPr 11 
aReaction conditions: 2 µL PaoABC (13.2 mg/mL), 33 µL catalase (3.3mg/mL), 3 µL substrate 
(1M in MeCN 10 mM Final concentration) in 50 mM pH 7.0 potassium phosphate buffer (262 
µL) b E value was calculated using the above equation .  
 
It is accepted that an E value of less than 15 for a specific substrate indicates poor 
enantioselectivity3. The E values of PaoABC for all aldehydes were below 15 indicating that 
PaoABC’s enantioselectivity is generally very low. This signifies that the active site of PaoABC 
is large which is not surprising as we have yet to find an aldehyde it will not oxidise. This large 
active site results in each enantiomer of the racemic aldehyde substrate having a similar binding 
interaction with the appropriate amino acid residues in the binding site leading to low enzyme 
enantioselectivity.  
The effect of chain length of the R group on the enantioselectivity is unclear. Although 
increasing the chain length from a methyl group to an ethyl group doubled the E value from 3-6 
(Table 10, entries 1 & 2), further chain length had a negative effect (Table 10, entries 3 & 4). 
This implies that there may not be a steric influence on the enantioselectivity or in the transition 
state, the freely rotating alkyl chains can position themselves away from the reaction centre. 
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Additionally, the presence of sterically demanding groups (Table 10, entries 5 & 6) showed no 
enantioselectivity and we believe these large groups are positioned too far away from the 
reaction site to influence the rate of the enantiomers reactivity. The potentially π stacking 
substrates also exhibited poor enantioselectivity (Table 10, entries 7 & 8). Encouragingly, the 
isopropyl aldehyde (Table 10, entry 9) provided a slightly imporoved E value of 11. The greater 
degree of substitution on the R group may limit the binding for one enantiomer. 
 
Table 11 Conversion, ee,  calculated E value and time course analysis of the oxidation of α-
substituted aldehydes by PaoABCa. 
 
Entry Substrate Time (min) Conv (%)b ee of acidc Ed 
1 340 60 43 39 3 
2 324 20 23 62 6 
3 325 60 26 50 4 
4 331 60 44 70 11 
aReaction conditions: 2 µL PaoABC (13.2 mg/mL), 33 µL catalase (3.3 mg/mL), 3 µL substrate 
(340, 324, 325, 321) (1M in MeCN 10 mM final concentration) in 50 mM pH 7.0 potassium 
phosphate buffer (262 µL). bConversion determined by normal phase HPLC. Conversion was 
adjusted by comparison of a 1:1 mix of aldehyde and acid. cee was calculated by chiral HPLC 
using a chiracel AD-H column with eluent 98:2 Hexane:IPA with a flow rate 1 mL/min. dE 
value calculated via the above equations 
 
R
O
H
R
O
OHPaoABC, Catalase
50mM KPi pH 7.0, O2, RT
R = Me (340)
       Et (324)
       Pr (325)
       iPr (331)
R = Me (341)
       Et (332)
       Pr (333)
       iPr (339)
Results!and!Discussion! ! Chapter!3!|!!
! 107!
 
Figure 22 Analysis of the reaction mixture of the 10 mM oxidation of α-substituted aldehdyes 
340, 324, 325 and 331 showing a decrease in ee with increasing conversion. 
 
We then set out to optimise the reaction conditions using the best substrate, isopropyl 
substituted aldehyde (331). We believed that changes in pH might alter the protonation state of 
key active site residues of paoABC. Higher pH may also facilitate enolisation of the α 
substituted aldehyde and may lead to better enantioselectivity if the rate of enolisation is faster 
than the oxidation of the unfavoured enantiomer239. Upon alteration of the pH (Table 12) no 
significant increase in the E value was observed although pH 10 (Table 16, entry 4) did provide 
conditions in which an E value of 14 was obtained. The pH optimum of PaoABC is between 6-8 
as we have shown (Figure 5) and when subjected to conditions outside this range, a decrease in 
activity is observed (Table 12, entry 1,4,5). Interestingly, PaoABC remains active even at 
extreme pHs albeit with lower conversions (Table 12, entry 5). 
 
 
 
 
0"
10"
20"
30"
40"
50"
60"
70"
80"
90"
100"
0" 10" 20" 30" 40" 50" 60" 70" 80" 90" 100"
ee
"o
f"a
ci
d"
pr
od
uc
t"
Conversion"(%)"
Conversion"vs"ee"of"acid"products"
Me"(340)"
Et"(324)"
Pr"(325)"
iPr"(331)"
Results!and!Discussion! ! Chapter!3!|!!
! 108!
 
 
Table 12 Effect of pH on the E value associated with the oxidation of 331 with PaoABCa 
 
Entry pH Time (min) 
Conversion 
(%)b 
eec Ed 
1 5 120 43.4 64 7 
2 7 60 44.3 70 10 
3 8 40 41 70 9 
4 10 120 40 79 14 
5 11 120 38.6 75 11 
aReaction conditions: 2 µL PaoABC (13.2 mg/mL), 33 µL catalase (3.3 mg/mL), 3 µL substrate 
(1M in MeCN 10 mM final concentration) in 50mM pH X buffer (262 µL). bConversion 
determined by normal phase HPLC. Conversion was adjusted by comparison of a 1:1 mix of 
aldehyde and acid. cee was calculated by chiral HPLC using a chiracel AD-H column with 
eluent 98:2 Hexane:IPA with a flow rate 1mL/min. dE value calculated via the above equations 
 
3.4 Second Generation substrate. 
With the success of the isopropyl aldehyde (331) we postulated that substrates with side chain 
groups that could interact with the active site may show increased enantioselectivity. To this 
end we proposed the synthesis of the lactol (346), which in an aqueous medium, would be in 
equilibrium with its aldehyde-alcohol (347). The free hydroxyl group could coordinate via 
hydrogen bonding which may lead to better enantiodiscrimination255 
 
3.4.1 Synthesis of second generation substrate 
A four step synthetic route was designed for the synthesis of alcohol 347 (Scheme 53), 
which comprised firstly of the alkylation of phenylacetaldehyde with the TBDMS protected 
hydroxy bromide, reduction of the alkylated product and subsequent Swern oxidation to furnish 
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the protected hydroxy aldehyde. Final deprotection of the TBDMS protected alcohol would 
afford the desired lactol 346. 
 
Scheme 53 Synthetic route to compound second generation substrate 
 
Initial attempts to alkylate phenylacetaldehyde (307) with the TBDMS protected 
alcohol (342) were unsuccessful using our previously established alkylating procedure 
employing LDA. To this end a solvent and base screen was initiated to determine optimum 
reaction conditions for the transformation (Table 13). 
Three bases were tested, LDA, NaH and t-BuOK. Only t-BuOK furnished the desired 
alkylated ester in 60% isolated yield. Further improvements were met by employing the polar 
aprotic solvent DMF, which provided the alkylated ester in 95% isolated yield (Table 13, entry 
4).  
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Table 13 Base and solvent screen for the alkylation of methyl phenylacetaldehyde 
 
Entry Base Solvent Temperature Time Yielda 
1 LDA THF -78°C to RT 16Hr Decomp. 
2 NaH ‘ 0°C to RT ‘ Decomp. 
3 t-BuOK ‘ ‘ ‘ 60% 
4 ‘ DMF ‘ ‘ 95% 
aIsolated yield of product 
 
 The previously employed LiAlH4 reduction step was again unsuitable with substrate 
343 as although the ester functional group was reduced, the protecting group was also cleaved 
to provide the deprotected diol (Table 14, entry 1). A possible explanation for this cleavage is 
the nucleophilic attack by hydride on the electrophilic silicon centre cleaving the Si-O bond in 
the process. This is surprising as TBDMS ethers are generally stable in the presence of 
LiAlH4256. Using either of the milder reducing agents DIBAL-H and lithium borohydride 
furnished the pure alcohol 344.  
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Table 14 Screening of chemical reductants 
 
Entry Reductant Solvent Temperature 
Yield 
(%)a 
1 LiAlH4 THF 0°C 0 
2 DIBAL-H DCM -78°C 50 
3 LiBH4 THF 0°C 65 
aReaction was stopped when all starting material was consumed as determined by TLC. Isolated 
yield of product. 
 
Swern oxidation of the mono protected alcohol 344 was successful in providing the protected 
aldehyde (345, 78% yield) and subsequent TBAF deprotection furnished the lactol (346) in 75% 
yield (Scheme 54). 
 
Scheme 54 Successful synthesis of lactol substrate 
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The carboxylic acid standard was synthesised through a two step reaction sequence from the 
alkylated ester (Scheme 55). 
 
 
Scheme 55 Proposed synthesis of carboxylic acid standard 
 
Base catalaysed hydrolysis of the protected ester (343) would provide the protected carboxylic 
acid (348). However, mild conditions were necessary to avoid the deprotection and subsequent 
cyclisation to form the unwanted lactone (350). Initially, a 2M aqueous lithium hydroxide 
solution in a 3:1 methanol: water mixture at room temperature was attempted but was met with 
the formation of the unwanted lactone product (350). A less basic system utilising 0.5M lithium 
hydroxide in THF/water (50:50) at 0°C was successful in the formation of the desired 
carboxylic acid (349) in 79% isolated yield. The common silyl deprotecting agents such as 
TBAF resulted in the unwanted cyclized lactone product. TBDMS deprotection was 
accomplished using the mild acid, camphorsulphonic acid (CSA) to provide the carboxylic acid 
standard in quantitative yield (Scheme 56). 
 
 
Scheme 56 Synthesis of carboxylic acid standard. 
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3.4.2 Enzymatic oxidation of lactol substrate. 
Interestingly when lactol 346 was subjected to oxidation by PaoABC, no carboxylic 
acid product was formed. DCPIP indicated oxidation was taken place but not to our expected 
product. The oxidation product was determined to be the lactone after HPLC analysis (Scheme 
57).  
 
 
Scheme 57 Lactone formation by PaoABC 
Although lactones have been formed from diols using alcohol dehydrogenases such as 
HLADH via a lactol intermediate257, the substrate for these oxidations is not the aldehyde but 
the hemiacetal. Aldehyde oxidases on the other hand are known to not accept hydrates due to 
the presence of nucleophilic Mo-OH and so the resulting product should be the acyclic alcohol-
acid. However in this case we obtain the lactone product Scheme 57. 
 
Scheme 58 Different substrates for molybdoenzymes and alcohol dehydrogenase 
 
In molybdoenzyme oxidations of aldehydes, the incorporated oxygen is derived from 
water208,216. We therefore believe that in the presence of tethered intramolecular nucleophiles 
such as the hydroxyl group present in our substrate, the rate of cleavage of the molybdoester 
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intermediate by water may be lower than cyclisation by the tethered hydroxyl group. (Figure 
23). To eliminate the possibility that the hydroxyl acid is spontaneously cyclizing we incubated 
the hydroxy-acid with paoABC. No cyclisation was evident after HPLC analysis and so we 
believe the postulated mechanism is plausible. 
 
 
Figure 23 Postulated mechanism for the formation of lactone products. 
 
Despite the interesting reactivity displayed by PaoABC on substrate 346 no 
enantiodiscrimination was observed and the lactone (350) was racemic at 50% conversion. 
 
3.5 Conclusion: 
The E values for the oxidation of a range of racemic aldehyde substrates by PaoABC 
have been determined. The enantioselectivity of PaoABC for aldehyde substrates is generally 
low and this correlates with unpublished findings that the active site of PaoABC is open and 
large. There is a steric influence associated with PaoABC’s enantioselectivity as sterically bulky 
carbons close to the reaction centre display slightly improved E values (14). To further test this 
steric effect, future studies could include substrates with a more sterically demanding R group 
such as trityl or t-butyl group. Additionally, medium engineering techniques such as the 
addition of water-miscible organic co-solvents to the reaction mixture258 or the use of ionic 
liquids could improve the enantioselectivity259. Directed evolution stratagies could also increase 
the enantioselectivity of PaoABC 
Kinetic resolutions are largely unsustainable in organic synthesis due to a theoretical 
50% maximum yield of enantiopure product. Therefore, if successful kinetic resolutions using 
PaoABC could be identified these could be adapted as dynamic kinetic resolutions by 
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manipulation of reaction conditions such as temperature or pH to facilitate in situ racemisation 
of the. However, at present wild type PaoABC is unsuitable to realise this task. Directed 
evolution strategies would be necessary to develop a more enantioselective catalyst. Further 
studies will then be needed to identify whether successful dynamic kinetic resolutions could be 
combined with the alcohol to aldehyde biotransformation catalysed by GOaseM3-5 or additional 
mutants in a one pot racemic alcohol to chiral carboxylic acid catalytic in vivo enzymatic 
cascade. 
Despite the lack of enantioselectivity associated with PaoABC, the biocatalyst did 
display unusual reactivity with lactols. The expected alcohol acid was not formed, rather the 
unexpected lactone was provided in a oxidative cyclisation transformation. This reaction has not 
been previously reported using molybdoenzymes. 
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Chapter 4 
4.0 Oxidative cyclisation of amino alcohols. 
4.1 Introduction 
Amide bond formation is a fundamental reaction in chemical synthesis260,261. The 
importance of amides in chemistry is well recognized and has been studied extensively over the 
past century262. Although many methods are known for the synthesis of amides, preparation 
under neutral conditions without the generation of copious amounts of waste is a challenging 
goal263. For this reason, the ACS GCIPR (American Chemical Society Green Chemistry 
Institute Pharmaceutical Roundtable) identified amide bond formation as one of the most 
problematic reaction in the pharmaceutical industry, and labeled it as a high  priority research 
field264. 
 Direct coupling between activated carboxylic acids (acid chlorides, anhydrides) is a 
common approach for amide bond formation. These methods suffer from several limitations 
such as the production of large amounts of waste (as a result of the use of stoichiometric 
coupling reagents), tedious work-up and difficulties in avoiding 
racemisation/epimerisation260,265. With the demand for environmentally benign methods for 
amide formation a number of transition metal-catalysed procedures266 starting from alcohols267-
269, aldehydes270, nitriles271, aryl halides272, aldoximes273, alkenes and alkenes274 have been 
developed. In particular, metal-catalysed reactions between an alcohol and amine in which only 
hydrogen is produced as a by-product are the most atom economical and environmentally 
friendly procedures for mild amide bond formation to date275,276.  
Biomimetic aerobic oxidation of amino alcohols to lactams have recently been reported 
by Bäckvall275. Oxidation was performed using a ruthenium catalyst which oxidised the 
protected amino alcohol to an aldehyde intermediate which spontaneously cyclised into the 
corresponding hemiaminal. The intermediate is subsequently transformed to the lactam product 
(Scheme 59). 
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Scheme 59  Aerobic lactamisation of amino alcohols 
 
This oxidative cyclisation approach has been demonstrated to provide five-, six-, and seven-
membered benzo fused lactams276 and also a range of lactones277. As only catalytic amounts of 
transition metals are required, these reactions hold good green credentials as atom economy is 
very high. Unfortunately they suffer from high temperatures and the use of environmentally 
damaging solvents. Solvents account for 80-90% of mass utilisation in a typical 
pharmaceutical/fine chemical process and contribute significantly to waste generation278. If the 
aforementioned transformation could be performed at ambient temperature in water with a 
biodegradable catalyst, it would possess superior green credentials and provide a possible 
solution to the lactam bond formation problem. Unfortunately this goal has not been achieved. 
We believe this transformation could be accomplished by employing our recently 
developed enzymatic cascade based on GOaseM3-5 and molybdenum hydroxylases. The double 
oxidation process could provide lactams from amino alcohols via an in situ generated imine. 
This transformation would afford a green amide bond forming reaction as molecular oxygen 
(air) is used as the oxident with the only side product being H2O2. 
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4.2 Activated amino alcohol cyclisation 
We have previously demonstrated in the group that 3,4-dihydrisoquinoline 
(DHIQ)(356) is an excellent substrate for E.coli XDH when used in a cascade with monoamine 
oxidase (MAO-N) which catalayses the oxidation of tetrahydroisoquinolines (THIQ) (355). 
(Scheme 60)  
 
 
Scheme 60 MAO-N D9/E.coli XDH oxidation of THIQ 
 
Hence, we were intrigued to test if the oxidised lactam product could be obtained from the 
oxidative cyclisation of the precursor amino alcohol (Scheme 61).  
 
Scheme 61 Proposed oxidative cyclisation biosynthetic route 
 
Amino alcohol 358 was prepared by reduction of the commercially available cyanoester 360 
with LiAlH4/AlCl3 albeit in low yield of 25%. Other reductants such as DIBAL-H, 
Superhydride  and LiAlH4 gave lower conversions to the desired amino alcohol (Scheme 62) 
 
 
Scheme 62 Synthesis of amino acid starting material 
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The oxidation of amino alcohol 358 with GOaseM3-5 was remarkably pH sensitive within the 
range of pH 7.0-8.5 with a pH of 7.0 required to achieve full conversion to DHIQ (Table 15, 
entry 1). Formation of DHIQ is presumed to occur by cyclisation of the initially formed amino 
aldehyde.  
 To identify which of our available molybdoenzymes was best suited for the 
transformation to the amide we performed the reaction with both PaoABC and E.coli XDH at 
different pHs to determine if optimimum mutual conditions with GOaseM3-5 could be obtained 
(Table 16). E. coli XDH performed extremely well at every pH, oxidising DHIQ to the 
corresponding lactam in 100% conversion. 
 
Table 15 Conversion of (2-(2-aminoethyl)phenyl)methanol (358) in GOaseM3-5 catalysed 
reactions with different pH-values of the reaction systema. 
 
 
Entry Molarity (mM) pH value Conversion [%]b 
1 10 7.0 100 
2 “ 7.5 39.7 
3 “ 8.0 47.6 
4 “ 8.5 11 
aReaction conditions: 103 µL GOaseM3-5 (3.0 mg/mL), 33 µL catalase (3.3 mg/mL), 3 µL 
substrate (1 M in MeCN 10 mM final concentration) in 100 mM pH X potassium phosphate 
buffer final volume 300 µL, 16hr.   bConversions adjusted by comparing the NMR of a 1:1  mix 
of amino alcohol 358 and DHIQ 356 with HPLC trace. HPLC-conditions: Chiracel OD-H 
column, 1.0 mL/min, 90% hexane (0.1% ethanolamine) : 10% IPA.  
 
 Unfortunately, PaoABC was less efficient at oxidising the imine affording only 65% 
conversion (Table 16, entry 1). However, with the increase of pH an increase in conversion was 
obtained (Table 16, entry 4). This result is noteworthy as this is the first time PaoABC has been 
reported to act on an imine substrate. The poor performance of PaoABC compared to E.coli 
XDH’s is not surprising as the natural substrate of E.coli XDH is xanthine which contains a 
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similar activated imine bond217. To this end, E.coli XDH was chosen as the second enzyme in 
the cascade as it showed satisfactory performance under the reaction conditions identical to the 
GOaseM3-5 catalysed step (Table 16, entry 5) 
To our delight, combining GOaseM3-5 and E.coli XDH in a one-pot reaction for the 
direct synthesis of lactam 357 with an overall conversion of 69% (Figure 24). HPLC analysis 
showed that DHIQ was only present in trace amounts under cascade conditions and was 
consumed immediately by XDH upon formation. GOaseM3-5 however oxidises amino alcohol 
358 at a much slower rate and this step is the limiting factor in the reaction. This observation is 
contradictory to the earlier result (Table 15, entry 1) in which quantitative conversion of DHIQ 
was obtained after 16hr. To this end we postulate that GOaseM3-5 may be inhibited by the 
lactam product which would result in decreased conversion of the lactam product. 
 
Table 16. Conversion of 3,4-dihydroisoquinoline (356) in PaoABC or E. coli XDH catalysed 
reactions with different pH-values of the reaction systema. 
 
Entry 
Molarity 
(mM) 
Aldehyde 
oxidase 
pH-value Conversion[%]b 
1 10 E. coli PaoABC 7.0 65 
2 ‘ E. coli PaoABC 7.5 77 
3 ‘ E. coli PaoABC 8.0 88 
4 ‘ E. coli PaoABC 8.5 85 
5 ‘ E. coli XDH 7.0 >99 
6 ‘ E. coli XDH 7.5 >99 
7 ‘ E. coli XDH 8.0 >99 
8 ‘ E. coli XDH 8.5 >99 
aReaction conditions: 5 µL PaoABC (13.2 mg/mL) or 50 µL E.coli XDH (1.1 mg/mL) 33 µL 
catalase (3.3 mg/mL), 3 µL substrate (1 M in MeCN 10mM Final concentration) in 50 mM pH 
X potassium phosphate buffer final volume 300 µL, 16hr  bConversions adjusted by comparing a 
1:1 mix of DHIQ (356) and lactam (357) Conditions: Chiracel OD-H column, 1.0 mL/min, 90% 
hexane (0.1% ethanolamine) : 10% IPA. 
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Figure 24 GOaseM3-5- XDH cascade timecourse for the conversion of aminoalcohol 358 to 
lactam 357 via the in-situ generated DHIQ (356). 
 
4.3 Determination of the true substrate for imine oxidation catalysed by molybdoenzymes 
PaoABC and XDH 
In the literature there are conflicting reports on the nature of the true substrate in imine 
oxidations catalysed by molybdoenzymes. Some reports indicate that molybdoenzymes act on 
the hemiaminal279 intermediate which could form in aqueous media while others indicate that 
the imine is the true substrate216. NMR analysis of DHIQ (356) in deuterated potassium 
phosphate buffer at pH 6.0-8.0 indicated that no amine aldehyde or DHIQ hemi-aminol was 
present (Figure 25). Only DHIQ signals were observed which suggests DHIQ is the true 
substrate for XDH rather than the amino aldehyde (Scheme 63). It is however possible that the 
hemi-aminal could be formed by enzyme catalysis. 
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Figure 25 NMR analysis of DHIQ (356) in pH 6-8 buffer indicates no aldehyde or hemi-aminal 
present in reaction conditions. Only DHIQ peaks are observed which suggestes that DHIQ is the 
substrate for XDH 
 
It is well documented that in the oxidation of aldehydes by xanthine oxidase the substrate is the 
aldehyde itself and not the hydrated aldehyde208,216. Since the hydrated aldehyde is formally 
analogous to the hemiaminal this fact provides additional support that the imine as the true 
substrate. 
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Scheme 63 Potential substrates for XDH imine oxidation. 
4.4 Oxidative cyclisation of unactivated amino alcohols 
We next turned our attention to a series of more challenging substrates for cascade 
oxidative cyclisation reactions- aliphatic amino alcohols (362-364) (Table 17). Both GOaseM3-5 
and F2 and three different xanthine oxidoreductase enzymes were tested: E.coli XDH, bovine 
xanthine oxidase (XO) and E. coli PaoABC. Neither the bovine (XO) or E.coli XDH gave any 
lactam products at pH 7.0-8.5 (Table 17, entries 6,7,13,14). To our surprise, in this case the 
combination of GOaseM3-5 and PaoABC performed much better, which was the opposite of 
what we observed in the DHIQ oxidation. Substrate with n=2 yielded a trace of valerolactam at 
pH 7.0 (Table 17, entry 8) but at pH 8.5 the conversion increased to 26% (Table 17, entry 11). 
With the shorter chain homologue (n=1) the same pH effect was evident, however in this case 
the conversion to 2-pyrrolidone (365) reached 85% at pH 8.5. The longer chain substrate n=3 
gave no conversion to caprolactam (367) when either alcohol oxidases were employed (Table 
17, entry 15 & 16).  
 The higher conversion to 2-pyrrolidone (365) compared with valerolactam (366) 
presumably reflects the more rapid formation of the 5 membered rather than 6-membered ring 
imine. It is unclear if any carboxylic acid is present in the reaction mixture as only the lactam 
products possess a suitable chromophore (amide bond) for detection by our HPLC. This 
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alternate product could account for the poor yield of the lactams as the longer chain aldehydes 
would be rapidly oxidised to the corresponding acids before cyclisation. Unfortunately another 
limitation is that the formation of imines or aldehydes cannot be monitored (no detectable 
chromophore) and so we cannot determine to what extent the galactose oxidase mutants are 
accepting the amino alcohols as substrates. 
 
Table 17 Conversion of aliphatic amino alcohols in GOaseM3-5/F2-XOR catalysed reactions at 
different pH values.  
 
Entry 
Substrate 
(n = X) 
GOase XOR Enzyme pH 
Yield  
[%][a] 
1 1 M3-5 E. coli PaoABC 7.0 9.6 
2 1 M3-5 E. coli PaoABC 7.5 41 
3 1 M3-5 E. coli PaoABC 8.0 56 
4 1 M3-5 E. coli PaoABC 8.5 85 
5 1 F2 E. coli PaoABC 8.5 22 
6 2 M3-5 Bovine XO 7.0 0 
7 2 M3-5 E. coli XDH 7.0 0 
8 2 M3-5 E. coli PaoABC 7.0 Trace 
9 2 M3-5 E. coli PaoABC 7.5 3.4 
10 2 M3-5 E. coli PaoABC 8.0 20 
11 2 M3-5 E. coli PaoABC 8.5 26 
12 2 F2 E. coli PaoABC 8.5 7.5 
13 2 M3-5 Bovine XO 8.5 0 
14 2 M3-5 E. coli XDH 8.5 0 
15 3 M3-5 E. coli PaoABC 8.5 0 
16 3 F2 E. coli PaoABC 8.5 0 
aReaction Conditions: 2.4 µL substrate (1M in MeCN), 103 µL GOase M3-5 or F2 (103 uL of 3.7 
mg/mL), 33 µL catalase (3.3mg/mL), XOR enzyme in 100mM KPi buffer (300 uL final 
volume). bYields calculated by calibration curves of 2-pyrrolidone, valerolactam and 
caprolactone. 
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It is evident that increasing pH has remarkable effect on conversion. A possible 
explanation for this is that the increased pH facilitates cyclisation of the assumed amino-
aldehyde intermediate giving a higher concentration of the imine for the PaoABC. 
Unfortunately at high pH, GOaseM3-5 is operating above its pH optimum whereas PaoABC is 
known to work over a broad pH range. In order to improve conversion, additional GOaseM3-5 
and XOR mutants must be created and improved analytical methods need to be developed to 
analyse not only product formation but also the intermediate imine and possible non-UV active 
side products. 
4.4 Steps towards β-Lactam forming reactions. 
It is well documented that for XOR-catalysed aldehyde oxidations, the aldehyde is the 
enzymatically active substrate and not the hydrate217. Previously we have demonstrated an 
oxidative cyclisation of hydroxyaldehydes to provide lactones. This may proceed by two 
pathways, 1) intramolecular nucleophilic displacement of the molbydoester via the free alcohol 
and 2) enzymatic oxidation of the lactol intermediate (Scheme 64). Although as already 
mentioned the former is more likely as aldehydes are the known substrates for XOR and not 
lactols. 
 
Scheme 64 Oxidative Lactone formation from hemiacetals  
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If the Mo-ester mechanism is a reality, it is possible more nucleophilic tethered amines 
could also displace the molybdo esters leading to lactam products but imine formation from 
oxidised amino alcohols would undergo further oxidation as already shown. However, short 
chain amino alcohols, which would form highly strained imines, would be excellent substates to 
test this hypothesis as imine formation would not occur. 
 β-Lactams contain a highly strained four membered lactam bond which is of vital 
importance in antibiotic drugs280. Four membered imines are extremely strained and their 
formation under the oxidative cyclisation conditions previously employed with amino alcohols 
and our enzymes would be highly unlikely.  
 
Scheme 65 Possible β-Lactam formation via a molybdoester intermediate 
 
 
Therefore the oxidation of amino alcohol would only produce amino aldehydes and these may 
cyclise via the proposed molybdoester intermediate (Scheme 65).   
 In order to test this hypothesis we synthesized the amino alcohol 368. Amino alcohol 
368 would not form the imine intermediate 372 and can also be detected via RP-HPLC. Upon 
analysis of the reaction mixture by LC-MS, we established that a mass peak corresponding to 
the β-lactam was present indicating that oxidative cyclisation may have taken place (Figure 26).  
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Figure 26 LC-MS of reaction mixture of the GOaseM3-5-PaoABC cascade indicating a mass 
peak corresponding to the desired lactam. 
 
In addition, when the reaction was subject to HPLC analysis all the starting material had been 
consumed and no peak corresponding to the amino acid was present further indicating the 
presence of the cyclized product.  Further work including the synthesis of a genuine standard of 
the β-Lactam and preparative scale biotransformation is ongoing. 
 
4.5 Conclusion 
  We have demonstrated that the oxidative cyclisation of amino alcohols to lactams is 
possible using two oxygen-dependent oxidases. The reaction holds very good green credentials 
as oxygen is the terminal oxidant and the atom economy is high and compares very well against 
other state of the art oxidative cyclisations275,276,281. The major limitation of this methodology is 
that the substrate scope is rather limited due the enzymes’ specificity. The Nylon-6 monomer 
caprolactam could not be synthesised using our oxidative cyclisation methodology and so 
additional mutants are required to extend the enzymes specificity. However the smaller 
pyrrolidone was formed in high conversion (85%). Moreover a refractive index detector (which 
the group has now) would be would be required to fully monitor the formation of intermediates 
without a chromophore. 
 In addition, we have briefly explored the application of oxidative cyclisation to form β-
lactams with promising initial results. We believe that this process has a potential to provide a 
NH
O
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green alternative to classical β-lactam forming reactions which often employ very harsh 
conditions or transition metals and use relatively inaccessible from difficult starting materials282-
284. However, this area must be explored in more detail. 
 Although the current work is limited to cyclic substrates, the approach could potentially 
be transferred to acyclic substrates. The major issue of utilising acyclic imines in buffered 
solutions is the relative stability. Acyclic imines are prone to hydrolysis in aqueous media to 
provide amines and aldehydes which are very good substrates for XOR. If the rate of oxidation 
of the imine is faster than that of the rate of hydrolysis then potentially any imine could be 
transformed into an amide product. However in aqueous media this may not be possible. If the 
substrate specificity of PaoABC could be switched to imine substrates, then perhaps the 
removal of imine substrate would shift the equilibrium towards imine formation. Additionally if 
the reactions could be conducted in organic solvents with minimum water, the rate of hydrolysis 
would probably be lower than the rate of oxidation. However, there are only few examples of 
oxidations by molybdoenzymes in organic solvents285. 
 The use of organic solvents for XOR-catalysed oxidations is indeed highly interesting. 
In a standard XOR catalysed oxidation the incorporated oxygen is derived from water. We have 
suggested that intramolecular displacement of the molybdo ester is possible using 
hydroxyaldehydes and potentially the amines. If reactions are conducted at very low 
concentrations of water in the presence of additional nucleophiles then perhaps esters and 
amides could potentially be synthesised from aldehydes.  
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Chapter 5 
5.0 Enzymatic synthesis of biomass derived furan-2,5 dicarboxylic acid (FDCA) 
5.1 Introduction 
With the rapid growth of the world population and continuing depletion of petroleum 
reserves, green approaches using renewable resources for the production of chemicals will be 
required45. Lignocellulosic biomass is an abundant, inexpensive and sustainable resource from 
which platform chemicals can be derived. 5-Hydroxymethylfurfural (HMF, 373) is derived 
from cellulose via dehydration of glucose and fructose. Due to the instability of HMF, its 
oxidized and more stable form furan-2,5-dicarboxylic acid (FDCA, 377) is listed as one of 
twelve sugar based platform chemicals of interest by the American DOE286,287. 
 Polyethylene terephthalate (PET) makes up 5.9% of the global plastics industry with 
approximately 15 million tons per year being manufactured. It is considered that bio-based 
furan-2,5-dicarboxylic acid (FDCA, 377) could replace PET in this and related co-polymers 
which would be a substantial step towards sustainable plastics manufacture288. In addition, 
FDCA is a building block287 and can be used to synthesise other polyesters289, polyamides290 and 
valuable furanic chemicals291. Obtaining FDCA from biomass at low cost will be essential to 
allow a paradigm shift in green manufacturing although this target is yet to be realized. 
 HMF consists of a furan ring with 2,5-disposed aldehyde and hydroxylmethyl 
functional groups. It can be synthesized from glucose/fructose by dehydration292 in high yield 
although currently only with continuous removal of water or extraction into non aqueous 
solvents or ionic liquids due to instability at high temperatures293. Numerous metal catalysts and 
nano particles have been employed such as Au-TiO2294, Au-C modified with Pd295, Au-
hydrotalicite296, Pt-C297, Au/TiO2298, Pt/ZrO2235, however, these reactions require high 
pressure/temperature and additional additives which decreases the sustainability for 
manufacturing.  Thus, there remains a number of challenges for the steps from cellulose to 
FDCA and their integration. 
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 A catalytic system that uses O2 from air and produces water as the only by-product 
would contribute to establishing a green and sustainable process for conversion of HMF (373) 
to FDCA (377)299. To this end, aerobic Pt nanoparticles300 and gold systems301 have been 
developed but usually require high pH which can partially decompose the unstable HMF. 
 Biocatalytic reactions offer many benefits in the context of green chemistry since they 
can be performed under mild conditions using a biodegradable catalysts302. Synthesis of FDCA 
from HMF has been demonstrated using whole cells, however the need for a continuous carbon 
source feed and low product recovery of the polar FDCA from cell biomass limited its 
potential303. Bioconversions using isolated enzymes can proceed at a significantly higher 
substrate concentration and combine higher productivity with lower water usage. Recently an 
FAD-dependent HMF oxidase was reported to fully oxidise HMF to FDCA using molecular 
oxygen albeit at low substrate concentrations304. In another approach, aryl alcohol oxidase 
(AAO) was used to convert HMF to 5-formylfuran-2-carboxylic acid (FFCA) which was then 
converted to FDCA by an unspecific peroxygenase (UPO)  in a second much slower step. 
 We believed that our previously developed GOaseM3-5- XDH/PaoABC system could be 
adopted for the synthesis of FDCA from HMF (Scheme 66). 
 
 
Scheme 66 Possible intermediates en route from HMF to FDCA. 
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5.1 Oxidation of HMF to FDCA 
5.1.1 Initial aldehyde oxidase screening 
Initial studies revealed that HMF was indeed a substrate for GOaseM3-5 yielding the 
dialdehyde DFF (374), however HMFCA (375) was not available to test. Four molybdenum 
dependent xanthine oxidoreducatases were chosen to screen for activity against all available 
aldehyde substrates DFF (374), HMF (373) and FFCA (376) (Table 18). 
 
Table 18 Screening of xanthine oxidoreductases for oxidation of  HMF, DFF, FFCA 
Entrya Enzyme HMF (373) DFF (374) FFCA (375) Oxidant 
1 E.coli XDHb Active Not active Not active O2 
2 XDH E232Vc Active Active Active DCPIP 
3 
XDH 
E232V/R310d 
Active Active Active DCPIP 
4 PaoABCe Active Active Active O2 
aReaction conditions: Potassium phosphate buffer (50mM, pH 7.6), 3 µL 0.1 M substrate), 30 
µL 0.01 M DCPIP(aq.) final volume 300 µL, 36°C. Activity was determined by the colour 
change from blue to colourless.b E.coli XDH (1.1 mg/mL), cXDH E232V (25.4 mg/mL), dXDH 
E232V/R310M (23 mg/mL), ePaoABC(13.3 mg/mL) 
 
The commercially available E. coli XDH, which we had previously shown to oxidise benzylic 
aldehydes was only active on HMF (Table 18, entry 1). The Rhodocococus capsulatus xanthine 
dehydrogenase (XDH) single variant E232V and double mutant XDH E232V/R310M showed 
activity against all three substrates. These variants possess very low reactivity using oxygen 
from air and require an exogenous electron acceptor such as DCPIP for high conversions as 
electron transport to oxygen is poor. PaoABC, however was able to oxidise all three substrates 
using molecular oxygen as its terminal electron acceptor and so was chosen for its green 
chemistry attributes. 
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5.1.2 Enzymatic oxidation of 50mM HMF by GOaseM3-5 and PaoABC 
A test cascade reaction was performed using HMF with both GOaseM3-5 and PaoABC present to 
identify if FDCA could be produced. Gratifyingly at 10 mM HMF concentration, almost full 
conversion to FDCA was observed (97%) after 1hr, with the key intermediates being DFF and 
FFCA (Figure 27). 
 
 
Figure 27 Enzyme cascade for conversion of HMF with dual combined enzymes (GOaseM3-5 + 
PaoABC) [HMF] = 10 mM 
 
We then investigated the effect of increasing the concentration of HMF (Table 19). At 20 mM 
HMF, after 1 hr, FDCA (44%) was formed along with HMFCA (50%), then after a further 1 hr, 
a small amount of HMFCA was converted to give a final conversion of 55% FDCA (Figure 28). 
This time course indicates that the formation of FDCA occurs mainly via DFF and FFCA and 
that HMFCA is a poor substrate for GOaseM3-5. It is also clear that PaoABC is responsible for 
the formation of HMFCA at this substrate concentration. 
Production of HMFCA could be avoided by using a sequential, stepwise process in 
which the GOaseM3-5 conversion of HMF to DFF was allowed to run to completion prior to 
addition of the PaoABC enzyme. This stepwise reaction furnished the desired FDCA as the only 
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oxidation product cleanly and with 100% conversion (Table 19, entry 3). On increasing the 
starting concentration of HMF further, we found that sufficient buffer capacity to control pH 
was important to enable the reaction to reach completion (Table 19, entry 6). 
 
 
Figure 28 Enzyme cascade for conversion of HMF with dual combined enzymes (GOaseM3-5 + 
PaoABC) [HMF] = 20 mM 
 
This has previously been reported in whole cell biotransformation of HMF to FDCA303. To 
increase the reaction concentration further, we decided that it was necessary to identify the 
reason for PaoABCs low activity at low pH. 
 
5.1.3 Optimisation of DFF conversion by PaoABC to 100mM substrate conc. 
We first implemented the 50 mM DFF transformation at a variety of pHs to identify the 
optimum pH (Table 20). At pH 6 no conversion to FDCA was observed however DFF was 
successfully converted to FFCA (Table 20, entry 1). Additionally pH 9 proved catastrophic to 
PaoABC reactivity as only 18% FFCA was obtained (Table 20, entry 4). The optimum pH for 
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the biotransformation was pH 7-8 in which quantitative conversion was observed after 2 hours 
(Table 20, entries 3-4). 
 
Table 19 Optimisation of the the HMF- 2-step oxidation cascadea 
 
Entry 
[HMF] 
(mM) 
pH 
Buffer 
(mM) 
DFFb FDCAc 
1 10 7.5 50 - 97 
2 20 “ “ - 55 
3 20 “ “ >99 >99 
4 30 “ “ >99 >99 
5 50 “ “ >99 0 
6 50 “ 100 >99 >99 
aReaction conditions: Entries 1&2 are one-pot with all enzymes present; entries 3-6 are 
sequential with PaoABC added after complete conversion to DFF. GOaseM3-5 (3.3 mg/mL) 103 
µL, catalase (3.3mg/mL) 33 µL, 3 µL of x M HMF (in MeCN), potassium phosphate buffer 
(xmM) pH 7.6, final volume 300 µL, then after full conversion to DFF, PaoABC (13.3 mg/mL) 
5 µL. bFormation of DFF was monitored via RP-HPLC using a Thermofisher Hypurity C18 
column with flow rate 0.6 mL/min using 85% water + 0.1% acetic acid and 15% MeCN. 
cFormation of FDCA was monitored via RP-HPLC using a Thermofisher Hypurity C18 column 
with flow rate 1 mL/min using a 98% 10 mM phosphate buffer (pH 6.5) and 2% MeCN mobile 
phase 
 
Increasing the concentration further to 80 mM DFF met with increased reaction times with 
quantitative conversion of DFF to FDCA at pH 7 in 4 hours. The reaction conducted at pH 8 
suffered from lower conversions to the desired carboxylic acid. Finally increasing the 
concentration further to 100 mM met with a major drop in pH (pH <5)(Figure 29) which was 
below optimum pH (6-8) for PaoABC, determined in a previous chapter (chapter 3).  
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Table 20 PaoABC catalysed oxidation of DFF 
 
Entry DFF (mM) pHc 
Buffer 
(mM) 
PaoABC 
(µL) 
Time 
(h) 
FFCAb  
(%) 
FDCAb 
(%) 
1 50 6 200 5 2 100 0 
2 “ 7 200 “ “ 0 >99 
3 “ 8 200 “ “ 0 >99 
4 “ 9 200 “ “ 18 0 
5 80 7 200 “ 4 0 >99 
6 “ 8 200 “ “ 44 66 
7a 100 7 200 “ 16 40 60 
8 “ 7 400 “ 6 0 >99 
PaoABC (13.3mg/mL) apH after 16 h = 4.5. bConversion adjusted by using a 1:1 standard of the 
aldehyde:acid by NMR and comparing the HPLC trace of the same sample and adjusting the 
absorbance accordingly. cInitial pH 
 
 
Figure 29 Time course of FDCA production showing decrease in pH over time for entry 8. 
 
The formation of hydrated aldehydes is heavily reliant on the pH of the system. In addition, the 
formation or lack of formation of hydrated aldehydes can have a significant impact on rates of 
oxidation by oxidases such as the recently reported FAD dependent HMFO oxidase by Fraaije. 
DFF readily forms its hydrate at pH 5-8 (Figure 30) however, FFCA does not (Figure 31). This 
O
OH
O H PaoABC
Buffer pH X, 37oC
catalase, O2 (air)
O
OH
O OH PaoABC
Buffer pH X, 37oC
catalase, O2 (air)
O
OHO
O OH
DFF, 374 FFCA, 376 FDCA, 377
5.8
6
6.2
6.4
6.6
6.8
7
7.2
0
20
40
60
80
100
0 1 2 3 4 5 6
pH
Re
ac
tio
n)
co
m
po
ne
nt
)(%
)
Time)(h)
DFF
FFCA
FDCA
pH
Results!and!Discussion! ! Chapter!5!|!!
! 136!
is a major issue for hydrate dependent oxidases such as HMFO304 and AAO305 as the final 
oxidation step is problematic. However, molybdo-dependent oxidases such as PaoABC require 
the aldehyde substrate which is present at all pHs and so the final oxidation of FFCA is not a 
problem. Therefore we believe that the drop in pH is responsible for reduced conversion as 
PaoABC working outside its optimum pH and not the inability of FFCA to form a hydrate. 
Increasing the substrate concentration further to 100 mM DFF, it was necessary to maintain the 
pH within the optimum of pH 7 by increasing the buffer capacity to 400 mM to allow sufficient 
conversion to the desired dicarboxylic acid (Table 20, entry 8). Thus it appears that the final 
oxidation of FFCA to FDCA is more pH sensitive than the HMF to DFF conversion. 
 
 
 
Figure 30 NMR analysis of DFF (374) clearly showing hydrate formation, peaks at 9.58, 7.59, 
6.82 and 6.15ppm. Ratio of hydrate: aldehyde was identical for each pH. 
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Figure 31 NMR analysis of FFCA (376)  showing no hydrate formation 
 
 
5.1.4 100 mM HMF to FDCA bio-bio in vivo cascade using GOaseM3-5 and PaoABC. 
With the optimized conditions for the DFF conversion in hand it was clear that high 
buffer capacity is essential for efficient catalysis (Table 20, entry 2). HMF at 70 mM 
concentration was cleanly converted to FDCA (Table 21, entry 1). At 100 mM an additional 
portion of catalase was required with the addition of PaoABC (Table 21, entries 2-3), possibly 
due to the extensive reaction time for the first oxidation (>16 hr), during which catalase may be 
deactivated. With our optimized conditions in hand for the conversion of 100 mM HMF to 
FDCA, the preparative scale oxidation of HMF was then realized. Isolation of FDCA by 
crystallisation has been successful after whole cell biotransformations303 however, the removal 
of biomass and numerous extractions into organic solvents reduce sustainability. Therefore, we 
were pleased to find that in our case heat treatment of the solution to precipitate the protein, 
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centrifugation, acidification and filtration is all that was required to obtain pure FDCA in 74% 
isolated yield (Table 21, entry 4) 
 
Table 21 Optimisation of the HMF- 2-step oxidation cascadea 
 
Entry HMF pH Buffer DFFb FDCAc 
1 70 7 300 >99 >99 (80)f 
2 100 “ 400 >99 0 
3d 100 “ “ >99 >99 
4d,e 100 “ “ >99 >99 (74)f 
aReaction conditions:. GOaseM3-5 (3.3 mg/mL) 103 µL, catalase (3.3 mg/mL) 33 µL, 3 µl of xM 
HMF (in MeCN), potassium phosphate buffer (x mM) pH 7.6, final volume 300 µL, then after 
full conversion to DFF, PaoABC (13.3 mg/mL) 5 µL. b Formation of DFF was monitored via 
RP-HPLCusing a Thermofisher Hypurity C18 column with flow rate 0.6mL/min using 85% 
water + 0.1% Acetic acid and 15% MeCN.cFormation FDCA was monitored via RP-HPLC 
using a Thermofisher Hypurity C18 column with flow rate 1mL/min using a 98% 10mM 
phosphate buffer (pH 6.5) and 2% MeCN mobile phase.d Additional portion of catalase was 
added with PaoABC. e Reaction performed on preparative scale. f Isolated yield 
 
5.1.5 Time course of HMF to FDCA bio-bio in vivo cascade using GOaseM3-5 and PaoABC 
For the 50 mM sequential reaction the initial oxidation of HMF was found to be the 
slower step (Figure 25). On addition of PaoABC there is a rapid oxidation of DFF to FFCA. It is 
noteworthy that FDCA is not produced rapidly until almost all of DFF is converted to FFCA. 
This suggests that the dialdehyde is a better substrate for PaoABC. DFF forms the hydrate 
rapidly in buffer but not the FFCA indicating that DFF is more activated to nucleophilic attack 
by water. Therefore we believe DFF is a better substrate because it is more prone to 
nucleophilic attack by the Mo-OH. 
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Figure 25 2-Step oxidation showing high conversion to DFF after 5 h and subsequent rapid 
oxidation of DFF to FFCA and FDCA 
 
Interestingly a small fraction of FFCA is produced prior to the addition of PaoABC which could 
be a result of residual H2O2 in the reaction however we cannot completely exclude the 
possibility of GOaseM3-5 carrying out the oxidation of the hydrate. If the latter is the case, then 
this would represent the first reported oxidation of an aldehyde by GOaseM3-5 
Turning our attention back to the dual enzyme one pot in vivo cascade, we postulated 
that a pH drop might be the limiting factor in our previous attempt at simultaneous catalysis. 
However, oxidation at 50 mM HMF with GOaseM3-5 and PaoABC combined at high buffer 
concentration resulted in predominatly HMFCA after 3 hr which was only slowly converted to 
FFCA (Figure 25). The latter was then rapidly oxidized to FDCA and after 20 hr, 56% of FDCA 
was present 
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Figure 26 Combined dual enzyme oxidation showing high conversion of HMF to HMFCA  
after 3hr and slow oxidation to FDCA over 20 hr 
 
5.2 Conclusion: 
In summary we have developed a promising tandem cascade reaction using two 
oxygen-dependent enzymes, galactose oxidase M3-5 and periplasmic aldehyde oxidase PaoABC, 
that results in high conversion of HMF to FDCA at ambient temperature, near neutral pH and 
using oxygen as the terminal oxidant. The substrate concentration of HMF (100mM) is the 
highest reported for an enzyme-based process and uses enzymes that do not require the addition 
of co-factors. PaoABC has performed extremely well compared to other aldehyde oxidases and 
is not limited by FFCAs inability to form its hydrate, which is the case with other reported 
procedures304. 
 The major limitation of this methodology is the sequential addition of enzymes. 
GOaseM3-5 represents a major limitation inflicted by many biocatalysts in which substrate 
specificity is an issue. Additional mutants of GOase or an alternative enzyme for the alcohol 
oxidation would lead to a more attractive process as continuous catalysis could take place. 
 The upstream reaction to produce HMF from cellulose would likely contain many 
dehydrated sugars and other impurities292. If our established oxidation procedure could be 
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applied to efficient oxidation of crude HMF, it would provide an extremely green and economic 
route to highly pure FDCA. To realise this further developments of the enzymes such as enzyme 
immobilization or additional genetic modifications to deal with high substrate concentrations or 
tolerate organic solvents would be necessary to create a viable industrial synthesis of FDCA. 
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Conclusion 
In conclusion, we have exploited two molybdenum-dependent oxidoreductases, E. coli 
XDH and PaoABC in preparative enzymatic cascades. E. coli XDH has been shown to accept a 
range of benzylic aldehydes and also activated imines such as xanthine and DHIQ. However, 
more challenging substrates such as unactivated and bulky aldehydes are not tolerated. PaoABC 
however tolerates a much wider spectrum of aldehydes and to this date all aldehydes tested have  
been accepted. PaoABC activity with imine substrates is much less than that of E. coli XDH, 
however unactivated imines are oxidised to a small degree. 
We have demonstrated a one-pot, single stage tandem cascade for the quantitative 
conversion of 26 alcohols directly to their corresponding carboxylic acids, including aliphatic 
examples employing three oxygen-dependent enzymes, GOaseM3-5, PaoABC and E. coli XDH. 
The major limitation with these cascades is the low substrate concentration that the enzymes 
tolerate. For the aryl alcohols, E. coli XDH can tolerate concentrations of >50 mM, however 
this may be alleviated by the use of PaoABC which can tolerate much higher substrate 
concentrations. Unfortunately, for aliphatic substrates GOaseM3-5 can only accept 
concentrations <30 mM. Creation of additional mutants will facilitate scale up of these cascade 
processes. In addition, we have observed a novel potentiation effect by combining GOaseM3-5 
and PaoABC and have therefore expanded the substrate scope of GOaseM3-5 by combining the 
alcohol oxidase with PaoABC. Alcohols previously believed thought to be non-substrates for 
GOaseM3-5 furnished carboxylic acids in cascade conditions with PaoABC. 
Possible enantiodiscrimination by PaoABC was also explored as a result of previous 
cascades in which we obtained 50% conversion, suggesting that a kinetic resolution may have 
occurred. In turn, a series of  -substituted aldehydes were synthesised which may be resolved 
or subject to DKR for synthesis of profen drugs. Unfortunately, the highest E-value obtained 
was 14. Despite the poor enantioselectivity of PaoABC, an interesting oxidative cyclisation 
mechanism was noted which could be applied to the synthesis of lactams or lactones. 
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With this oxidative cyclisation in hand, we demonstrated that amino alcohols could be 
cyclized to lactams via an in situ generated imine using both GOaseM3-5 and E. coli XDH or 
PaoABC. The reaction holds good green credentials as oxygen is the terminal oxidant and atom 
economy is very high. The major drawback to this cascade is the narrow substrate scope. 
Activated imines such as DHIQ could be successfully oxidized in high conversion, however 6 
and 7 membered ring lactams could not be formed in any appreciable conversion. In addition, a 
 -lactam product may have been formed (indicated by mass spec) via internal displacement of 
the postulated molybdo ester which would highlight novel reactivity of these molybdo enzymes. 
With the established biocatalytic cascade utilising PaoABC and GOaseM3-5 we demonstrated 
that FDCA can be obtained starting from 100 mM HMF concentration. This represents the 
highest concentration reported for an enzyme-based process and uses enzymes that do not 
require the addition of co-factors. PaoABC performed extremely well when compared to other 
aldehyde oxidases and is not limited by FFCAs inability to form its hydrate. The major 
limitation of this procedure is the sequential addition of the biocatalyst to avoid substrate 
specificity issues in which HMFCA is a poor substrate for GOaseM3-5. Further directed 
evolution of GOaseM3-5 or immobilization may expand its substrate scope and thus allow a 
continuous process.                                                         .                                      
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Experimental 
Chapter 6 
6.0 Experimental 
6.1 General Experimental 
Analytical thin layer chromatography (TLC) was performed on Whatman F254 precoated silica 
gel plates (250 µm thickness). Visualization was accomplished with a UV light and/or a KMnO4 
solution. Flash column chromatography (FCC) was performed using Whatman Silica Gel 
Purasil® 60Å (230-400 mesh). Solvents for extraction and FCC were technical grade. Reported 
solvents mixtures for both TLC and FCC were volume/volume mixtures. Solvents were of 
analytical or HPLC grade and were purchased dried over molecular sieves where necessary.  
Normal and reverse phase HPLC was performed on an Agilent system (Santa Clara, CA, USA) 
equipped with a G1379A degasser, G1312A binary pump, a G1329 well plate autosampler unit, 
a G1315B diode array detector and a G1316A temperature controlled column compartment. GC 
analysis was performed on Agilent 6850 GCs equipped with a Gerstel Multipurposesampler 
MPS2L using an Alltech SE-30, 30.0 m x 320 µm x 0.25 µm GC capillary column. Elemental 
analysis and mass spectrometry was provided by the University of Liverpool. 1H NMR and 13C 
NMR were recorded on Bruker AV 500 MHz & Bruker DPX 400 MHz NMR spectrometers in 
the indicated deuterated solvents. For 1H NMR CDCl3 was set to 7.26 ppm (CDCl3 singlet) and 
for 13C NMR to 77.66 ppm (CDCl3 centre of triplet). All values for 1H NMR and 13C NMR 
chemical shifts for deuterated solvents were obtained from Cambridge Isotope Labs. Data are 
reported in the following order: chemical shift in ppm (δ) (multiplicity, which are indicated by 
br (broadened), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet)); assignment of 2nd 
order pattern, if applicable; coupling constants (J, Hz); integration. Infrared spectra (IR) were 
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obtained on a Perkin-Elmer Spectrum 100 series FTIR spectrophotometer. Peaks are reported in 
cm-1 Unless otherwise indicated, all reactions were carried out in flame dried round bottom 
flasks and under an inert atmosphere of nitrogen or Argon. Syringes and needles were oven-
dried (125°C) and cooled in a desiccator. All substrate were purified by column 
chromatography. All chemicals unless included in the experimental section were commercially 
available. 
 
6.2 Experimental procedure for Chapter 2 
6.2.1 Screening of E. coli XDH towards a diverse set of selected aldehyde substrates using 
DCPIP 
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The screening of E. coli xanthine dehydrogenase was accomplished using a 96-well, clear, 
flatbottomed polystyrene microtitre plate in a final volume of 200 µL in potassium phosphate 
buffer (50 mM, pH 7.6) containing per well: 1 mM of the respective substrate, 0.1 mM DCPIP, 
20 µL XDH solution (1.1 mg/mL stock solution). The activity of E. coli XDH towards the 
compounds tested was assessed by eye based on the loss of blue colour. 
 
6.2.2 Time course analysis for the oxidation of benzaldehyde derivatives (1mM) by E. coli 
XDH  
 
 
To a 1mL-Eppendorf was added 50 mM potassium phosphate buffer pH 7.5 (50 mM), 3 µL 
substrate (0.1M in MeCN), 50 µL of E. coli XDH (1.1 mg/mL), final volume 300 µL. After the 
indicated times 30 µL of the reaction was removed, acidified with 10 µL, centrifuged and 
analysed by RP-HPLC. For HPLC conditions see Section 6.2.4. 
 
6.2.3 Oxidation of p-nitrobenzaldehyde (1mM) by incremental addition of substrate 
 
 
 
To a 1 mL Eppendorf was added 50 mM potassium phosphate buffer pH 7.5 (50 mM), 3 µL p-
nitrobenzaldehyde (221) (0.1M in MeCN), 50 µL of E. coli XDH (1.1 mg/mL), final volume 
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300 µL. The reaction was then vigourously shaken and the reaction left in a shaking incubator at 
37°C. After 2.5 hours, 30 µL of the reaction was removed, acidified with 10 µL of 1M HCl and 
analysed by RP-HPLC. Another 3 µL of p-nitrobenzaldehyde (221) was added and the reaction 
left for a further 2.5 hours before an aliquot was taken as previously described. A final 3µL of 
p-nitrobenzaldehyde (221) was added and the recaction left overnight. A final aliquot was taken 
and analysed by RP-HPLC. For HPLC condition see Section 6.2.4 
 
6.2.4 General method for bio-bio-catalytic cascade reaction for synthesis of benzoic acids 
from benzyl alcohols  in a one-pot one-step approach 
 
 
 
To a 1 mL-Eppendorf tube was added 69 µL of 50mM potassium phosphate buffer pH 7.6, 75 
µL catalase ( 1mg/mL), 3 µL of substrate (100 mM stock in MeCN), 50 µL of E.coli XDH (1.1 
mg/mL) and 103 µL of GOaseM3-5 (3.7 mg/mL). The reaction was then vigourously shaken and 
left in an incubator at 37°C overnight with periodic shaking. Analysis was done by RP-HPLC, 
see Table 22 
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O
     GOase M3-5,
buffer pH 7.6, 37oC
   catalase, O2 (air)
R R
       E. coli XDH
  buffer pH 7.6, 37oC
    catalase, O2 (air)
OH
R =  4-NO2-Ph, 4-Br-Ph, H,  4-Cl-Ph,  4-MeO-Ph, 2-MeO-Ph, 
3-Cl-Ph, 3-Br-Ph,  4-Me-Ph,  2-F-Ph,  3-F-Ph,  2-Br-Ph, 
3-MeO-Ph, 2,6-Cl2-Ph, Ar = 2-thiophenyl, Ar = 2-furanyl
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Table 22 Galactose oxidase M3-5-E.coli xanthine dehydrogenase cascade reactions for 
formation of acids from alcohols in a one-pot one-step approach. Substrates, HPLC-retention 
times of alcohols, aldehydes and acid and percentage of conversions after 16 hr based on HPLC 
peak areas (ʎ = 254 nm). 
 
Entry Substrate Alcohol 
Retention 
Time 
(Min) 
Aldehyde 
Retention 
Time 
(Min) 
Acid 
Retention 
Time 
(Min) 
10mM 
Conversion 
Alc:Ald:Acd 
HPLC 
Condtions 
1 
 
6.4 14.0 10.06 0:0:100 A 
2 
 
5.4 10.94 8.9 0:0:100 A 
3 
 
3.05 5.98 4.08 0:0:100 B 
4 
 
4.7 4.4 2.1 0:100:0 A 
5 
 
4.4 9.02 6.5 0:0:100 B 
6 
 
2.5 5.2 3.4 0:0:100 A 
7 
 
2.9 5.7 2.77 0:0:100 A 
8 
 
5.1 5.9 8.1 0:0:100 C 
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9 
 
2.73 5.4 2.37 100:0:0 E 
10 
 
3.1 5.3 4.6 0:0:100 A 
11 
 
3.1 4.5 4.9 0:0:100 D 
12 
 
2.82 5.4 4.5 0:0:100 A 
13 
 
3.1 6.0 4.6 0:0:100 A 
14 
 
3.8 7.7 5.1 0:0:100 B 
15 
 
4.0 8.9 3.5 0:0:100 B 
16 
 
4.0 8.9 3.5 0:0:100 A 
HPLC conditions: RP-phase column, ThermoFishserHypurity C-18 column, flow rate 1.0 
mL/min, UV 254 nm, Method A: 25% MeCN: 75% water + 0.1% TFA; Method B: 25% 
MeCN: 75% water + 0.1% TFA; Method C: 1% MeCN : 99% water + 0.1% TFA;Method D: 
15% MeCN : 85% water + 0.1% TFA;Method E: 40% MeCN: 60% water + 0.1% TFA. 
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6.2.5 Optimisation of the bio-biocatalytic cascade for synthesis of 3-methoxybenzoic acid 
from 3-methoxybenzyl alcohol  in a one-pot one-step approach 
 
 
 
To a 1 mL-Eppendorf was added 50 mM NaPi buffer pH 7.6, X µL catalase (stock 1 mg/mL), 
3- methoxybenzyl alcohol (10-100 mM), 50 µL of E. coli XDH (1.1 mg/mL) and 103 µL of 
GOase M3-5 (3.7 mg/mL). The reaction was left in a shaking incubator at 36 °C. The reaction 
was opened to air every hour, closed and shaken to oxygenate the buffer placed back into the 
incubator. After the indicated time 50 µL of the reaction mixture was acidified with 20 µL of 2 
M HCl, centrifuged and analysed by RP-HPLC. Conversions reported are based on relative 
response factors determined via NMR-HPLC correlations. (see table 22) 
 
6.2.6 Time course analysis of the bio-biocatalytic cascadefor synthesis of 3-methoxybenzoic 
acid from 3-methoxybenzyl alcohol in a one-pot one-step approach 
 
In a 1-mL-Eppendorf was added 50 mM potassium phosphate buffer pH 7.6, 33 µL catalase 
(stock 3.3mg/mL), 3-methoxybenzyl alcohol (50 mM), 50 µL of E. coli XDH (1.1 mg/mL) and 
103 µL of GOase M3-5 (3.7 mg/mL), final volume 300 µL. The reaction was left in a shaking 
incubator at 36 °C. The reaction was periodically opened to air, closed and shaken to oxygenate 
the buffer and put back into the incubator. After the indicated times 5 µL of the reaction was 
extracted, acidified with 10 µL 1M HCl and diluted with 85 µL distilled water. The aliquots 
were analysed by RP-HPLC and conversions corrected by response factors  determined via 
NMR-HPLC correlations. 
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Figure 27 HPLC trace of a 1:1:1 mixture of 3-methoxybenzyl alcohol (241) (3.14 min), 3-
methoxybenzoic acid (258)(4.98 min) and 3-methoxybenzaldehyde (220) (7.78 min). HPLC 
conditions ThermoFisherHypurity C-18 column, flow rate 1.0 mL/min, UV 254 nm,  25% 
MeCN: 75% water + 0.1% TFA. 
. 
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Figure 28 1H NMR spectrum (500 MHz) of a 1:1:1 mixture of 3-methoxybenzyl alcohol (241) 
(3.8 ppm), 3- methoxybenzoic acid (258) (3.86 ppm) and 3-methoxybenzaldehyde (220) (3.89 
ppm). 
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6.2.7 pH-Profile for oxidation of m-anisaldehyde with PaoABC 
 
 
 
 
3 µL of a 1 M solution of m-anisaldehyde (220) was added to 33 µL catalase (3.3 mg/ml) in 262 
µL of various pH phosphate buffer (50 mM). 1 µL of PaoABC (13.3mg/mL) was then added 
and the reaction was shaken vigorously. Aliquots of the reaction mixture were removed, 
acidified with 2 M HCl, centrifuged and analysed by RP HPLC (For HPLC conditions see 
6.2.5) 
 
Table 22 PaoABC catalysed oxidation of m-anisaldehyde (220) at different pH. 
 
  Conversion (%)a 
Entry pH 20min 40min 60min 90min 120min 
1 5 5.68 11.27 14.03 31.48 46.2 
2 5.5 9.32 14.2 23.15 38.9 54.6 
3 6 12.3 30.6 39.2 63.5 82.2 
4 6.5 11.8 20.2 41.2 62.2 89.2 
5 7 16.2 34.7 50.2 72.2 90.2 
6 7.5 11.2 28.2 34.2 65.2 83.2 
7 8 12.2 26.2 - 72.2 91.2 
aConversion adjusted by analysing a 1:1 standard of the aldehyde:acid by NMR and comparing 
the HPLC trace of the same sample and adjusting the absorbance accordingly (Section 6.2.6) 
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6.2.8 Screening of PaoABC towards a diverse set of selected aldehyde substrates using 
DCPIP 
 
 
The screening of E. coli xanthine dehydrogenase was accomplished using a 96-well, clear, 
flatbottomed polystyrene microtitre plate in a final volume of 200 µL in potassium phosphate 
buffer (50 mM, pH 7.6) containing per well: 1 mM of the respective substrate, 0.1mM DCPIP, 5 
µL PaoABC solution (13.3 mg/mL stock solution). The activity of E. coli XDH towards the 
compounds tested was assessed by eye based on the loss of colour. 
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6.2.9 General method for bio-bio-catalytic cascade reaction for synthesis of carboxylic 
acids from alcohols  in a one-pot one-step approach 
 
 
To 50 mM pH 7.6 potassium phosphate buffer (159 µL) and 33 µL catalase (3.3 mg/mL) was 
added 3µL of substrate alcohol (1 M in MeCN, 10 mM final concentration). 103 µL of GOase 
M3-5 (1.3 mg/mL) and 5µL PaoABC (13.2 mg/mL) was then added. The reaction was incubated 
at 37°C in a shaking incubator and left shake overnight. The reaction was quenched by the 
addition of 50µL 1 M HCl and extracted into 200 µL DCM. The DCM was then analysed by 
GC 
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Table 23 Galactose oxidase M3-5 PaoABC cascade reactions for formation of acids from 
alcohols in a one-pot one-step approach. Substrates, GC-retention times of alcohols, aldehydes 
and acid and percentage of conversions after 16hr based on GC peak areas 
 
R= -CH2OH -CHO -CO2H Conversion 
(%) 
 
11.87 11.28 13.98 100 
 
14.91 14.52 16.92 100 
 
8.9 7.57 11.48 100 
 
7.18 N/A 9.584 100 
 
4.71 N/A 8.449 100 
 
10.91 9.68 12.78 100 
 
10.92 9.6 13.0 100 
 
7.8 6.2 10.1 50 
 
14.7 13.8 16.38 0 
 
11.49 10.4 13.6 100 
Experimental! ! Chapter!6!|!!
! 157!
 
7.60 7.07 10.718 81 
GC Conditions: All samples were analysed using an Alltech SE-30, 30.0 m x 320 µm x 0.25 µm 
GC capillary column (40°C for 5 min, 50°C/min to 140°C and held for 5 min, 10°C/min to 
300°C). 
 
6.2.10 Timecourse analysis of 10 mM cascade for oxidation of phenylethanol (10mM) 
 
 
To a solution of 200 mM pH 7.6 potassium phosphate buffer (159 µL) and 33 µL catalase (3.3 
mg/mL) was added 3 µL of phenylethanol (284) (1M in MeCN, 10mM final concentration). 103 
µL of GOase M3-5 (3 mg/mL) and 5 µL PaoABC (13.2 mg/mL) was then added and the 
reaction incubated at 36°C in a shaking incubator and left to shake. 30 µL aliquots of reaction 
mixture were taken out, acidified by addition of 20 µL of 1M HCl, centrifuged and analysed by 
RP-HPLC. HPLC conditions: ODS-Hypersil C18 column, 1 mL/min, 82% water (0.1% TFA) 
18% MeCN. 
 
6.2.11 GOaseM3-5 PaoABC 30mM scale conversion of 3-phenylbutanol 
 
To a solution of pH 7.6 50 mM phosphate buffer was added 15 µL of 3-phenylbutanol (285) 
(2M in MeCN). GOase M3-5 (1.3 mg/mL) and PaoABC (13.3 mg/mL) was then added to final 
volume 1 mL. The reaction was then placed in a shaking incubator for 16 hr. The reaction was 
then acidified to pH 1 using 1M HCl and extracted into CDCl3 and analysed by H1 NMR
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Figure 29 1H NMR spectrum (500 MHz) of the crude reaction mixture (Table 7, entry 1), Signals at 1.35 correspond to the CH3 of acid product, Signals at 
1.29 correspond to alcohol product. 
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Figure 30  1H NMR spectrum (500 MHz) of the crude reaction mixture (Table 7, entry 2), Signals at 1.35 correspond to the CH3 of acid product, Signals at 
1.29 correspond to alcohol product. 
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Figure 31 1H NMR spectrum (500 MHz) of the crude reaction mixture (Table 7, entry 3), Signals at 1.35 correspond to the CH3 of acid product, Signals at 
1.29 correspond to alcohol product. 
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Figure 32 1H NMR spectrum (500 MHz) of the crude reaction mixture (Table 7, entry 4), Signals at 1.35 correspond to the CH3 of acid product, Signals at 
1.29 correspond to alcohol product. 
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6.2.12 GOaseM3-5 inhibition studies 
 
 
To 50mM phosphate buffer pH 7.5 was added 3 µL benzaldehyde and a specific 
concentration of phenylacetaldehyde as indicated in Table 8. 103 µL of GOaseM3-5 (3mg/mL) 
was then added and the reaction (final volume 300 µL) placed in a shaking incubator at 37°C. 
After 1 hour the reaction was quenched with 1M HCl and analysed by RP-HPLC. HPLC 
conditionns: ODS-Hypersil C18 column, 1 mL/min, 82% water (0.1% TFA) 18% MeCN. 
 
6.3 Experimental procedures for Chapter 3  !
6.3.1 General procedure for the alkylation of methyl phenylacetate. 
Under a nitrogen atmosphere, to a stirred colourless solution of diisopropylamine (2.05 mL, 
14.7mmol) in anhydrous tetrahydrofuran (133 mL), was added n-butyl lithium (9.16mL of 
1.6M solution in n-hexane, 14.7mmol) was added dropwise. The resultant pale yellow 
mixture was then stirred for 15  minutes. The reaction mixture was cooled to -78oC and then 
methyl phenylacetate (1.88 mL, 13.3mmol) was added dropwsise forming the enolate.  The 
consequent stirred reaction mixture was left for 15 minutes at -78oC. The alkyl halide 
(14.7mmol) was then added to the reaction mixture dropwsie. The resultant mixture was then 
left stirring at room temperature until reaction was complete as determined by TLC. The 
reaction mixture was quenched with saturated ammonium chloride (60 mL) and extracted 
with diethyl ether (3x30 mL). The combined organic extracts were then dried over anhydrous 
magnesium sulphate. Filtration and removal of the solvent under reduced pressure gave a 
crude oil.  The crude product was then purified by flash column chromatography furnishing a 
pure oil.  
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methyl 2-phenylbutanoate (308) 
The crude product was purified by flash column chromatography (98:2 
hexane:diethyl ether) furnishing a pure colourless oil (1.66 g, 70%). 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 4H), 7.30 – 7.26 (m, 1H), 
3.68 (s, 3H), 3.48 (t, J = 7.4 Hz, 1H), 2.18 – 2.07 (m, 1H), 1.87 – 1.79 (m, 1H), 0.92 (t, J = 
7.3 Hz, 3H);  13C NMR (500 MHz, CDCl3) δ 174.50, 139.11, 128.56, 127.94, 127.17, 53.38, 
51.86,  26.75, 12.15;  HRMS CI+: C11H14O2NH4+ {[M+NH4]+}, Calc.: 196.1333, Found: 
196.1339;  IR: 3030, 2966, 2876, 1732, 1492, 1454, 1351, 1202, 1161, 732cm-1.  
 
methyl 2-phenylpentanoate (309) 
 The crude product was purified by flash column chromatography 
(97.5:2.5 hexane:diethyl ether) furnishing a pure colourless oil (1.45 g, 
67%). 
 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 4H), 7.30 – 7.25 (m, 1H), 3.68 (s, 3H), 3.59 
(t, J = 7.7 Hz, 1H), 2.11 – 2.04  (m, 1H), 1.82 – 1.75 (m, 1H), 1.36 – 1.24  (m, 2H), 0.94 (t, J 
= 7.3 Hz, 3H);  13C NMR (500 MHz, CDCl3) δ 174.59, 139.28, 128.56, 127.92, 127.14,  
51.87, 51.38, 35.67, 20.74, 13.79; HRMS CI+: C12H16O2NH4+ {[M+NH4]+}, Calc.: 210.1489, 
Found: 210.1493; IR: 3063, 3030, 2872, 1732, 1454, 1433, 1350, 1231, 1198, 698cm-1 
 
methyl 2-phenylhexanoate (310) 
 The crude product was purified by flash column chromatography 
(97.5:2.5 hexane:diethyl ether) furnishing a pure colourless oil (1.91 g, 
69%). 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.23 (m, 5H), 3.69 (s, 3H), 
3.61-3.50 (m, 1H), 2.12-2.05 (m, 1H), 1.85-1.75 (m, 1H), 1.40-1.15 (m, 4H), 0.87(d, J = 7.2 
Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 174.6, 139.3, 128.6, 127.9, 127.1, 51.9, 51.6, 33.3, 
29.7, 22.5, 13.9; HRMS CI+: C16H16O2H+ {[M+NH4]+}, Calc.: 224.1652, Found: 224.1645; 
IR: 3086, 306, 2950, 1731, 1495, 1454, 1434, 1350, 1213, 1152, 1030cm-1 
 
OMe
O
Et
308
OMe
O
Pr
309
OMe
O
Bu
310
Experimental! ! Chapter!6!|!!
, 164!
methyl 4-methyl-2-phenylpentanoate (311) 
 The reaction mixture was left overnight to achieve completion. The 
crude product was purified by flash column chromatography (98:2 
hexane:diethyl ether) furnishing a pure colourless oil (1.48 g, 54%). 1H 
NMR (500 MHz, CDCl3) δ 7.36 – 7.25 (m, 5H), 3.72 – 3.66 (m, 4H), 
1.99 (ddd, J = 13.6, 8.0, 7.3 Hz, 1H), 1.71 (ddd, J = 13.6, 8.0, 6.7 Hz, 1H), 1.53 – 1.44 (m, 
1H), 0.93 (d, J = 6.6 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 174.72, 139.34, 128.59, 
127.95, 127.15, 51.93, 49.52, 42.51, 25.85, 22.62, 22.22; HRMS CI+: C13H18O2NH4+ 
{[M+NH4]+}, Calc.: 224.1645, Found: 224.1645;  IR: 3065, 3030, 2955, 1733, 1454, 1434, 
1244, 1197, 731cm-1 
 
methyl 2,3-diphenylpropanoate (312) 
 The crude product was purified by flash column chromatography (99:1 
hexane:diethyl ether) furnishing a pure colourless oil (1.44 g, 63%). 1H 
NMR (500 MHz, CDCl3) δ 7.39 – 7.23 (m, 7H), 7.23 – 7.18 (m, 1H), 
7.18 – 7.11 (m, 2H), 3.88 (dd, J = 8.8, 6.7 Hz, 1H), 3.63 (s, 3H), 3.45 (dd, 
J = 13.7, 8.8 Hz, 1H), 3.05 (dd, J = 13.7, 6.7 Hz, 1H); 13C NMR (500 MHz, CDCl3) δ 
173.83, 139.04, 138.63, 128.92, 128.64, 128.33, 127.94, 127.39, 126.37, 53.61, 52.00, 39.82; 
HRMS CI+: C16H16O2H+ {[M+H]+}, Calc.: 241.1223, Found: 241.1225; IR: 3086, 306, 
2950, 1731, 1495, 1454, 1434, 1350, 1213, 1152, 1030cm-1 
 
methyl 3-cyclohexyl-2-phenylpropanoate (313) 
 The crude product was purified by flash column chromatography (99:1 
hexane:diethyl ether) furnishing a pure colourless oil (1.93 g, 59%). 1H 
NMR (500 MHz, CDCl3) δ 7.38 – 7.23 (m, 5H), 3.72 (t, J = 7.8 Hz, 1H), 
3.67 (s, 3H), 2.06 – 1.95 (m, 1H), 1.81 – 1.59 (m, 6H), 1.25 – 1.09 (m, 
4H), 0.97 – 0.89 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 174.80, 139.50, 128.58, 128.49, 
127.11, 51.94, 48.77, 41.12, 35.29, 33.29, 32.99, 26.50, 26.12,  26.09; HRMS CI+: 
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C16H22O2NH4+ {[M+NH4]+}, Calc.: 264.1958, Found: 264.1963;  IR: 2921, 2850, 1734, 1495, 
1449, 1307, 1155, 697cm-1. 
 
methyl 2-phenylpent-4-enoate (314) 
The crude product was purified by flash column chromatography (98:2 
hexane:diethyl ether) furnishing a pure colourless oil (1.67 g, 66%). 1H 
NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 4H), 7.30 – 7.26 (m, 1H), 
5.75 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.10 (dq, J = 17.1, 1.6 Hz, 1H), 
5.03 (dq J = 10.2, 1.6 Hz, 1H), 3.68 (s, 3H), 3.67 (m, 1H), 2.89 – 2.82 (m, 1H), 2.57 – 2.51 
(m, 1H). 13C NMR (500 MHz, CDCl3) δ 173.87, 138.54, 135.24, 128.63, 127.91, 127.33, 
116.97, 76.76, 51.98, 51.41, 37.59; HRMS CI+: C12H14O2H+ {[M+H]+}, Calc.: 191.1067, 
Found: 191.1066;  IR: 3078, 3066, 3030, 3004, 2951, 1732, 1620, 1434, 1229, 1160cm-1. 
 
methyl 3-methyl-2-phenylbutanoate (315) 
Under a nitrogen atmosphere, to a stirred colourless solution of 
diisipropylamine (2.05 mL, 14.7 mmol) in anhydrous tetrahydrofuran 
(133 mL), n-Butyl Lithium (9.16 mL of 1.6M solution in n-hexane, 
14.7mmol) was added dropwise. The resultant pale yellow mixture was 
then stirred for 15 minutes. The reaction mixture was then cooled to -78oC and methyl 
phenylacetate (1.88 mL, 13.3 mmol) was added dropwise forming the enolate.  The resultant 
stirred reaction mixture was left for 15 minutes at -78oC. 2-Bromopropane (1.37 mL, 14.7 
mmol) and DMPU (1.61 mL, 13.3 mmol) in anhydrous THF (4 mL) was then added 
dropwise. The resultant stirred reaction mixture was left overnight at room temperature. Once 
complete, the reaction mixture was quenched with saturated ammonium chloride (60 mL) and 
extracted with diethyl ether (3x30 mL). The combined organic extracts were then dried over 
anhydrous magnesium sulphate. Filtration and removal of the solvent under reduced pressure 
gave a crude oil.  The crude product was then purified by flash column chromatography (98:2 
n-hexane:diethyl ether) furnishing a pure colourless oil (1.61 g, 63%). 1H NMR (500 MHz, 
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CDCl3) δ 7.37 – 7.31 (m, 4H), 7.30 – 7.25 (m, 1H), 3.67 (s, 3H), 3.18 (d, J = 10.5 Hz, 1H), 
2.41 – 2.33 (m, 1H), 1.06 (d, J = 6.5 Hz, 3H), 0.73 (d, J = 6.7 Hz, 3H); 13C NMR (500 MHz, 
CDCl3) δ 174.44, 138.34, 128.47, 128.45, 127.22, 60.00, 51.72, 31.92, 22.66, 21.49, 20.20; 
HRMS CI+: C12H16O2NH4+ {[M+NH4]+}, Calc.: 210.1489, Found: 210.1493;  IR: 3064, 
2959, 2872, 1732, 1468, 1454, 1072, 1011, 698cm-1. 
 
methyl 4-((tert-butyldimethylsilyl)oxy)-2-phenylbutanoate (343) 
Under a nitrogen atmosphere, to a stirred solution of potassium tert-
butoxide (4.1 g, 36.6 mmol) in anhydrous DMF (333 mL) was added 
dropwise methyl phenylacetate (4.69 mL, 33 mmol).  The reaction 
mixture was left stirring for one hour.  (2-bromoethoxy)(tert-butyl)dimethylsilane (8.76 g, 36 
mmol) was added dropwsie. The resultant stirred reaction mixture was left stirring overnight. 
Once complete, the reaction mixture was quenched with saturated ammonium chloride (100 
mL) and extracted with diethyl ether (3x30 mL). The combined organic extracts were then 
dried over anhydrous magnesium sulphate, filtered and concentrated in vacuo to give a crude 
oil.  The crude product was then purified by flash column chromatography (97:3 
hexane:diethyl ether) furnishing a pure colourless oil (7.0g, 69%). 1H NMR (500 MHz, 
CDCl3) δ 7.36 – 7.25 (m, 5H), 3.84 (t, J = 7.6 Hz, 1H), 3.69 – 3.59 (m, 4H), 3.55 – 3.48 (m, 
1H), 2.38 – 2.28 (m, 1H), 2.00 – 1.91 (m, 1H), 0.92 (d, J = 1.5 Hz, 9H), 0.03 (d, J = 5.3 Hz, 
6H); HRMS CI+: C17H28O3SiH+ {[M+H]+}, Calc.: 309.188, Found: 309.1892; 13C NMR 
(500 MHz, CDCl3) δ 174.46, 138.95,  128.60,  128.07, 127.19, 60.34, 51.93, 47.60,  36.22,  
25.9, 18.28, -5.43, -5.48; IR: 3031, 2857, 1736, 1455, 1434, 1360, 1255, 1161, 1065, 950cm-1 
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6.3.2 Synthesis of alcohols from alkylated esters 
2-phenylbutan-1-ol (316) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 308 
(1.2004 g, 6,74 mmol), dissolved in 67 mL anhydrous diethyl at 0oC, was 
added lithium aluminium hydride (0.7668 g, 20.2 mmol). The resultant 
mixture was stirred at room temperature for 2 hr. The reaction mixture was quenched with 
saturated sodium sulfate solution (added dropwise) until no effervescence was observed and a 
white precipitate formed. The mixture was filtered and the solvent of the filtrate was 
evaporated under reduced pressure furnishing a colourless pure oil (0.7187 g, 71%).1H NMR 
(500 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H), 7.29 – 7.22 (m, 3H), 3.81 – 3.73 (m, 2H), 2.74 – 
2.69 (m, 1H), 1.84 – 1.73 (m, 1H), 1.64 – 1.57 (m, 1H), 1.40 (br s, 1H), 0.87 (t, J = 7.4 Hz, 
3H); 13C NMR (500 MHz, CDCl3) δ 142.30, 128.62, 128.12, 126.69,  67.33, 50.51, 25.00, 
11.98; HRMS CI+: C10H14ONH4+ {[M+NH4]+}, Calc.: 168.1383, Found: 168.1385; IR: 3339, 
3028, 2961, 2929, 1494, 1453, 1378, 1034, 698cm-1. 
 
2-phenylpentan-1-ol (317) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 
309 (1.2006 g, 6.24 mmol), dissolved in 62 mL anhydrous diethyl at 0oC, 
was added lithium aluminium hydride (0.7109 g, 18.73 mmol). The 
resultant mixture was stirred at room temperature for 3 hr. The rereaction mixture was 
quenched with saturated sodium sulfate solution (added dropwsie) until no effervescence was 
observed and a white precipitate formed.  The mixture was filtered and the solvent of the 
filtrate was evaporated under reduced pressure furnishing a colourless pure oil (0.8334 g, 
81%). 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H), 7.25 – 7.19 (m, 3H), 3.77 – 3.69 
(m, 2H), 2.82 – 2.76 (m, 1H), 1.71 – 1.62 (m, 1H), 1.60 – 1.51 (m, 1H), 1.23 (sex, J = 7.4 Hz, 
2H), 0.87 (t, J = 7.4 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 142.51, 128.62, 128.08, 126.68, 
67.61, 48.44, 34.28, 20.49, 14.11; HRMS CI+: C11H16ONH4+ {[M+NH4]+}, Calc.: 182.1540, 
Found: 182.1541; IR: 3334, 3028, 2929, 1493, 1453, 1379, 1050, 733cm-1 
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2-phenylpentan-1-ol (318) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 310 
(1.5009 g, 7.27 mmol), dissolved in 73 mL anhydrous diethyl at 0oC, was 
added lithium aluminium hydride (0.8284 g, 21.83 mmol). The resultant 
mixture was stirred at room temperature for 3 hr. The rereaction mixture was quenched with 
saturated sodium sulfate solution (added dropwsie) until no effervescence was observed and a 
white precipitate formed.  The mixture was filtered and the solvent of the filtrate was 
evaporated under reduced pressure furnishing a colourless pure oil (1.013g, 85%).1H NMR 
(500 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H), 7.29 – 7.22 (m, 3H), 3.82 – 3.66 (m, 2H), 2.82 – 
2.77 (m, 1H), 1.76 – 1.69 (m, 1H), 1.62 – 1.56 (m, 5.4 Hz, 1H), 1.41 – 1.11 (m, 5H), 0.87 (t, J 
= 7.2 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 142.57, 128.62, 128.07, 126.67, 67.64, 48.71, 
31.78, 29.56, 22.75, 13.96; HRMS CI+: C12H18ONH4+ {[M+NH4]+}, Calc.: 196.1696, Found: 
196.1698; IR: 3370, 3084, 2955, 1708, 1452, 1377, 1363, 1051cm-1 
 
4-methyl-2-phenylpentan-1-ol (319) 
 Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 
311 (1.1011 g, 5.34 mmol), dissolved in 53 mL anhydrous diethyl at 0oC, 
was added lithium aluminium hydride (0.6077 g, 16.01 mmol). The 
resultant mixture was stirred at room temperature for 3 hr. The rereaction 
mixture was quenched with saturated sodium sulfate solution (added dropwsie) until no 
effervescence was observed and a white precipitate formed.  The mixture was filtered and the 
solvent of the filtrate was evaporated under reduced pressure furnishing a colourless pure oil 
(1.013g, 85%).1H NMR (500 MHz, CDCl3) δ 7.40 – 7.31 (m, 2H), 7.29 – 7.21 (m, 3H), 3.78 
– 3.65 (m, 2H), 2.95 – 2.87 (m, 1H), 1.64 – 1.54 (m, 1H), 1.52 – 1.36 (m, 3H), 0.89 (d, J = 
8.3 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 142.50, 128.64, 128.12, 126.68, 68.03, 46.44, 
41.18, 25.27, 23.54, 21.84; HRMS CI+: C12H18ONH4+ {[M+NH4]+}, Calc.: 196.1696, Found: 
196.1699;  IR: 3354, 3044, 2937, 2772, 1488, 1446, 1389, 1088, 673cm-1. 
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2,3-diphenylpropan-1-ol (320) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 312 
(1.7016 g, 7.08 mmol), dissolved in 71 mL anhydrous diethyl at 0oC, was 
added lithium aluminium hydride (0.8062 g, 21.24 mmol). The resultant 
mixture was stirred at room temperature for 1 hour. The reaction mixture 
was quenched with saturated sodium sulfate solution (added dropwsie) until no effervescence 
was observed and a white precipitate formed.  The mixture was filtered and the solvent of the 
filtrate was evaporated under reduced pressure furnishing a colourless pure oil (1.0221 g, 
68%).1H NMR (500 MHz, CDCl3) δ7.42-7.12 (M, 10H), 3.86 – 3.78 (m, 2H), 3.13 (quin, J = 
7.4 Hz 1H), 3.06 (dd, J = 13.5, 7.4 Hz, 1H), 2.94 (dd, J = 13.5, 7.5 Hz, 1H), 1.34 (br s, 1H); 
13C NMR (500 MHz, CDCl3) δ 141.90, 139.91, 129.06, 128.64, 128.25, 128.10, 126.86, 
126.03, 66.39, 53.44, 38.72; HRMS CI+: C15H16ONH4+ {[M+NH4]+}, Calc.: 230.1539, 
Found: 230.1549;  IR: 3369, 3084, 2924, 1494, 1452, 1265, 1060, 1027, 696cm-1. 
 
3-cyclohexyl-2-phenylpropan-1-ol (321) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 313 
(1.5012 g, 6.09 mmol), dissolved in 61 mL anhydrous diethyl at 0oC, was 
added lithium aluminium hydride (0.6938 g, 18.28 mmol). The resultant 
mixture was stirred at room temperature for 16 hours. The reaction mixture was quenched 
with saturated sodium sulfate solution (added dropwsie) until no effervescence was observed 
and a white precipitate formed. The mixture was filtered and the solvent of the filtrate was 
evaporated under reduced pressure furnishing a colourless pure oil (0.7712g, 58%).1H NMR 
(500 MHz, CDCl3) δ 7.35 (t, J = 7.4 Hz, 2H), 7.30 – 7.20 (m, 3H), 3.79 – 3.64 (m, 2H), 2.98 
– 2.92 (m, 1H), 1.81 (d, J = 13.1 Hz, 1H), 1.72 – 1.43 (m, 7H), 1.30 (br s, 1H), 1.23 – 1.12 
(m, 4H), 0.99 – 0.81 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 142.64, 128.65, 128.10, 
126.65, 68.08, 45.56, 39.75, 34.70, 34.18, 32.78, 26.59, 26.22, 26.11; HRMS CI+: 
C15H22ONH4+ {[M+NH4]+}, Calc.: 236.2009, Found: 236.2015;  IR: 3368, 2920, 2849, 1494, 
1448, 13360, 1053, 699cm-1 
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2-phenylpent-4-en-1-ol (322) 
Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 314 
(1.2018 g, 6.32 mmol), dissolved in 63 mL anhydrous diethyl at 0oC, was 
added lithium aluminium hydride (0.7192 g, 18.95 mmol). The resultant 
mixture was stirred at room temperature for 1 hour. The reaction mixture was quenched with 
saturated sodium sulfate solution (added dropwise) until no effervescence was observed and a 
white precipitate formed.  The mixture was filtered and the solvent of the filtrate was 
evaporated under reduced pressure furnishing a colourless pure oil (0.6561 g, 64%).1H NMR 
(500 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H), 7.29 – 7.22 (m, 3H), 5.75 (dddd, J = 17.1, 10.1, 
7.5, 6.5 Hz, 1H), 5.06 (dq, J = 17.1, 1.6 Hz, 1H), 4.99 (dq, J = 10.1, 1.6 Hz, 1H), 3.87 – 3.72 
(m, 2H), 2.91 (quin, J = 7.1, 1H), 2.54 - 2.48 (m, 1H), 2.45 – 2.39 (m, 1H), 2.19 (br s, 1H); 
13C NMR (500 MHz, CDCl3) δ 141.92, 136.35, 128.63, 128.04, 126.80, 116.38, 66.92, 
48.18, 36.63; HRMS CI+: C11H14ONH4+ {[M+NH4]+}, Calc.: 180.1383, Found: 180.1385;  
IR: 3362, 3077, 3063, 3028, 2917, 1601, 1493, 1442, 1053cm-1 
 
3-methyl-2-phenylbutan-1-ol (323) 
 Under a nitrogen atmosphere, to a stirred solution of the alkylated ester 
315 (1.2010 g, 6.25 mmol), dissolved in 63 mL anhydrous diethyl at 0oC, 
was added lithium aluminium hydride (0.7112 g, 18.74 mmol). The 
resultant mixture was stirred at room temperature for 2 hour. The reaction mixture was 
quenched with saturated sodium sulfate solution (added dropwise) until no effervescence was 
observed and a white precipitate formed.  The mixture was filtered and the solvent of the 
filtrate was evaporated under reduced pressure furnishing a colourless pure oil (0.9958g, 
97%).1H NMR (500 MHz, CDCl3) δ 7.38 – 7.32 (m, 2H), 7.30 – 7.20 (m, 3H), 3.96 (dd, J = 
11.1, 4.7 Hz, 1H), 3.88 – 3.81 (m, 1H), 2.55 – 2.51 (m, 1H), 2.02 – 1.89 (m, 1H), 1.25 (br s, 
1H), 1.03 (d, J = 6.7 Hz, 3H), 0.76 (d, J = 6.8 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 
141.68, 128.73, 128.53, 126.70, 65.23, 55.82, 30.08, 21.02, 21.00; HRMS CI+: C11H16ONH4+ 
OH
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{[M+NH4]+}, Calc.: 182.1539, Found: 182.1541;  IR: 3360, 3061, 2957, 2872, 1494, 1453, 
1385, 1078, 699cm-1. 
 
4-((tert-butyldimethylsilyl)oxy)-2-phenylbutan-1-ol (344) 
 
Compound 343 (3.4 g, 11.3 mmol) was dissolved in THF (30 mL) in 
250 mL round-bottomed flask at 0°C. NaBH4 (0.86 g, 22.6 mmol), 
LiCl (0.96 g, 22.6 mmol) and ethanol (20 mL) was then added. The 
reaction mixture was stirred for 23 hours at room temperature. The solvent mixture was 
evaporated in vacuo and the product was extracted with CH2Cl2 and water. Organic layer was 
dried with MgSO4 and evaporated in vacuo. The crude product was purified by flash column 
chromatography (70:30 hexane: diethyl ether) to provide a colourless oil (2.5 g, 80%).1H 
NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 2H), 7.27 – 7.19 (m, 3H), 3.80 – 3.71 (m, 2H), 
3.70 – 3.64 (m, 1H), 3.58 – 3.51 (m, 1H), 2.96 (quin, J = 6.9 Hz, 1H), 2.35 (s, 1H), 2.02 – 
1.91 (m, 1H), 1.90 – 1.80 (m, 1H), 0.89 (s, 9H), 0.03 (d, J = 3.8 Hz, 6H); 13C NMR (500 
MHz, CDCl3) δ 142.72, 128.62, 127.89, 126.67, 68.15, 61.48, 47.26, 38.32, 25.92, 18.28, -
5.71, -5.43; HRMS CI+: C16H28O2SiNH4+ {[M+NH4]+}, Calc.: 298.2197, Found: 298.2199; 
IR: 3384, 3029, 2857, 1471, 1253, 1081, 1043, 832cm-1. 
 
6.3.3 Synthesis of aldehydes from alcohols. 
2-phenylbutanal (324) 
Under a nitrogen atmosphere, oxalyl chloride (0.21 mL, 2.54mmol) in 
dichloromethane 21m at -78oC, was added dropwise DMSO (0.36 mL, 
5.08mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 316 (0.3184 g, 2.11 mmol) dissolved in 
a little dichloromethane was added dropwise to the reaction mixture and left sit for 45 
minutes at -78oC. Triethylamine (1.48 mL, 10.6mmol) was then added and the reaction 
brought to room temperature and left for 4 hours. The reaction mixture was quenched with 
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saturated ammonium chloride solution. The mixture was then extracted with dichloromethane 
three times. The combined organic extracts were washed with water three times and once 
with brine. The organic layer was then dried with anhydrous magnesium sulphate, filtered and 
concentrated in vacuo to provide the crude product. After flash chromatography (95:5 hexane: 
diethyl ether), the product was isolated as a colourless oil (0.1845 g, 59%) 1H NMR (500 
MHz, CDCl3) δ 9.71 (d, J = 2.1 Hz, 1H), 7.40 (t, J = 7.3Hz, 2H), 7.35 – 7.30 (m, 1H), 7.24 – 
7.20 (m, 2H), 3.43 (ddd, J = 8.4, 6.6, 2.1 Hz, 1H), 2.14 (ddd, J = 14.1, 7.4, 6.6 Hz, 1H), 1.79 
(ddd, J = 14.1, 7.4, 6.6 Hz, 1H), 0.93 (t, J = 7.4 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 
201.03, 136.30, 129.01, 128.83, 127.53, 60.88, 22.95, 11.72; HRMS CI+: C10H12OH+ 
{[M+H]+}, Calc.: 149.0961, Found: 149.0961; IR: 3084, 2965, 2815, 2714, 1720, 1492, 1453, 
756cm-1. 
 
2-phenylpentanal (325) 
Under a nitrogen atmosphere, oxalyl chloride (0.25 mL, 2.93mmol) in 
dichloromethane 29 mL at -78oC, was added dropwise DMSO (0.42 ml, 
5.88mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 317 (0.4014 g, 2.44 
mmol) dissolved in a little dichloromethane was added dropwise to the reaction mixture and 
left sit for 45 minutes at -78oC. Triethylamine (1.71 mL, 12.22 mmol) was then added and the 
reaction brought to room temperature and left for 3 hours. The reaction mixture was quenched 
with saturated ammonium chloride solution. The mixture was then extracted with 
dichloromethane three times. The combined organic extracts were washed with water three 
times and once with brine. The organic layer was then dried with anhydrous magnesium 
sulphate, filtered and concentrated in vacuo to provide the crude product. After flash 
chromatography (95:5 hexane: diethyl ether), the product was isolated as a colourless oil 
(0.2691g, 68%) 1H NMR (500 MHz, CDCl3) δ 9.70 (d, J = 2.1 Hz, 1H), 7.44 – 7.36 (m, 2H), 
7.35 – 7.29 (m, 1H), 7.25 – 7.19 (m, 2H), 3.53 (ddd, J = 8.4, 6.5, 2.1 Hz, 1H), 2.12 – 2.02 (m, 
1H), 1.81 – 1.70 (m, 1H), 1.32 (sex, J = 7.4 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H); 13C NMR (500 
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MHz, CDCl3) δ 201.06, 136.50, 129.01, 128.79, 127.50, 58.96, 31.79, 20.27, 13.91; HRMS 
CI+: C11H14OH+ {[M+H]+}, Calc.: 163.1117, Found: 163.1122; IR: 3063, 2958, 2814, 2714, 
1721, 1493, 1454, 1380, 1082cm-1. 
 
2-phenylhexanal (326) 
Under a nitrogen atmosphere, oxalyl chloride (0.40 mL, 4.71mmol) in 
dichloromethane 39 mL at -78oC, was added dropwise DMSO (0.67 ml, 
9.43 mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 318 (0.7002 g, 3.93mmol) dissolved in 
a little dichloromethane was added dropwise to the reaction mixture and left sit for 45 
minutes at -78oC. Triethylamine (2.74g, 19.64 mmol) was then added and the reaction 
brought to room temperature and left for 3 hours. The reaction mixture was quenched with 
saturated ammonium chloride solution. The mixture was then extracted with dichloromethane 
three times. The combined organic extracts were washed with water three times and once 
with brine. The organic layer was then dried with anhydrous magnesium sulphate, filtered and 
concentrated in vacuo to provide the crude product. After flash chromatography (96:4 
hexane:diethyl ether), the product was isolated as a colourless oil (0.4291 g, 62%) 1H NMR 
(500 MHz, CDCl3) δ 9.70 (s, 1H), 7.40 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.5 Hz, 1H), 7.22 (d, J 
= 7.5 Hz, 2H), 3.51 (t, J = 7.5 Hz, 1H), 2.14 – 2.06 (m, 1H), 1.82 – 1.70 (m, 1H), 1.40 – 1.23 
(m, 4H), 0.90 (t, J = 7.1 Hz, 4H); 13C NMR (500 MHz, CDCl3) δ 201.05, 136.54, 129.01, 
128.78, 127.49, 59.21, 29.41, 29.25, 22.55, 13.86; HRMS CI+: C12H16ONH4+ {[M+NH4]+}, 
Calc.: 194.1539, Found: 194.1543;  IR: 3062, 2930, 2813, 2712, 1721, 1492, 1453, 1379, 
1075cm-1. 
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4-methyl-2-phenylpentanal (327) 
 Under a nitrogen atmosphere, oxalyl chloride (0.18 mL, 2.09mmol) in 
dichloromethane 21 mL at -78oC, was added dropwise DMSO (0.3 mL, 4.17 
mmol) dissolved in a little dichloromethane. The resultant mixture was left 
for 15 minutes at -78oC. Subsequently the alcohol 319 (0.3100 g, 1.74 mmol) 
dissolved in a little dichloromethane was added dropwise to the reaction mixture and left sit 
for 45 minutes at -78oC. Triethylamine (1.21 mL, 8.70 mmol) was then added and the reaction 
brought to room temperature and left for 4 hours. The reaction mixture was quenched with 
saturated ammonium chloride solution. The mixture was then extracted with dichloromethane 
three times. The combined organic extracts were washed with water three times and once 
with brine. The organic layer was then dried with anhydrous magnesium sulphate, filtered and 
concentrated in vacuo to provide the crude product. After flash chromatography (96:4 
hexane:diethyl ether), the product was isolated as a colourless oil (0.2024 g, 66%) 1H NMR 
(500 MHz, CDCl3) δ 9.69 (s, 1H), 7.40 (t, J = 7.8 Hz, 2H), 7.34-7.29 (m, 1H), 7.23 (d, J = 
7.8 Hz, 2H), 3.63 (t, J = 7.5 Hz, 1H), 1.97 – 1.90 (m, 1H), 1.77-1.65 (m, 1H), 1.51 (sept, J = 
6.9 Hz, 1H), 0.96 – 0.91 (m, 6H); 13C NMR (500 MHz, CDCl3) δ 201.08, 136.52, 129.04, 
128.80, 127.51, 57.25, 38.53, 25.33, 23.02, 21.96; HRMS CI+: C13H16ONH4+ {[M+NH4]+}, 
Calc.: 194.1539, Found: 194.1543; IR: 3063, 2956, 2812, 2713, 1721, 1492, 1467, 1367, 
1074, 756cm-1. 
 
2,3-diphenylpropanal (328) 
Under a nitrogen atmosphere, oxalyl chloride (0.29 mL, 3.4mmol) in 
dichloromethane 34 mL at -78oC, was added dropwise DMSO (0.31 mL, 
4.41mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 320 (0.6012 g, 2.83 
mmol) dissolved in a little dichloromethane was added dropwise to the reaction mixture and 
left sit for 45 minutes at -78oC. Triethylamine (0.31 mL, 3.4 mmol) was then added and the 
reaction brought to room temperature and left for 4 hours. The reaction mixture was quenched 
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with saturated ammonium chloride solution. The mixture was then extracted with 
dichloromethane three times. The combined organic extracts were washed with water three 
times and once with brine. The organic layer was then dried with anhydrous magnesium 
sulphate, filtered and concentrated in vacuo to provide the crude product. After flash 
chromatography (96:4 hexane:diethyl ether), the product was isolated as a colourless oil 
(0.2569g, 54%) 1H NMR (500 MHz, CDCl3) δ 9.78 (s, 1H), 7.40 – 7.34 (m, 2H), 7.34 – 7.29 
(m, 1H), 7.25 – 7.22 (m, 2H), 7.21 – 7.14 (m, 3H), 7.10 – 7.06 (m, 2H), 3.86 (t, J = 7.4 Hz, 
1H), 3.50 (dd, J = 14.0, 7.4 Hz, 1H), 3.00 (dd, J = 14.0, 7.4 Hz, 1H); 13C NMR (500 MHz, 
CDCl3) δ 199.93, 138.81, 135.73, 129.05, 128.36, 128.31, 128.15, 127.71, 126.33, 60.97, 
36.18; HRMS CI+: C15H14ONH4+ {[M+NH4]+}, Calc.: 228.1383, Found: 228.1391;  IR: 
3085, 2817, 2716, 1719, 1493, 1452, 1029cm-1. 
 
3-cyclohexyl-2-phenylpropanal (329) 
Under a nitrogen atmosphere, oxalyl chloride (0.19 mL, 2.2 mmol) in 
dichloromethane 18.4 mL at -78oC, was added dropwise DMSO (0.31ml, 
4.41mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 321 (0.4016 g, 1.84 
mmol) dissolved in a little dichloromethane was added dropwise to the reaction mixture and 
left sit for 45 minutes at -78oC. Triethylamine (1.28 mL, 9.20 mmol) was then added and the 
reaction brought to room temperature and left for 4 hours. The reaction mixture was quenched 
with saturated ammonium chloride solution. The mixture was then extracted with 
dichloromethane three times. The combined organic extracts were washed with water three 
times and once with brine. The organic layer was then dried with anhydrous magnesium 
sulphate, filtered and concentrated in vacuo to provide the crude product. After flash 
chromatography (96:4 hexane:diethyl ether), the product was isolated as a colourless oil 
(0.2569g, 54%) 1H NMR (500 MHz, CDCl3) δ 9.68 (s, 1H), 7.40 (t, J = 7.4 Hz, 2H), 7.32 (d, 
J = 7.4 Hz, 1H), 7.22 (d, J = 7.4 Hz, 2H), 3.66 (t, J = 7.1 Hz, 1H), 1.96 (p, J = 7.1 Hz, 1H), 
1.79 (d, J = 13.0 Hz, 1H), 1.74 – 1.60 (m, 6H), 1.24 – 1.14 (m, 4H), 1.01 – 0.87 (m, 2H); 13C 
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NMR (500 MHz, CDCl3) δ 201.20, 136.66, 129.04, 128.78, 127.47,  56.48, 37.14, 34.71, 
33.69, 32.81, 26.46, 26.12, 26.05; HRMS CI+: C15H20ONH4+ {[M+NH4]+}, Calc.: 234.1853, 
Found: 234.1862;  IR: 3061, 2920, 2709, 1721, 1492, 1448, 1074, 891cm-1. 
 
2-phenylpent-4-enal (330) 
Under a nitrogen atmosphere, oxalyl chloride (0.4001g, 2.47mmol) in 
dichloromethane 30 mL at -78oC, was added dropwise DMSO (0.42 mL, 
5.92mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 322 (0.4001g, 2.47 
mmol) dissolved in a little dichloromethane was added dropwise to the reaction mixture and 
left sit for 45 minutes at -78oC. Triethylamine (1.72 ml, 12.33 mmol) was then added and the 
reaction brought to room temperature and left for 4 hours. The reaction mixture was quenched 
with saturated ammonium chloride solution. The mixture was then extracted with 
dichloromethane three times. The combined organic extracts were washed with water three 
times and once with brine. The organic layer was then dried with anhydrous magnesium 
sulphate, filtered and concentrated in vacuo to provide the crude product. After flash 
chromatography (95:5 hexane:diethyl ether), the product was isolated as a colourless oil 
(0.2451 g, 62%) 1H NMR (500 MHz, CDCl3) δ 9.72 (d, J = 1.8 Hz, 1H), 7.43 – 7.38 (m, 
2H), 7.35 – 7.31 (m, 1H), 7.24 – 7.20 (m, 2H), 5.74 (ddt, J = 17.1, 10.1, 6.9 Hz, 1H), 5.08 
(dq, J = 17.1, 1.5 Hz, 1H), 5.03 (dq, J = 10.1, 1.5 Hz, 1H), 3.64 (ddd, J = 8.2, 7.0, 1.8 Hz, 
1H), 2.92 – 2.83 (m, 1H), 2.53 (m, 1H); 13C NMR (500 MHz, CDCl3) δ 200.14, 135.71, 
134.87, 129.07, 128.88, 127.68,  117.18, 58.76, 33.97; HRMS CI+: C10H12ONH4+ 
{[M+NH4]+}, Calc.: 178.1226, Found: 178.1226;  IR: 3079, 2979, 2817, 2717, 1721, 1492, 
915cm-1 
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3-methyl-2-phenylbutanal (331) 
Under a nitrogen atmosphere, oxalyl chloride (0.19 mL, 2.19 mmol) in 
dichloromethane 13 mL at -78oC, was added dropwise DMSO (0.31 mL, 
4.39 mmol) dissolved in a little dichloromethane. The resultant mixture was 
left for 15 minutes at -78oC. Subsequently the alcohol 323 (0.3000 g, 1.33 
mmol) dissolved in a little dichloromethane was added dropwise to the reaction mixture and 
left sit for 45 minutes at -78oC. Triethylamine (1.28 mL, 9.14 mmol) was then added and the 
reaction brought to room temperature and left for 4 hours. The reaction mixture was quenched 
with saturated ammonium chloride solution. The mixture was then extracted with 
dichloromethane three times. The combined organic extracts were washed with water three 
times and once with brine. The organic layer was then dried with anhydrous magnesium 
sulphate, filtered and concentrated in vacuo to provide the crude product. After flash 
chromatography (96:4 hexane:diethyl ether), the product was isolated as a colourless oil 
(0.1597 g, 74%) 1H NMR (500 MHz, CDCl3) δ 9.73 (s, 1H), 7.39 (t, J = 7.358 Hz, 2H), 7.32 
(t, J = 7.35 Hz, 1H), 7.21 (d, J = 7.35 Hz, 2H), 3.21 (d, J = 9.7 Hz, 1H), 2.48 – 2.41 (m, 1H), 
1.07 (d, J = 6.7, 3H), 0.80 (d, J = 6.9, 3H); 13C NMR (500 MHz, CDCl3) δ 201.13, 135.50, 
129.32, 128.90, 127.47, 66.86, 28.80, 21.19, 20.05; HRMS CI+: C11H14ONH4+ {[M+NH4]+}, 
Calc.: 180.1383, Found: 180.1385;  IR: 3082, 2960, 2711, 1721, 1491, 1466, 1388, 1046cm-1. 
 
4-((tert-butyldimethylsilyl)oxy)-2-phenylbutanal (345) 
 
Under a nitrogen atmosphere, oxalyl chloride (0.7 mL, 8.16 mmol) in 
dichloromethane 60 mL at -78oC, was added dropwise DMSO (1.08 
mL, 15.3 mmol) dissolved in a little dichloromethane. The resultant 
mixture was left for 15 minutes at -78oC. Subsequently the alcohol 344 (1.42 g, 5.1 mmol) 
dissolved in a little dichloromethane was added dropwise to the reaction mixture and left sit 
for 45 minutes at -78oC. Triethylamine (12.8 mL, 51 mmol) was then added and the reaction 
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brought to room temperature and left for 4 hours. The reaction mixture was quenched with 
saturated ammonium chloride solution. The mixture was then extracted with dichloromethane 
three times. The combined organic extracts were washed with water three times and once 
with brine. The organic layer was then dried with anhydrous magnesium sulphate, filtered and 
concentrated in vacuo to provide the crude product. After flash chromatography (96:4 
hexane:diethyl ether), the product was isolated as a colourless oil (0.7091 g, 50%) 1H NMR 
(500 MHz, CDCl3) δ 9.71 (s, 1H), 7.39 – 7.34 (m, 2H), 7.32 – 7.27 (m, 1H), 7.22 – 7.18 (m, 
2H), 3.81 – 3.75 (m, 1H), 3.69 – 3.63 (m, 1H), 3.54 – 3.47 (m, 1H), 2.40 – 2.31 (m, 1H), 1.92 
– 1.84 (m, 1H), 0.89 (s, 9H), 0.03 (d, J = 3.8 Hz,  6H); 13C NMR (500 MHz, CDCl3) δ 
200.78, 136.12, 129.01, 127.54,  60.06, 55.63, 32.90, 25.90, 18.25, -5.44, -5.45; HRMS CI+: 
C16H26O2SiNH4+ {[M+NH4]+}, Calc.: 296.2041, Found: 2096.2044; IR: 2924, 2855, 1731, 
1462, 1388, 1287, 1118, 1073cm-1. 
 
6.3.4 Synthesis of Carboxylic acids 
 
2-phenylbutanoic acid (332) 
To a stirred solution of the alkylated ester 308 (200.7 mg, 1.13 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8 mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The aqueous layer was 
acidified with 2 M hydrochloric acid until a cloudy solution formed. The reaction mixture 
was then extracted with diethyl ether (3x10 mL). The organic extracts were then dried over 
magnesium sulphate, filtered and concentrated in vacuo to furnish a white crystalline solid 
(128.9 mg, 64%). ). 1H NMR (500 MHz, CDCl3) δ 11.55 (br s, 1H), 7.38 – 7.27 (m, 5H), 
3.49 (t, J = 7.7 Hz, 1H), 2.16 – 2.09 (m, 1H), 1.89 – 1.81 (m, 1H), 0.94 (t, J = 7.3 Hz, 3H); 
13C NMR (500 MHz, CDCl3) δ 180.05, 138.37, 128.63, 128.09, 127.43, 53.30, 26.30, 12.10; 
HRMS CI+: C10H12O2NH4+ {[M+NH4]+}, Calc.: 182.1176, Found: 182.1181; IR: 3058, 2964, 
2608, 1714, 1454, 1415, 1308, 1283, 1220, 937cm-1. 
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2-phenylpentanoic acid (333) 
To a stirred solution of the alkylated ester 309 (211.1 mg, 1.10 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8 mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The aqueous layer was 
acidified with 2M hydrochloric acid until a cloudy solution formed. The reaction mixture was 
then extracted with diethyl ether (3x10mL). The organic extracts were then dried over 
magnesium sulphate, filtered and concentrated in vacuo to furnish a white crystalline solid 
(128.9 mg, 64%). 1H NMR (500 MHz, CDCl3) δ 11.45 (br s, 1H), 7.39 – 7.29 (m, 5H), 3.60 
(t, J = 7.7 Hz, 1H), 2.13 – 2.05 (m, 1H), 1.86 – 1.75 (m, 1H), 1.41 – 1.23 (m, 2H), 0.95 (t, J = 
7.3 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 180.49, 138.54, 128.63, 128.08, 127.41, 51.35, 
35.17, 20.67, 13.79; HRMS CI+: C11H14O2NH4+ {[M+NH4]+}, Calc.: 196.1333, Found: 
196.1332; IR: 3086, 2957, 2619, 1692, 1449, 1411, 1292, 1213, 948cm-1. 
 
2-phenylhexanoic acid (334) 
To a stirred solution of the alkylated ester 310 (202.3mg, 0.981 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8 mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The aqueous layer was 
acidified with 2 M hydrochloric acid until a cloudy solution formed. The reaction mixture 
was then extracted with diethyl ether (3x10 mL). The organic extracts were then dried over 
magnesium sulphate, filtered and concentrated in vacuo to furnish a white crystalline solid 
(113.2g, 60%). 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.24 (m, 6H), 3.55 (t, J = 7.7 Hz, 1H), 
2.06 – 2.13 (m, 1H), 1.77 – 1.84 (m, 1H), 1.42 – 1.18 (m, 4H), 0.89 (t, J = 7.0 Hz, 3H); 13C 
NMR (500 MHz, CDCl3) δ 180.08, 138.64, 128.62, 128.05, 127.38, 51.60, 32.82, 29.63, 
22.43, 13.85; HRMS CI+: C12H16O2NH4+ {[M+NH4]+}, Calc.: 210.1489, Found: 210.1493;  
IR: 3030, 2860, 1701, 1455, 1413, 1380, 1239, 725cm-1. 
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4-methyl-2-phenylpentanoic acid (335) 
To a stirred solution of the alkylated ester 311 (201.9 mg, 0.979 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The 
aqueous layer was acidified with 2 M hydrochloric acid until a cloudy solution formed. The 
reaction mixture was then extracted with diethyl ether (3x10 mL). The organic extracts were 
then dried over magnesium sulphate, filtered and concentrated in vacuo to furnish a white 
crystalline solid (133.6 g, 71%). 1H NMR (500 MHz, CDCl3) δ 7.41 – 7.26 (m, 7H), 3.71 – 
3.67 (m, 1H), 1.99 (dd, J = 13.6, 6.6 Hz, 1H), 1.72 (dd, J = 13.6, 6.8 Hz, 1H), 1.59 – 1.46 (m, 
1H), 0.94 (d, J = 6.6 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 180.61, 138.60, 129.40, 
128.66, 128.11, 127.42, 49.53, 42.01, 41.12, 25.77, 22.60, 22.21; HRMS CI+: C12H16O2NH4+ 
{[M+NH4]+}, Calc.: 210.1489, Found: 210.1493; IR: 3063, 2930, 2653, 1690, 1453, 1406, 
1283, 1237, 1211, 1185, 932cm-1. 
 
2,3-diphenylpropanoic acid (336) 
To a stirred solution of the alkylated ester 312 (212.0 mg, 0.882 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The 
aqueous layer was acidified with 2 M hydrochloric acid until a cloudy solution formed. The 
reaction mixture was then extracted with diethyl ether (3x10 mL). The organic extracts were 
then dried over magnesium sulphate, filtered and concentrated in vacuo to furnish a white 
crystalline solid (145.7mg, 73%). 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.27 (m, 6H), 7.27 – 
7.17 (m, 3H), 7.30 – 7.10 (m, 2H), 3.89 (dd, J = 8.4, 7.0 Hz, 1H), 3.43 (dd, J = 13.9, 8.4 Hz, 
1H), 3.06 (dd, J = 13.9, 7.0 Hz, 1H), 1.28 (s, 1H); 13C NMR (500 MHz, CDCl3) δ 178.18, 
138.69, 137.96, 128.91, 128.70, 128.37, 128.08, 127.61, 126.45, 53.34, 39.30; HRMS CI+: 
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C15H14O2NH4+ {[M+NH4]+}, Calc.: 244.1332, Found: 244.1337;  IR: 3162, 3029, 2926, 1720, 
1493, 1451, 1399, 1251cm-1. 
 
3-cyclohexyl-2-phenylpropanoic acid (337) 
To a stirred solution of the alkylated ester 313 (200.6 mg, 0.818 mmol) 
dissolved in THF (4 mL), was added 2M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The 
aqueous layer was acidified with 2 M hydrochloric acid until a cloudy solution formed. The 
reaction mixture was then extracted with diethyl ether (3x10 mL). The organic extracts were 
then dried over magnesium sulphate, filtered and concentrated in vacuo to furnish a white 
crystalline solid (96.9mg, 51%). 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.26 (m, 5H), 3.72 (t, 
J = 7.7 Hz, 1H), 2.02 – 1.97 (m, 1H), 1.81 – 1.59 (m, 6H), 1.23 – 1.12 (m, 4H), 0.99 – 0.87 
(m, 2H); 13C NMR (500 MHz, CDCl3) δ 180.16, 138.78, 128.64, 128.08, 127.36,  48.67, 
40.62, 35.12, 33.28, 32.93, 26.47, 26.07, 26.03; HRMS CI+: C15H20O2NH4+ {[M+NH4]+}, 
Calc.: 250.1802, Found: 250.1802;  IR: 3058, 2922, 1695, 1449, 1410, 1329, 1233, 956cm-1 
 
 
2-phenylpent-4-enoic acid (338) 
To a stirred solution of the alkylated ester 314 (200.3 mg, 1.05 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The 
aqueous layer was acidified with 2 M hydrochloric acid until a cloudy solution formed. The 
reaction mixture was then extracted with diethyl ether (3x10 mL). The organic extracts were 
then dried over magnesium sulphate, filtered and concentrated in vacuo to furnish a white 
crystalline solid (131.5 mg, 71%). 1H NMR (500 MHz, CDCl3) δ 10.30 (br s, 1H), 7.38 – 
7.29 (m, 5H), 5.75 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.14 – 5.00 (m, 2H), 3.68 (dd, J = 8.4, 
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7.1 Hz, 1H), 2.85 (dddt, J = 14.4, 8.4, 6.8, 1.2 Hz, 1H), 2.60 – 2.50 (dddt, J = 14.4, 7.1, 6,8, 
1.2 Hz, 1H); 13C NMR (500 MHz, CDCl3) δ 178.60, 137.84, 134.88, 128.71, 128.05, 127.59, 
117.27, 51.21, 37.09; HRMS CI+: C11H12O2H+ {[M+H]+}, Calc.: 177.091, Found: 177.0908;  
IR: 3058, 2895, 2648, 1702, 1453, 1439, 1414, 1244,  978cm-1. 
 
3-methyl-2-phenylbutanoic acid (339) 
To a stirred solution of the alkylated ester 315 (203.1 mg, 1.06 mmol) 
dissolved in THF (4 mL), was added 2 M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 80oC 
overnight. Diethyl ether was added and the aqueous layer removed. The 
aqueous layer was acidified with 2 M hydrochloric acid until a cloudy solution formed. The 
reaction mixture was then extracted with diethyl ether (3x10 mL). The organic extracts were 
then dried over magnesium sulphate, filtered and concentrated in vacuo to furnish a white 
crystalline solid (187.0 mg, 99%). 1H NMR (500 MHz, CDCl3) δ 10.87 (br s, 1H), 7.39 – 
7.25 (m, 5H), 3.16 (d, J = 10.6 Hz, 1H), 2.39 – 2.32 (m,1H), 1.10 (d, J = 6.5 Hz, 3H), 0.73 (d, 
J = 6.7 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 180.16, 137.75, 128.60, 128.53, 127.45, 
60.04, 31.56, 21.46, 20.11; HRMS CI+: C11H14O2NH4+ {[M+NH4]+}, Calc.: 196.1332, 
Found: 196.1339;  IR: 3065, 2966, 2868, 1698, 1454, 1407, 1385, 1288, 1185, 965cm-1. 
 
4-((tert-butyldimethylsilyl)oxy)-2-phenylbutanoic acid (348) 
To a stirred solution of the alkylated ester 343 (210.6 mg, 0.68 mmol) 
dissolved in THF (2.4 mL), was added 0.5M aqueous lithium 
hydroxide (2.4 mL, 1.19 mmol) at 0oC. Once the reaction was 
complete, diethyl ether (8 mL) was added forming a biphasic reaction mixture. The aqueous 
layer was then isolated and acidified with dropwsie addition of 1 M hydrochloric acid until 
pH 3 using a pH meter. The reaction mixture was then extracted with diethyl ether (3x10 ml). 
The organic extracts were then dried over magnesium sulphate filtered and concentrated in 
vacuo to furnished a pure white crystalline solid (131.9 g, 66%). 1H NMR (500 MHz, 
O
OH
339
O
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CDCl3) δ 7.37 – 7.27 (m, 5H), 3.84 (t, J = 7.4 Hz, 1H), 3.68 – 3.61 (m, 1H), 3.56 – 3.50 (m, 
1H), 2.40 – 2.31 (m, 1H), 2.00 – 1.91 (m, 1H), 0.90 (s, 9H), 0.02 (d, J = 5.8 Hz, 6H); 13C 
NMR (500 MHz, CDCl3) δ 179.42, 138.30, 128.66, 128.20, 127.42, 60.37, 47.82, 35.72, 
25.91, 25.87, 18.24, -5.49, -5.51; HRMS CI+: C16H26O3SiNH4+ {[M+NH4]+}, Calc.: 
312.1990, Found: 312.1992; IR: 3067, 2929, 2645, 1704, 1250, 1086, 962cm-1. 
 
6.3.5 Synthesis of lactones 
3-phenyldihydrofuran-2(3H)-one (350) 
To a stirred solution of the alkylated ester 343 (200.9 mg, 0.68 mmol) 
dissolved in THF (4 mL), was added 2M aqueous sodium hydroxide (4 mL, 
8mmol). The resultant reaction mixture was heated under reflux at 100oC 
overnight. To this was added diethyl ether (8 mL) forming a biphasic reaction mixture. The 
aqueous layer was then isolated and acidified with 2 M hydrochloric acid until a cloudy 
solution formed. The reaction mixture was then extracted with diethyl ether (3x10 mL). The 
organic extracts were then dried over magnesium sulphate filtered and concentrated in vacuo 
to furnished a viscous brown oil (77.1 mg, 73%). 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.25 
(m, 5H), 7.39 – 7.25 (m, 5H), 4.48 – 4.42 (m,1H), 4.36 – 4.32 (m,1H), 2.25 – 2.18 (m,1H), 
2.66 – 2.58 (m,1H), 2.46 – 2.40 (m, 1H); 13C NMR (500 MHz, CDCl3) δ 177.52, 136.65, 
128.95, 128.11, 127.67, 66.56, 45.52, 31.58; HRMS CI+: C10H10O2NH4+ {[M+NH4]+}, Calc.: 
180.1020, Found: 180.1023;  IR: 3031, 2920, 1743, 1485, 1444, 1426, 1234, 1175, 1155cm-1. 
 
6.3.6 Deprotection of TBDMS protected alcohols. 
 
4-hydroxy-2-phenylbutanoic acid (349) 
 To a solution of acid 348 (0.1g, 0.4 mmol) dissolved in 3 mL DCM and 3 
mL MeOH was added CSA (0.082g, 0.35 mmol) at -10°C and left stir for 1 
hour. Saturated NaHCO3 was added and the reaction extracted into DCM. 
The organic layer was dried with MgSO4, filtered and concentrated in vacuo to give a white 
O
O
350
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O
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crystalline solid in quantitative yield. 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 
3.84 (t, J = 7.6Hz), 3.7-3.65 (m,1H), 3.63-3.57 (m, 1H), 2.38(dddd, J = 13.89, 7.89, 7.03, 
5.32Hz), 2.07-1.99 (m, 1H). HRMS CI+: C10H12O3NH4+ {[M+NH4]+}, Calc.: 196.1030, 
Found: 196.1023;  IR: 3031, 2920, 1760, 1485, 1444, 1426, 1234, 1175, 1155cm-1. 
 
3-phenyltetrahydrofuran-2-ol (346) 
To a solution of 345 (0.4g, 1.4 mmol) in 10 mL THF was added 2.8 mL 
TBAF (1 M, 2.8 mmol) at -40°C. The reaction was left stir for 30mins. 
After this time the reaction was quenched with saturated solution of 
ammonia chloride and the reaction brought to room temperature. The reaction was extracted 
three times DCM and the organic layer dried with MgSO4, filtered and concentrated in vacuo 
to yield a white solid (0.17 g, 75%). 
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.24 (m, 7H), 5.53 (t, J=3.8Hz, 0.3H), 5.46 (t, J = 
2.64Hz, 1H), 4.31(td, J = 8.75, 2.48 Hz, 0.3H), 4.27-4.19 (m, 1H), 4.15 (td, J = 8.1, 5.0 Hz, 
1H), 4.02 (dq, J = 8.0, 1.0 Hz, 0.3H), 3.39 (dd, J = 7.7, 4.5 Hz, 0.3H), 3.36 (td, J = 8.23, 2.32 
Hz, 1H), 2.76(bs, 1H), 2.58-2.44 (m, 1.3H), 2.32-2.24 (m, 0.3H), 2.07 (m, 1H) 13C NMR 
(500 MHz, CDCl3) δ 141.8, 128.8, 128.6, 128.4, 127.25, 127.04, 126.69. 104.0, 98.5, 67.5, 
52.2, 32.8. HRMS CI+: C10H12O2NH4+{[M+NH4+]}, Calc: 180.2104, Found: 180.2101 
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Initial PaoABC catalysed oxidation of α-substituted aldehydes 
 
3µL of of a 1M stock solution of compound 324-331 and 33 µL catalase (3.3 mg/mL) was 
added to 50mM KPi-buffer pH 7.5. 2 µL of PaoABC(13.2mg/mL) was then added. Final 
concentration 300 µL. The reaction was then placed in a shaking incubator and incubated at 
room temperature for 2 hours. 50 µL of 1M NaOH was then added with 300 µL of DCM. The 
organic layer was extracted and concentrated in vacuo. The solid was then re-suspended in 
300µL of a 10% IPA : 90% hexane solution and analysed by normal phase HPLC. HPLC 
conditions: chiracell AD-H column 95:5 hex:IPA, flowrate = 1mL/min. Conversions adjusted 
by the comparison of a 1:1 NMR authenticated standard of aldehyde and acid. 
 
E value of α-substituted aldehydes and time course analysis 
3 µL of of a 1 M stock solution of compound 324-331 and 33 µL catalase (3.3 mg/mL) was 
added to 50 mM KPi-buffer pH 7.5. 2 µL of PaoABC(13.2mg/mL) was then added. Final 
concentration 300 µL. The reaction was then placed in a shaking incubator and incubated at 
room temperature. The reaction was then closely monitored by normal HPLC. For each 
alqiquot, 20µL of the reaction was extracted. 20 µL of 1 M NaOH and 300 µL DCM was then 
added. The organic layer was extracted and concentrated in vacuo. The solid was then re-
suspended in 100 µL of a 10% IPA : 90% hexane solution and analysed by normal phase 
HPLC. HPLC conditions: chiracell AD-H column 95:5 hex:IPA, flowrate = 1mL/min. 
Conversions adjusted by the comparison of a 1:1 NMR authenticated standard of aldehyde 
and acid.  E value then calculated via equation 1. 
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pH affect on the E value associated with the oxidation of 331 with PaoABC 
3 µL of of a 1M stock solution of compound 331 and 33 µL catalase (3.3 mg/mL) was added 
to added to buffers listed in Table 12 (50 mM). 2 µL of PaoABC (13.2 mg/mL) was then 
added. Final concentration 300 µL. The reaction was then placed in a shaking incubator and 
incubated at room temperature. The reaction was closely monitored by normal HPLC. For 
each alqiquot, 20 µL of the reaction was extracted. 20 µL of 1 M NaOH and 300 µL DCM 
was then added. The organic layer was extracted and concentrated in vacuo. The solid was 
then re-suspended in 100 µL of a 10% IPA : 90% hexane solution and analysed by normal 
phase HPLC. HPLC conditions: chiracell AD-H column 95:5 hex:IPA, flowrate = 1mL/min. 
Conversions adjusted by the comparison of a 1:1 NMR authenticated standard of aldehyde 
and acid.  E value then calculated via equation 1. 
 
6.4 Experimental procedures for Chapter 4 !
6.4.1 Synthesis of amino alcohol substrates. 
Synthesis of (2-(2-aminoethyl)phenyl)methanol (358) 
Methyl 2-(cyanomethyl)benzoate (360) (3 g, 17.1 mmol) in Et2O (30 mL) 
was added dropwise to a stirred solution of AlCl3 / LiAlH4 [AlCl3 (5 g, 
37.6 mmol, 2.2 eq) in THF (60 mL) was added to a suspension of LiAlH4 
(1.4 g, 37.6 mmol, 2.2 equiv) in THF (36 mL)]. This combined suspension was then left to 
stir overnight at room temperature and quenched with a mixture of water (26 mL) and H2SO4 
(52 mL, 3 M). The resulting solution was extracted with Et2O (3 x 80 mL), the aqueous phase 
was then basified to pH ~12 by addition of solid KOH. After further dilution with H2O (120 
mL) the aqueous phase was further extracted with EtOAc (5 x 120 mL). The 5 new extracts 
were combined and dried over Na2SO4 before evaporating to yield the crude product as a dark 
brown oil. Purification via FCC on deactivated silica (1% Et3N) (10 % MeOH/DCM) to yield 
a pale solid (1.6 g, 62 %). NMR 1H (400 MHz, CDCl3) δ 7.33-7.19 (m, 4H) 4.59 (s, 2H), 3.05 
(br s, 2H), 2.99 (t, J = 4.6 Hz, 2H), 2.85 (t, J = 6.1Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 
NH2
OH
358
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140.43, 138.87, 130.04, 129.84, 128.39, 126.64, 62.87, 53.45, 34.85, HRMS CI+: C9H13ON 
H+ {[M+H]+} Calc. 152.107, Found. 152.1072. 
 
3-amino-2-phenylpropan-1-ol (368) 
 Ethyl 2-cyano-2-phenylacetate (1 g, 5.2 mmol) in Et2O (10 mL) was 
added dropwise to a stirred solution of AlCl3 / LiAlH4 [AlCl3 (1.6g, 12.5 
mmol, 2.2 eq) in THF (20 mL) was added to a suspension of LiAlH4 
(0.46g, 12.5 mmol, 2.2 equiv) in THF (12 mL)]. This combined suspension was then left to 
stir overnight at room temperature and quenched with a mixture of water (26 mL) and H2SO4 
(52 mL, 3 M). The resulting solution was extracted with Et2O (3 x 80 mL), the aqueous phase 
was then basified to pH ~12 by addition of solid KOH. After further dilution with H2O (120 
mL) the aqueous phase was further extracted with EtOAc (5 x 120 mL). The 5 new extracts 
were combined and dried over Na2SO4 before evaporating to yield the crude product as a dark 
brown oil. Purification via FCC on deactivated silica (1% Et3N) (10 % MeOH/DCM) to yield 
a yellow  oil (0.1g, 18%). NMR 1H (500 MHz, DMSO-d6) δ 7.32-7.26 (m, 2H), 7.23-7.17 (m, 
2H), 3.68-3.62 (m, 1H). 3.61-3.55(m, 1H), 2.94(dd, J = 11.8 Hz, 6.42, 1H), 2.81-2.75 (m, 
1H), 2.74-2.67(m, 1H), 13C NMR (100 MHz, DMSO-d6) δ 143.2, 128.6, 128.5, 126.6, 64.9, 
51.3, 45.2. HRMS CI+: C9H13ON H+ {[M+H]+} Calc. 152.1004, Found.152.1062 
 
6.4.2 Determination of response factors for 3,4-dihydroisoquinoline, 3,4- 
dihydroisoquinolin-1(2H)-one and (2-(2-aminoethyl)phenyl)methanol 
 
A 1:1:1 standard mixture of DHIQ (356):lactam (357):amino alcohol (358) was prepared and 
analysed by 1H NMR. The HPLC trace of this standard was recorded to obtain a calibrated 
standard to take account of response factors when calculating actual conversion for lactam 
production. HPLC conditions: Chiracel OD-H column, 1.0 mL/min, 90% Hexane (0.1% 
ethanolamine):10% IPA. 
 
OH
NH2
368
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Figure 33 HPLC and 1H NMR analysis of a 1:1:1 mixture of standards of DHIQ (356) lactam 
(357) amino alcohol (358). 
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6.4.3 Procedure and pH-screen for the GOase catalysed oxidation of (2-(2- 
aminoethyl)phenyl)methanol (358) 
 
 
3 µL of (2-(2-aminoethyl)phenyl)methanol (358) (1M in DMF) and 33 µL catalase (3.3 
mg/mL) was added to 200 mM KPi-buffer. 103 µL of GOase M3-5 (3.7 mg/mL) was added 
to give a final volume of 300 µL. The reaction was then placed in a shaking incubator and 
incubated at 37°C and 250 rpm for 16h. 50 uL of 1 M NaOH was then added with 300 µL of 
DCM. The organic layer was extracted and concentrated in vacuo. The solid was then re-
suspended in 300 µL of a 10% IPA : 90% hexane solution and analysed by normal phase 
HPLC. For HPLC conditions see 6.4.2. Conversion reported are based on relative response 
factors determined via NMR-HPLC correlations (Figure 33) 
 
6.4.4 Procedure and pH-screen for the XDH/aldehyde oxidase catalysed oxidation of 3,4-
dihydroisoquinoline (357)  
 
3 µL of a DHIQ 356 (1M in DMF) and 33 µL catalase (3.3mg/mL) was added to 200mM 
potassium phosphate buffer. 5 µl of E.coli PaoABC (13.3mg/mL) or 50 µL of E.coli XDH 
(1.1mg/mL) was added to a final volume of 300 µL. The reaction was then placed in a 
shaking incubator and left for 16h. 300 µL of DCM was then added and the organic layer 
extracted and concentrated in vacuo. The solid was then re-suspended in 300 µL of a 10% 
IPA:90% hexane solution and analysed by normal phase HPLC. For HPLC conditions see 
6.4.2. . Conversion reported are based on relative response factors determined via NMR-
HPLC correlations (Figure 33) 
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6.4.5 Procedure for GOase-XDH cascade reactions for the synthesis of 3,4- 
dihydroisoquinolin-1(2H)-one (357). 
 
 
 
3 µL of (2-(2-aminoethyl)phenyl)methanol 358 (1M in DMF) and 33 µL catalase (3.3 
mg/mL) was added to 200 mM KPi-buffer (pH 7.0) with 103 µL of GOase M3-5 (3mg/mL) 
and 50 µL XDH (1.1 mg/mL) to a final volume of 300 µL. The reaction was then placed in a 
shaking incubator and incubated at 37°C and 250 rpm for 16h. 50 µL of 1M NaOH was then 
added and the mixture extracted with 300 uL of DCM. The organic layer was separated and 
concentrated in vacuo. The solid was then re-suspended in 300 µL of a 10% IPA : 90% 
hexane solution and analysed by normal phase HPLC. The conversion to the lactam was 69%. 
Conversion reported are based on relative response factors determined via NMR-HPLC 
correlations (Figure 33). 
 
6.4.6 Calibration curves of 2-pyrrolidone and valerolactam 
6.4.6.1 2-pyrrolidone (365) 
Solutions of 2-pyrrolidone (365) were prepared in triplicate and analysed by RP-HPLC. A 
calibration curve was then produced using the average of each molarity. HPLC conditions: 
Thermofisher ODS Hypersil C-18 column, flow-rate 1.0 mL/min, 15% MeCN : 85% H2O 
(0.1% TFA). 
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Figure 34 Calibration curve for 2-pyrrolidone (365) used for the determination of product 
concentrations in reactions with 362. 
 
6.4.6.2 Valerolactam (366) 
Solutions of valerolactam (366) were prepared in triplicate and analysed by RP-HPLC. A 
calibration curve was then produced using the average of each molarity. HPLC conditions: 
Thermofisher ODS Hypersil C-18 column, flow-rate 1.0 mL/min, 10% MeOH : 90% H2O 
(0.1% TFA) 
 
 
Figure 35 Calibration curve for valerolactam (366) used for the determination of product 
concentrations in reactions with 363. 
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6.4.7 Procedure for GOase-XDH cascade reactions for the synthesis of lactams by 
oxidative cyclisation 
 
2.1 µL of aliphatic amino alcohol 262-264 (1 M in water) and 33 µL catalase (3.3 mg/mL) 
was added to 200 mM KPi-buffer. 103 µL of GOase M3-5 or F2 (3.7 mg/mL) and 5 µL of E. 
coli PaoABC (13.3 mg/mL) or 50 µL of E. coli XDH (1.1 mg/mL) was added to give a final 
volume of 300 µL. The reaction was then placed in a shaking incubator and incubated at 37°C 
and 250 rpm for 16h. The reaction was then centrifuged at 13,000 rpm for 2 minutes and then 
analysed by RP-HPLC. Yields calculated by calibration curves of 2-pyrrolidone (365) and 
valerolactam (366) (Section 6.4.6). 
 
6.4.8 Procedure for GOase-PaoABC cascade reactions for the synthesis of 3-
phenylazetidin-2-one (371) 
 
3 µL of 3-amino-2-phenylpropan-1-ol (368) (1M in DMF) and 33 µL catalase (3.3 mg/mL) 
was added to 200 mM KPi-buffer (pH 7.0) with 103 µL of GOase M3-5 (3.7 mg/mL) and 50 
µL XDH (1.1 mg/mL) to a final volume of 300 µL. The reaction was then placed in a shaking 
incubator and incubated at 37°C and 250 rpm for 16h. 50 µL of 1M NaOH was then added 
and the reaction analysed by LC-MS. HPLC Conditions = ODS hypurity C-18, Hold 1 min 
(95% H2O + 0.1% ammonia formate : 5% MeCN)), 2.5 min (30% H2O + 0.1% ammonia 
formate : 70% MeCN), 6 min (30% H2O + 0.1% ammonia formate : 70% MeCN), 7 min 
(95% H2O + 0.1% ammonia formate : 5% MeCN), flow rate 1 mL/min. 
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6.5 Experimental procedure for chapter 5. 
 
6.5.1 Screening of XOR for the oxidation of HMF (373), DFF (374) and FFCA (377) 
The screening of suitable XOR was accomplished using a 96-well, clear, flatbottomed 
polystyrene microtitre plate in a final volume of 200 µL in potassium phosphate buffer (50 
mM, pH 7.6) containing per well: 1 mM of the respective substrate (HMF, DFF or FFCA) 
0.1mM DCPIP. 20 µL E.coli XDH solution (1.1 mg/mL stock solution), 20 µL XDH E232V 
(25.4 mg/mL), 20 µL XDH E232V/R310M (23 mg/mL) or 5 µL PaoABC (13.3 mg/mL) was 
added to each well and the activity was  assessed by eye based on the loss of blue colour. 
 
6.5.2 10 mM and 20 mM combined dual enzyme (GOase M3-5 +PaoABC) time course 
oxidation of HMF (373) to FDCA (377). 
 
To a solution of 200 mM potassium phosphate buffer (pH 7) (156 µL) and catalase 33 µL (3.3 
mg/mL) was added 3 µL or 6 µL HMF (373) (1M in MeCN). 103 µL GOase M3-5 (3.3 
mg/mL solution) and 5 µL PaoABC (13.3 mg/mL) was then added and the reaction incubated 
at 37°C in a shaking incubator. Aliquots (10 µL) of the reaction were then diluted with 50 µL 
distilled water and 10 µL 1 M HCl. The aliquot was then centrifuged and analysed by RP-
HPLC. HPLC conditions: Bio-Rad Aminex HPX-87H, 300 mm × 7.8 mm pre-packed column 
with 100% 0.005 M H2SO4 at 60°C with flow rate 0.6mL/min. 
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6.5.3 Optimisation of DFF (374) oxidation using PaoABC 
 
To a solution of potassium phosphate buffer was added DFF (374) (2M in MeCN), 33 µL 
catalase (3.3 mg/mL) and PaoABC (13.3 mg/mL), final volume 300 µL. The reaction was 
vigorously shaken and placed in a shaking incubator at 37°C. Aliquots of the reaction mixture 
were taken out, acidified with 2 M HCl and analysed by RP HPLC. HPLC Conditions: 
Thermo Fisher Hypurity C18, 98% 10 mM phosphate buffer pH 6.5, 2% MeCN with a flow 
rate of 1 mL/min. 
 
6.5.4 Preparative scale oxidation of DFF (374) with PaoABC 
To a solution of 400 mM pH 7 phosphate buffer was added DFF (374) (37 mg, 0.29 mmol), 
330 µL catalase (3.3 mg/mL), 150 µL MeCN and 50 µL PaoABC (13.3 mg/mL), final 
volume 3 mL. The reaction was vigorously shaken and placed in a shaking incubator at 37°C. 
The pH was maintained at pH 7 by the careful addition of 1 M NaOH. After this time the 
reaction was heated to 80°C for 5 minutes and left cool. The solution containing denatured 
protein was centrifuged and the supernatant removed. The supernatant was then cooled to 0°C 
and concentrated HCl was added until a precipitate formed. The solution was then centrifuged 
and the supernatant removed and the pellet washed with 1 M HCl. The pellet was dissolved in 
acetone and then concentrated in vacuo three times yielding FDCA (377) as a slight yellow 
solid (41 mg, 0.26 mmol, 90%). 1H-NMR (500 MHz, DMSO-d6) δ ppm: 13.63 (bs, 2H), 
7.29 (s, 2H) 13C (500 MHz, DMSO-d6) δ ppm: 159.4, 147.5, 118.86 
 
6.5.5 50 mM 2 step time course oxidation of HMF (373) using GOase M3-5 and PaoABC 
To a solution of 400 mM potassium phosphate buffer (pH 7) (156 µL) and catalase 33 µL (3.3 
mg/mL) was added 7.5 µL 1 (2 M in MeCN). 103 µL GOase M3-5 (3.3 mg/mL solution) was 
then added and incubated at 37°C in a shaking incubator. Aliquots (10 µL) of the reaction 
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were then diluted with 90 µL distilled water and 10 µL 1 M HCl. The aliquot was then 
centrifuged and analysed by RP-HPLC. After all 373 was oxidised, as determined by HPLC, 
5 µL PaoABC (13.3 mg/mL) was added and the reaction placed back into the shaking 
incubator and aliquots taken as previously. HPLC conditions: Bio-Rad Aminex HPX-87H, 
300 mm × 7.8 mm pre-packed column with 100% 0.005 M H2SO4 at 60°C with flow rate 0.6 
mL/min. 
 
6.5.6 Preparative scale 0.1 M HMF 3 mL oxidation procedure 
 
To a solution of 400 mM pH 7 potassium phosphate buffer (1.09 mL), MeCN (0.03mL) and 
catalase (0.33 mL of a 3.3 mg/mL solution) was added 373 (38 mg, 0.3 mmol) (final 
concentration = 100mM). GOase M3-5 (1.5 mL of a 3.3 mg/mL solution) was then added and 
the reaction shaken at 37°C in an incubated shaker for 10 h. After this time, another portion of 
catalase (0.33 mL of a 3.3 mg/mL solution) was added along with PaoABC (0.05 mL of a 
13.2 mg/mL solution) and left for another 5 h in the shaking incubator. The pH was carefully 
monitored and adjusted to pH 7 with 1 M NaOH. After this time the reaction was heated to 
80°C for 5 minutes and left to cool. The solution containing denatured protein was 
centrifuged and the supernatant removed. The supernatant was then cooled to 0°C and 
concentrated HCl was added until a precipitate formed. The solution was then centrifuged and 
the supernatant removed and the pellet washed with 1M HCl. The pellet was dissolved in 
acetone and then concentrated in vacuo three times yielding 2 as a slight yellow solid (35 mg, 
0.22 mmol, 74% yield). 1H-NMR (500 MHz, DMSO-d6) δ ppm: 13.63 (bs, 2H), 7.29 (s, 
2H) 13C (500 MHz, DMSO-d6) δ ppm: 159.4, 147.5, 118.86
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Figure 36 H NMR spectrum (500 MHz) of isolated FDCA (377) ( Signal at 7.40ppm correspond to aromatic CH of acid product, broad signal from 13.63ppm 
correspond to carboxylic acid peak.
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6.5.6 1:1:1:1 standard of HMF (373), DFF (374), HMFCA (375), FFCA (376) and FDCA 
(377) used to adjust absorbance in Chapter 6.5 
 
 
Figure 37  1:1:1:1 standard of HMF (373), DFF (374), HMFCA (375), FFCA (376) and 
FDCA (377) used to adjust absorbance in section 7.0. Peaks used in NMR are FFCA = 9.67, 
DFF = 9.51, DFF Hydrate = 9.421, HMF = 9.38, FDCA = 6.92 and HMFCA = 4.4. HPLC 
Conditions: Bio-Rad Aminex HPX-87H, 300 mm × 7.8 mm pre-packed column with 100% 
0.005 M H2SO4 at 60°C with flow rate 0.6 mL/min. 
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